
<html lang="en"     class="pb-page"  data-request-id="4085d6ad-7f85-4313-a6d6-19cddce267bb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2002.45.issue-17;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm020143r;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family" /></meta><meta name="dc.Creator" content="Anjali  Pandey,*,†" /></meta><meta name="dc.Creator" content="Deborah L.  Volkots,†" /></meta><meta name="dc.Creator" content="Joseph M.  Seroogy,†" /></meta><meta name="dc.Creator" content="Jack W.  Rose,†" /></meta><meta name="dc.Creator" content="Jin-Chen  Yu,‡" /></meta><meta name="dc.Creator" content="Joseph L.  Lambing,§" /></meta><meta name="dc.Creator" content="Athiwat  Hutchaleelaha,§" /></meta><meta name="dc.Creator" content="Stanley J.  Hollenbach,‖" /></meta><meta name="dc.Creator" content="Keith  Abe,‖" /></meta><meta name="dc.Creator" content="Neill A.  Giese,‡ and" /></meta><meta name="dc.Creator" content="Robert M.  Scarborough†" /></meta><meta name="dc.Description" content="We have previously found that the 4-[4-(N-substituted carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolines can function as potent and selective inhibitors of platelet-derived growth factor receptor ..." /></meta><meta name="Description" content="We have previously found that the 4-[4-(N-substituted carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolines can function as potent and selective inhibitors of platelet-derived growth factor receptor ..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="July 23, 2002" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm020143r" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-45-17-3772" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(02)00143-7" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2002 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm020143r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm020143r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm020143r" /></link>
        
    
    

<title>Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm020143r" /></meta><meta property="og:title" content="Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rn00001.jpeg" /></meta><meta property="og:description" content=" We have previously found that the 4-[4-(N-substituted carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolines can function as potent and selective inhibitors of platelet-derived growth factor receptor (PDGFR) phosphorylation. A series of highly potent, specific, orally active, small molecule kinase inhibitors directed against members of PDGFR receptor have been developed through modifications of the novel quinazoline template I. Systematic modifications in the A-bicyclic ring and D-rings of protype I were carried out to afford potent analogues, which display IC50 values of &lt;250 nM in cellular βPDGFR phosphorylation assays. An optimized analogue in this series, 75 (CT53518), inhibits Flt-3, βPDGFR, and c-Kit receptor phosphorylation with IC50 values of 50−200 nM, whereas 15−20-fold less potent activity against CSF-1R was observed. This analogue also inhibits autophosphorylation of Flt-3 ligand-stimulated wild-type Flt-3 and a constitutively activated Flt-3/internal tandem duplication (ITD) with IC50 values of 30−100 nM. Through this optimization process, 75 was found to be metabolically stable and has desirable pharmacokinetic properties in all animal species studied (F% &gt; 50%, T1/2 &gt; 8 h). Oral administration of 75 promotes mice survival and significantly delayed disease progression in a Flt-3/ITD-mediated leukemia mouse model and shows efficacy in a nude mouse model of chronic myelomonocytic leukemia.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm020143r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm020143r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm020143r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm020143r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm020143r&amp;href=/doi/10.1021/jm020143r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2002</span><span class="cit-fg-volume">, 45</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 3772-3793</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/45/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm0208774" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm0201767" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anjali++Pandey">Anjali Pandey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+L.++Volkots">Deborah L. Volkots</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Seroogy">Joseph M. Seroogy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jack+W.++Rose">Jack W. Rose</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin-Chen++Yu">Jin-Chen Yu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+L.++Lambing">Joseph L. Lambing</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Athiwat++Hutchaleelaha">Athiwat Hutchaleelaha</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanley+J.++Hollenbach">Stanley J. Hollenbach</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Abe">Keith Abe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neill+A.++Giese">Neill A. Giese</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Scarborough">Robert M. Scarborough</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm020143r&amp;href=/doi/10.1021%2Fjm020143r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2002</span></span><span class="cit-volume">, 45</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 3772–3793</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 23, 2002</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 April 2002</li><li><span class="item_label"><b>Published</b> online</span>23 July 2002</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 August 2002</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm020143r" title="DOI URL">https://doi.org/10.1021/jm020143r</a></div><div class="article_header-article-copyright"><strong>Copyright © 2002 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3772%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnjali%2BPandey%252C%2BDeborah%2BL.%2BVolkots%252C%2BJoseph%2BM.%2BSeroogy%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D45%26issueNum%3D17%26contentID%3Djm020143r%26title%3DIdentification%2Bof%2BOrally%2BActive%252C%2BPotent%252C%2Band%2BSelective%2B4-Piperazinylquinazolines%2Bas%2BAntagonists%2Bof%2Bthe%2BPlatelet-Derived%2BGrowth%2BFactor%2BReceptor%2BTyrosine%2BKinase%2BFamily%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3793%26publicationDate%3DAugust%2B2002">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm020143r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2311</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">92</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm020143r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anjali&quot;,&quot;last_name&quot;:&quot;Pandey&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;L. Volkots&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Seroogy&quot;},{&quot;first_name&quot;:&quot;Jack&quot;,&quot;last_name&quot;:&quot;W. Rose&quot;},{&quot;first_name&quot;:&quot;Jin-Chen&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;L. Lambing&quot;},{&quot;first_name&quot;:&quot;Athiwat&quot;,&quot;last_name&quot;:&quot;Hutchaleelaha&quot;},{&quot;first_name&quot;:&quot;Stanley&quot;,&quot;last_name&quot;:&quot;J. Hollenbach&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Abe&quot;},{&quot;first_name&quot;:&quot;Neill&quot;,&quot;last_name&quot;:&quot;A. Giese&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Scarborough&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2002&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;45&quot;,&quot;pages&quot;:&quot;3772-3793&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm020143r&quot;},&quot;abstract&quot;:&quot;We have previously found that the 4-[4-(N-substituted carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolines can function as potent and selective inhibitors of platelet-derived growth factor receptor (PDGFR) phosphorylation. A series of highly potent, specific, orally active, small molecule kinase inhibitors directed against members of PDGFR receptor have been developed through modifications of the novel quinazoline template I. Systematic modifications in the A-bicyclic ring and D-rings of protype I were carried out to afford potent analogues, which display IC50 values of &lt;250 nM in cellular βPDGFR phosphorylation assays. An optimized analogue in this series, 75 (CT53518), inhibits Flt-3, βPDGFR, and c-Kit receptor phosphorylation with IC50 values of 50−200 nM, whereas 15−20-fold less potent activity against CSF-1R was observed. This analogue also inhibits autophosphorylation of Flt-3 ligand-stimulated wild-type Flt-3 and a constitutively activated Flt-3/internal tandem duplication (ITD) with IC50 values of 30−1&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm020143r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm020143r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm020143r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm020143r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm020143r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm020143r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm020143r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm020143r&amp;href=/doi/10.1021/jm020143r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm020143r" /></input><a href="/doi/pdf/10.1021/jm020143r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (282 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm020143r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm020143r%26sid%3Dliteratum%253Aachs%26pmid%3D12166950%26genre%3Darticle%26aulast%3DPandey%26date%3D2002%26atitle%3DIdentification%2Bof%2BOrally%2BActive%252C%2BPotent%252C%2Band%2BSelective%2B4-Piperazinylquinazolines%2Bas%2BAntagonists%2Bof%2Bthe%2BPlatelet-Derived%2BGrowth%2BFactor%2BReceptor%2BTyrosine%2BKinase%2BFamily%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D45%26issue%3D17%26spage%3D3772%26epage%3D3793%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/45/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have previously found that the 4-[4-(N-substituted carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolines can function as potent and selective inhibitors of platelet-derived growth factor receptor (PDGFR) phosphorylation. A series of highly potent, specific, orally active, small molecule kinase inhibitors directed against members of PDGFR receptor have been developed through modifications of the novel quinazoline template <b>I</b>. Systematic modifications in the A-bicyclic ring and D-rings of protype <b>I</b> were carried out to afford potent analogues, which display IC<sub>50</sub> values of <250 nM in cellular βPDGFR phosphorylation assays. An optimized analogue in this series, <b>75</b> (CT53518), inhibits Flt-3, βPDGFR, and c-Kit receptor phosphorylation with IC<sub>50</sub> values of 50−200 nM, whereas 15−20-fold less potent activity against CSF-1R was observed. This analogue also inhibits autophosphorylation of Flt-3 ligand-stimulated wild-type Flt-3 and a constitutively activated Flt-3/internal tandem duplication (ITD) with IC<sub>50</sub> values of 30−100 nM. Through this optimization process, <b>75</b> was found to be metabolically stable and has desirable pharmacokinetic properties in all animal species studied (<i>F</i>% > 50%, <i>T</i><sub>1/2</sub> > 8 h). Oral administration of <b>75</b> promotes mice survival and significantly delayed disease progression in a Flt-3/ITD-mediated leukemia mouse model and shows efficacy in a nude mouse model of chronic myelomonocytic leukemia. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm020143rAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Tel.:  650-244-6950. Fax:  650-244-9287. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7716191d161b1e2807161913120e371a071e5914181a59">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm020143rAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Medicinal Chemistry Department.</p></span></div><div class="fnGroupItem" id="jm020143rAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Biology Department.</p></span></div><div class="fnGroupItem" id="jm020143rAF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Drug Metabolism Pharmacokinetic Department.</p></span></div><div class="fnGroupItem" id="jm020143rAF5"><span><h4><span class="NLM_fn-symbol">‖</span></h4></span><span><p class="last">  In Vivo Sciences.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The platelet-derived growth factor receptor (PDGFR) family belongs to the large family of receptor tyrosine kinases (RTK) that are characterized by an extracellular ligand-binding region, a single transmembrane spanning region, and intracellular tyrosine kinase domains.<sup><a onclick="showRef(event, 'jm020143rb00001'); return false;" href="javascript:void(0);" class="ref jm020143rb00001">1</a></sup> PDGFRs are contained within the RTK type III subfamily that is distinguished by five immunoglobin-like repeats in the extracellular domain and a split tyrosine kinase in the intracellular domain.<sup><a onclick="showRef(event, 'jm020143rb00002'); return false;" href="javascript:void(0);" class="ref jm020143rb00002">2</a></sup> Abnormal PDGF-induced cell proliferation has been proposed to lead to proliferative disorders such as atherosclerosis, restenosis following percutaneous coronary intervention, glomerulosclerosis, liver cirrhosis, and certain cancers.<sup><a onclick="showRef(event, 'jm020143rb00003 jm020143rb00004 jm020143rb00005 jm020143rb00006 jm020143rb00007'); return false;" href="javascript:void(0);" class="ref jm020143rb00003 jm020143rb00004 jm020143rb00005 jm020143rb00006 jm020143rb00007">3-7</a></sup> The members of the PDGFR family include αPDGFR and βPDGFR, colony-stimulating factor 1 receptor (CSF-1R), Flt-3, and c-Kit.<sup><a onclick="showRef(event, 'jm020143rb00008'); return false;" href="javascript:void(0);" class="ref jm020143rb00008">8</a></sup> Within this kinase subfamily, mutated c-Kit has been identified in mastocytosis, acute myelogenous leukemia (AML), and gastrointestinal stromal tumors.<sup><a onclick="showRef(event, 'jm020143rb00009 jm020143rb00010 jm020143rb00011'); return false;" href="javascript:void(0);" class="ref jm020143rb00009 jm020143rb00010 jm020143rb00011">9-11</a></sup> Flt-3 is expressed on blasts in most patients with AML.<sup><a onclick="showRef(event, 'jm020143rb00012'); return false;" href="javascript:void(0);" class="ref jm020143rb00012">12</a></sup> Internal tandem duplication (ITD) mutations of Flt-3 have been found in ∼30% of AML patients.<sup><a onclick="showRef(event, 'jm020143rb00013'); return false;" href="javascript:void(0);" class="ref jm020143rb00013">13</a></sup> These mutations constitutively activate the receptor and appear to be associated with poor prognosis, making Flt-3 kinase inhibition an attractive therapeutic strategy.<sup><a onclick="showRef(event, 'jm020143rb00014'); return false;" href="javascript:void(0);" class="ref jm020143rb00014">14</a></sup> Other studies have identified chromosomal translocations involving the βPDGFR in chronic myelomonocyctic leukemia (CMML).<sup><a onclick="showRef(event, 'jm020143rb00015'); return false;" href="javascript:void(0);" class="ref jm020143rb00015">15</a></sup></div><div class="NLM_p last">Several adenosine 5‘-triphosphate (ATP) competitive inhibitors of PDGFR phosphorylation have been previously reported including 3-arylquinolines,<sup><a onclick="showRef(event, 'jm020143rb00016'); return false;" href="javascript:void(0);" class="ref jm020143rb00016">16</a></sup> 3-arylquinoxalines,<sup><a onclick="showRef(event, 'jm020143rb00017'); return false;" href="javascript:void(0);" class="ref jm020143rb00017">17</a></sup> phenylaminopyrimidines,<sup><a onclick="showRef(event, 'jm020143rb00018'); return false;" href="javascript:void(0);" class="ref jm020143rb00018">18</a></sup> pyrazoles,<sup><a onclick="showRef(event, 'jm020143rb00019'); return false;" href="javascript:void(0);" class="ref jm020143rb00019">19</a></sup> and phenylbenzimidazoles derivatives<sup><a onclick="showRef(event, 'jm020143rb00020'); return false;" href="javascript:void(0);" class="ref jm020143rb00020">20</a></sup> (Figure 1<a data-tab="pane-pcw-Figures" href="#jm020143rf00001" id="" class=" internalNav"></a>). We recently demonstrated that CT52923 (<b>II</b>, Figure 1), an analogue within this novel series of 4-[4-(N-substituted thiocarbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolines, is a potent inhibitor of PDGF receptor phosphorylation.<sup><a onclick="showRef(event, 'jm020143rb00021'); return false;" href="javascript:void(0);" class="ref jm020143rb00021">21</a></sup> Previous structure−activity studies in this series have identified structural features of these inhibitors that contribute to their specific βPDGFR inhibitory activity including electron-donating substitutions at the 6- and 7-positions in the A-ring of the quinazoline ring and a piperazinylurea or the piperazinylthiourea moiety attached at the 4-position of the quinazoline that is critical for inhibitory potency and PDGFR family specificity.<sup>21b</sup><b><sup>,</sup></b><sup><a onclick="showRef(event, 'jm020143rb00022'); return false;" href="javascript:void(0);" class="ref jm020143rb00022">22</a></sup> Additionally, one hydrogen atom on the nitrogen of the urea/thiourea moiety, an unsubstituted piperazine B-ring, and bulky hydrophobic functionality at the 4-position on the phenyl D-ring give optimal kinase antagonists. Despite extensive knowledge concerning this pharmacophore, analogues with appropriate pharmaceutical properties have not been identified to date. In this paper, we will present our efforts within the 4-piperazinylquinazoline class of PDGFR family inhibitors involving efforts to increase the potency of analogues in human plasma, obtaining and retaining appropriate kinase specificity of analogues, and <a name="jm004501703773" id="jm004501703773"></a> achieving desirable pharmacokinetic properties including high oral bioavailability and long plasma half-life. <div id="_i4"><figure id="jm020143rf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Known class of PDGFR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As depicted in Scheme 1<a data-tab="pane-pcw-Figures" href="#jm020143rh00001" id="" class=" internalNav"></a>, compounds <b>3</b>−<b>14</b> were prepared by treatment of the known 6,7-bismethoxyethoxy chloroquinazoline <b>1</b><sup><a onclick="showRef(event, 'jm020143rb00023'); return false;" href="javascript:void(0);" class="ref jm020143rb00023">23</a></sup> with Boc-piperazine followed by removal of the Boc-protecting group to afford <b>2</b>, followed by urea formation. Four protocols were used to synthesize urea analogues from various para-substituted anilines (Scheme 1). Condensation of <b>2</b> with commercially available isocyanates was carried out in either dichloromethane or dimethylformamide (DMF) (method A). Treatment of various anilines with <i>N</i>,<i>N</i>‘-disuccinimidyl carbonate (DSC) in the presence of triethylamine in dichloromethane, followed by reaction with intermediate <b>2</b>, was used to provide the desired ureas (method B). Sequential carbonylation of anilines with triphosgene in the presence of triethylamine, followed by addition of <b>2</b> in situ, also gave the desired ureas (method C). Heating <b>2</b> with various 4-nitrophenylcarbamates, which were individually prepared by reacting the corresponding anilines with 4-nitrophenylchloroformate in the presence of triethylamine, also provided the ureas (method D). <div id="_i7"><figure id="jm020143rh00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00001.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Boc-piperazine, K<sub>2</sub>CO<sub>3</sub>, DMF, 65 °C, 6 h. (b) 4 N HCl/dioxane. (c) Method A:  R-PhNCO, CH<sub>2</sub>Cl<sub>2</sub> or DMF; method B:  (i) R-NH<sub>2</sub>, DSC, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (ii) Compound <b>2</b>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; method C:  (i) R-PhNH<sub>2</sub>, triphosgene, Et<sub>3</sub>N, CH<sub>3</sub>CN; (ii) Compound <b>2</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN; method D:  (i) R-PhNH<sub>2</sub>, 4-NO<sub>2</sub>Ph-OCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (ii) Compound <b>2</b>, heat.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The synthesis of 6-H,7-methoxyethoxy analogues <b>19</b>, <b>21</b>, and <b>23</b> was achieved via the intermediate <b>17 </b>(Scheme 2<a data-tab="pane-pcw-Figures" href="#jm020143rh00002" id="" class=" internalNav"></a>), which was synthesized starting from 7-fluoro-3<i>H</i>-quinazolin-4-one (<b>15</b>).<sup><a onclick="showRef(event, 'jm020143rb00024'); return false;" href="javascript:void(0);" class="ref jm020143rb00024">24</a></sup> The 7-fluoro-3<i>H</i>-quinazolin-4-one was reacted with methoxyethoxyethanol to afford quinazolin-4-one (<b>16</b>), followed by chlorination and piperazine addition to give (<b>17</b>) (Scheme 2). The urea linkage formed in the final products was again achieved by reaction of <b>17</b> using the methods described in Scheme 1. <div id="_i9"><figure id="jm020143rh00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00002.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) HCONH<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, 140 °C, o/n. (b) 2-Methoxy ethanol, NaH, DMF, 90 °C. (c) POCl<sub>3</sub>, 110 °C. (d) Piperazine, <i>i</i>PrOH, reflux, 2 h. (e) See Scheme 1 urea formation.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The synthesis of 6,7-disubstituted analogues <b>29</b>−<b>32</b> is shown in Scheme 3<a data-tab="pane-pcw-Figures" href="#jm020143rh00003" id="" class=" internalNav"></a>, where ethyl 3-hydroxy-4-fluorobenzoate is alkylated with chloroethylpiperidine or chloroethyl morpholine followed by displacement of the fluoro group by the anion of 2-methoxyethanol to provide esters <b>25a</b>,<b>b</b>. The regiospecific nitration of <b>25a</b> or <b>25b</b> and subsequent reduction of the nitro groups resulted in amino esters <b>26a</b>,<b>b</b>. The cyclization of amino esters <b>26a</b> or <b>26b</b> with formamide yielded the quinazolinone intermediates <b>27a</b>,<b>b</b>, which were subsequently chlorinated with thionyl chloride in the presence of a catalytic amount of DMF to afford the corresponding 4-chloroquinazolines. These reactive intermediates were subsequently reacted with Boc-piperazine followed by deprotection to give the 4-piperazinylquinazolines <b>28a</b>,<b>b</b>. The final urea linkage formation was achieved by one of the methods as described in Scheme 1. <div id="_i11"><figure id="jm020143rh00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00003.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) 1-(2-Chloroethyl)piperidine or 1-(2-chloroethyl)morpholine, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 6 h. (b) 2-Methoxy ethanol, NaH, DMF, 90 °C. (c) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, AcOH, −5 °C to room temperature. (d) 10% Pd/C. (e) HCONH<sub>2</sub>, HCO<sub>2</sub>NH, reflux, 12 h. (f) SOCl<sub>2</sub>, catalytic DMF, 60 °C. (g) Boc-piperazine, isopropanol, reflux. (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>. (i) See Scheme 1 urea formation.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The synthesis of isomeric intermediates with basic groups at the C-7 position of the quinazoline nucleus (analogues <b>37</b>−<b>40)</b> is shown in Scheme 4<a data-tab="pane-pcw-Figures" href="#jm020143rh00004" id="" class=" internalNav"></a>. Ethyl 3-hydroxy-4-fluorobenzoate was alkylated with 2-methoxyethyl bromide followed by displacement of the fluorine atom with the anion of 2-piperidin-1-yl or 2-morpholin-<a name="jm004501703774" id="jm004501703774"></a> 1-yl ethanol to give intermediates <b>33a</b>,<b>b</b>. The same reaction sequence utilized in Scheme 3 was followed to achieve the synthesis of final products. <div id="_i13"><figure id="jm020143rh00004" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00004.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Methoxyethoxy bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 6 h. (b) 2-Piperidin-1-yl-ethanol or 2-morpholin-1-yl ethanol or 2-pyrrolin-1-yl ethanol, NaH, DMF, 90 °C. (c) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, AcOH, −5 °C to room temperature. (d) 10% Pd/C. (e) HCONH<sub>2</sub>, HCO<sub>2</sub>NH, reflux, 12 h. (f) SOCl<sub>2</sub>, catalytic DMF, 60 °C. (g) Boc-piperazine, isopropanol, reflux. (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>. (i) See Scheme 1 urea formation. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The synthesis of 6-methoxy-7-substituted analogues is represented in Scheme 5<a data-tab="pane-pcw-Figures" href="#jm020143rh00005" id="" class=" internalNav"></a>. Commercially available vanillic acid was dibenzylated followed by nitration to afford intermediate <b>41</b>. The nitroester intermediate <b>41</b> was then reduced and cyclized with formamide to form the quinazolinone ring, followed by chlorination to afford intermediate <b>42</b>. The chloro group was displaced with <a name="jm004501703775" id="jm004501703775"></a> Boc-piperazine followed by debenzylation under hydrogenation conditions to afford intermediate <b>43</b>. The intermediate <b>43</b> was alkylated with 2-chloroethyl <i>p</i>-toluenesulfonate for C-2-linked analogues (Table 4) and with 3-chloropropyl <i>p</i>-toluenesulfonate for C-3-linked analogues to afford intermediates <b>44a</b>,<b>b</b>, respectively (Table 5). The chloroalkyl intermediates <b>44a</b>,<b>b</b> were condensed with various secondary amines. The final urea-linked analogues <b>45</b>−<b>55</b> and<b> 60</b>−<b>87</b> were synthesized as described in earlier schemes. These analogues were also synthesized via an alternate route described in Scheme 6<a data-tab="pane-pcw-Figures" href="#jm020143rh00006" id="" class=" internalNav"></a>. Ethylvanillate was alkylated with 2-chloroethyl <i>p</i>-toluenesulfonate for C-2-linked analogues (Table 4) and with 1-bromo-3-chloropropane for C-3-linked analogues (Table 5) to afford intermediates <b>56a</b>,<b>b</b>, respectively (Scheme 6). The chloroalkyl intermediates were then condensed with various secondary amines, followed by nitration and subsequent reduction to provide intermediate aminoesters <b>57a</b>,<b>b</b>, respectively. Cyclization with formamide afforded the corresponding quinazolinones <b>58a</b>,<b>b</b>, which were subsequently chlorinated to give 4-Cl-quinazoline intermediates <b>59a</b>,<b>b</b>. The 4-chloro group was displaced in the presence of potassium carbonate in DMF with piperazine-1-carboxylic acid(4-cyanophenyl)amide or piperazine-1-carboxylic acid(4-isopropoxyphenyl)amide to give analogues <b>45</b>−<b>55 </b>and <b>60</b>−<b>87</b>. <div id="_i15"><figure id="jm020143rh00005" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00005.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, room temperature. (b) HNO<sub>3</sub>, AcOH, 0−100 °C, o/n. (c) SnCl<sub>2</sub>, 2H<sub>2</sub>O, EtOAc, 50 °C, o/n. (d) HCONH<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, 145 °C, 12 h. (e) SOCl<sub>2</sub>, catalytic DMF, toluene, reflux. (f) Boc-piperazine, DIEA, THF, 40 °C, o/n. (g) Pd(OH)<sub>2</sub>/C, EtOH, 50 psi H<sub>2</sub>, o/n. (h) Chloroethyl tosylate for <i>n</i> = 0 and chloropropyl tosylate for <i>n</i> = 1, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, o/n. (i) R1 = basic moiety such as piperidine etc., DMF, 80 °C. (j) 4 N HCl, dioxane. (k) Substituted anilines; methods A−D as in Scheme 1. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm020143rh00006" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00006.jpeg" id="_i17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) For <i>n</i> = 0, chloroethyl tosylate or for <i>n</i> = 1, 1-bromo-3-chloropropane, K<sub>2</sub>CO<sub>3</sub>, DMF, reflux. (b) HNO<sub>3</sub>, AcOH, 0−20 °C. (c) R<sub>1</sub> = basic substituent, K<sub>2</sub>CO<sub>3</sub>, <i>n</i>Bu<sub>4</sub>NBr, toluene, 90 °C. (d) 10% Pd/C, HCO<sub>2</sub>K, EtOH, H<sub>2</sub>O. (e) HCONH<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, 135 °C, 12 h. (f) SOCl<sub>2</sub>, catalytic DMF, toluene, reflux. (g) K<sub>2</sub>CO<sub>3</sub>, DMF, toluene, 45 °C, 8 h. (h) EtOH, AcCl. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">The synthesis of 6-methoxy-7-alkyoxysulfone-substituted analogues (Table 6) is outlined in Scheme 7<a data-tab="pane-pcw-Figures" href="#jm020143rh00007" id="" class=" internalNav"></a>. The intermediate <b>43</b> was alkylated with 3-chloropropyl <i>p</i>-toluenesulfonate followed by displacement with various alkylthiolates to afford the thioether intermediate <b>88</b>. The thioether <b>88</b> was then oxidized with <i>m</i>-chloroperbenzoic acid to afford the respective sulfones, followed by deprotection and urea formation as described in earlier schemes. <div id="_i18"><figure id="jm020143rh00007" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00007.jpeg" id="_i19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Chloropropyl tosylate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, o/n. (b) R<sub>1</sub>SH, NaH, or KHMDS, THF, room temperature. (c) <i>m</i>CPBA, DCM, room temperature. (d) 4 N HCl, dioxane. (e) DSC, Et<sub>3</sub>N, DCM.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previous studies have identified a new class of potent and selective inhibitors of PDGFR phosphorylation containing the 4-[4-(N-substituted-carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline nucleus.<sup>21</sup> The quinazoline and pyrimidine nucleus appeared to us to be attractive for lead optimization as this template has been previously exploited to develop orally active EGFR tyrosine kinase inhibitors that are currently in clinical <a name="jm004501703776" id="jm004501703776"></a> trials (Figure 2<a data-tab="pane-pcw-Figures" href="#jm020143rf00002" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm020143rb00025 jm020143rb00026 jm020143rb00027 jm020143rb00028 jm020143rb00029'); return false;" href="javascript:void(0);" class="ref jm020143rb00025 jm020143rb00026 jm020143rb00027 jm020143rb00028 jm020143rb00029">25-29</a></sup> Despite the promising biological activity within this novel series of PDGFR inhibitors, the initial 6,7-dimethoxyquinazoline-4-piperazinyl urea series of analogues, in most cases, displayed poor aqueous solubility. We additionally found that many of these analogues were unstable in vitro in human liver microsomes (HLM) and their potency was diminished as much as 50-fold when their cellular activity was measured in the presence of human plasma. <div id="_i21"><figure id="jm020143rf00002" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00002.jpeg" id="_i22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 EGFR tyrosine kinase inhibitors in clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">In this paper, we report our efforts toward increasing RTK potency in plasma, achieving good kinase specificity, and achieving desirable pharmacokinetic properties including high oral bioavailability and long plasma half-life. We initiated the structure−activity relationship (SAR) exploration of the A-bicyclic ring, the C-urea linkage, and the D-ring to extensively characterize and optimize the properties of this series. All of the analogues synthesized were evaluated for their inhibition of βPDGFR phosphorylation using the known cell-based assay.<sup><a onclick="showRef(event, 'jm020143rb00030'); return false;" href="javascript:void(0);" class="ref jm020143rb00030">21,30</a></sup> It should be pointed out from the start that the SAR obtained from such cell-based assays potentially report a combination of intrinsic activity of compounds against the kinase target modulated by the ability of compounds to permeate the cell wall during the assay. Because the ultimate goal of our study was to identify compounds that can effectively inhibit RTK activity intracellularly, the cell-based assay was believed sufficient to develop a robust SAR to guide drug candidate selection. </div><div class="NLM_p"><b>1. D-Ring Modifications. </b>To improve the kinase inhibitory activity and aqueous solubility characteristics in the series, we initially utilized a strategy of incorporation of methoxyethoxy side chains at the 6,7-positions of the quinazoline nucleus. A similar strategy has previously provided improved physical properties of EGFR inhibitors.<sup><a onclick="showRef(event, 'jm020143rb00031'); return false;" href="javascript:void(0);" class="ref jm020143rb00031">31</a></sup> As shown in Table 1<a class="ref showTableEvent internalNav" data-ID="jm020143rt00001" href="#jm020143rt00001"></a>, substitutions were simultaneously explored in the phenyl D-ring within the 6,7-dimethoxyethoxy quinazoline series. Our previous investigation of various substituents on the D-phenyl ring indicated that bulky hydrophobic substitution at the 4-position increased kinase inhibitory activity.<sup>22</sup> Similar to previous observations, the activity of 4-<i>tert</i>-butyl analogue (<b>3</b>) was significantly improved as compared with the 4-CN analogue (<b>4</b>) in this new series. The bulky 4-phenoxy derivative (<b>10</b>) also showed potent activity. Unfortunately, the stability of the 4-<i>tert</i>-butyl analogue (<b>3</b>) and the 4-phenoxy analogues (<b>10</b>) in HLM was not encouraging (<i>T</i><sub>1/2</sub> < 10 min).  Nevertheless, the high potency shown by bulky substituents at the 4-position of the phenyl group prompted us to <a name="jm004501703777" id="jm004501703777"></a> evaluate additional compounds in this series. The addition of small substituents on the 4-phenoxy ring analogue was found to be acceptable, such as <i>p</i>-methyl (<b>12</b>) and <i>p</i>-Br (<b>13</b>), since both substituents retained good <a name="jm004501703778" id="jm004501703778"></a> inhibitory activity. However, the <i>p</i>-<i>tert</i>-butyl analogue (<b>11</b>) showed a 6-fold reduced activity. Even more hydrophobic and bulky substituents such as 5-isoquinolyoxy (<b>6</b>), 2-naphthoxy (<b>7</b>), and 4-indolyoxy (<b>8</b>) retained good potency (IC<sub>50</sub> < 150 nM). Within the 6,7-dimethoxyethoxy quinazoline series, the general observations were that hydrophobic bulky urea analogues showed absolute increases in potency in cell assays containing human plasma and increased aqueous solubility over the previous 6,7-dimethoxy series. However, there was still a considerable shift in the obtained IC<sub>50</sub> values depending on whether the assays were run in the presence or absence of plasma (Table 1). This presumably can be attributed to the high plasma protein binding properties of the analogues since the compounds were found to be stable under the assay conditions (Table 1). This series of specific substitutions on the phenyl ring also resulted in derivatives with low stability in rat and HLM (<i>T</i><sub>1/2</sub> = 6−20 min), most likely attributable to several sites of potential metabolism. Taking this in vitro data into account, it was not surprising to find that this series of analogues did not display desirable pharmacokinetic properties in the rat, where we were targeting the oral bioavailability of compounds to be greater than 20% and the plasma half-life to be >3 h (data not shown). Of interest in this series was the observation that the 4-CN (<b>4</b>) and 4-isopropoxy (<b>14</b>) substitutents in the D-ring afford the most metabolically stable analogues (<i>T</i><sub>1/2</sub> = 70−90 min). <div class="NLM_table-wrap" id="jm020143rt00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Inhibitory Activity in β-PDGFR Phosphorylation Assay</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00001a.gif" alt="" id="_i23" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Autophosphorylation was measured in intact cells using two site ELISA as described elsewhere.<sup>21,29</sup> Assay conditions for PDGFR phosphorylation in the presence and absence of plasma are described in the Experimental Section. IC<sub>50</sub> values are expressed as the average of at least three determinations. The average error for the determinations was ±15%.<i><sup>b</sup></i><sup></sup> HLM assay.</p></div></div></div><div class="NLM_p"><b>2. A-Ring Modifications. </b>As shown in Table 2<a class="ref showTableEvent internalNav" data-ID="jm020143rt00002" href="#jm020143rt00002"></a>, we also investigated the 6-H,7-methoxyethoxy and 6-OMe,7-methoxyethoxy substitution pattern in the A-ring in order to potentially increase the stability in liver microsomes and attain optimal PK properties since preliminary studies suggested that demethylation within the 6,7-dimethoxy series was a potential liability. Unfortunately, the 6-H,7-methoxyethoxy analogue resulted in a 4.5-fold lower potency (<b>23</b> vs <b>22</b>). In the case of bulky hydrophobic substituents in the D-ring, the 6-H and 6-methoxy analogues were shown to have similar potency in the phosphorylation assay (<b>18</b> vs <b>19 </b>and<b> 20 </b>vs<b> 21</b>). The corresponding human liver microsomal half-life of 6-H,7-substituted series of compounds was found to be 25−33 min, which was modestly longer than the 6,7-dimethoxyethoxy series. The 4-cyano analogue <b>22 </b>and the 4-isopropoxy analogue <b>24</b> again displayed greater stability in HLM (<i>T</i><sub>1/2</sub> = 80−110 min). <div class="NLM_table-wrap" id="jm020143rt00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Inhibitory Activity in β-PDGFR Phosphorylation Assay</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00002a.gif" alt="" id="_i24" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a,b</sup></i><sup></sup> See Table 1.</p></div></div></div><div class="NLM_p">In efforts to improve the aqueous solubility in this series, we also investigated the addition of basic solubilizing functionality at either the C-6 or C-7 side chains of the quinazoline ring system since there have been several reports in the kinase inhibitor literature wherein the addition of a 3-morpholinoalkoxy group at either C-6 or C-7 of various 4-anilinoquinazolines results in not only improved aqueous solubility but also improved cellular activity.<sup><a onclick="showRef(event, 'jm020143rb00032 jm020143rb00033 jm020143rb00034'); return false;" href="javascript:void(0);" class="ref jm020143rb00032 jm020143rb00033 jm020143rb00034">32-34</a></sup> In our series, various basic groups were introduced into the alkoxy side chains, a versatile way to modify physical properties over a wide range of basicity and lipophilicity. The basic amine side chains were appended to either the C-6 or the C-7 of the methoxyethoxy series (Table 3<a class="ref showTableEvent internalNav" data-ID="jm020143rt00003" href="#jm020143rt00003"></a>). Because of early observations that 4-CN and 4-isopropoxy D-ring substitution <a name="jm004501703779" id="jm004501703779"></a> afforded analogues with greatly improved liver microsome stability (analogues <b>4</b>, <b>14</b>, <b>22</b>, and <b>24</b>), these D-ring substitutions were kept constant. The morpholine-containing analogues (<b>29 </b>and<b> 30</b>) at the C-6 position resulted in equal or lower potency in the phosphorylation assay as compared to <b>4 </b>and<b> 14</b>, respectively. The piperidine-substituted analogues (<b>31</b> and <b>32</b>) at the C-6 side chain significantly improved the potency in comparison to the morpholine analogues (<b>29</b> and <b>30</b>). The piperidine-containing analogue with the isopropoxy group in the D-ring was 20-fold more potent than the morpholine-containing analogue (<b>32</b> vs <b>30</b>). Placing the piperidine-containing side chain at the C-7 alkoxy side chain resulted in enhancement of potency by at least 4-fold (<b>37</b> vs <b>31</b>). The piperidine-containing side chain placed at either the 6- or the 7-position in the D-ring isopropoxy series resulted in similar potent analogues (<b>38</b> vs <b>32</b>). Because the morpholine-containing side chains in the 6-substituted analogues resulted in decreased potency, we did not synthesize the corresponding analogues with morpholine-containing C-7 side chain in the 6,7-disubstituted series. In this series, the isopropoxy D-ring substitution afforded analogues with greatly improved liver microsome stability (analogues <b>31</b>, <b>32</b>, and <b>40</b>). <div class="NLM_table-wrap" id="jm020143rt00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  In Vitro Activity for 6,7-Disubstituted Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00003a.gif" alt="" id="_i25" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a,b</sup></i><sup></sup> See Table 1.</p></div></div></div><div class="NLM_p">In another series, various C-7 basic groups with a fixed ethylene unit were examined with a constant 6-methoxy group and 4-cyanophenyl urea moieties (Table 4<a class="ref showTableEvent internalNav" data-ID="jm020143rt00004" href="#jm020143rt00004"></a>). The morpholine-containing analogue in this series resulted in nearly equivalent potency in the plasma-containing cellular assay (<b>45</b> vs <b>22</b>), whereas the piperidine-containing analogue resulted in a 7-fold increase in potency (<b>46</b> vs <b>22</b>). The 4-hydroxypiperidine-containing analogue resulted in 33-fold lower potency as compared to the piperidine-containing analogue (<b>47</b> vs <b>46</b>). The 4-piperidone-containing analogue (<b>49</b>) had similar potency as the methoxyethoxy analogue (<b>22</b>) and was found to be 6-fold less potent than the piperidine-containing analogue <b>46</b>. The pyrrolidine-containing analogue (<b>53</b>) was found to be more potent than methoxy analogue <b>22</b> but was 3-fold less potent than the corresponding piperidine analogue (<b>46</b>). Substitution of the side chain with less basic aromatic amines such as pyrrole and imidazole resulted in 4−9-fold lower potency (<b>54</b> and <b>55</b> vs <b>22</b>). The substitution with piperazine resulted in 12-fold lower potency (<b>50</b> vs <b>22</b>). Other basic groups studied were found to be detrimental to the activity in this series or not as potent as the piperidine-containing analogues. We also examined the same basic side chains at C-7 in analogues containing a 4-<a name="jm004501703781" id="jm004501703781"></a> isopropoxyphenylurea D-region. The SAR was found to be subtly different than the 4-cyanophenylurea series. In this series, the piperidine and morpholine-containing analogues are of similar potency (<b>60</b> vs <b>61</b>). The substitution with the less basic triazole moiety resulted in 3−5-fold lower potency. The substitution with 1-tetrazole (<b>68</b>) resulted in 10-fold lower potency, whereas 2-fold lower potency was observed with the 2-tetrazole substitution (<b>69</b>). The basic and/or heteroaromatic substituents such as imidazole, pyrrole, triazole, and tetrazole in the C-7 alkoxy side chain resulted in decreases in potency to various degrees (<b>54</b>,<b> 55</b>, <b>62</b>−<b>65</b>, and <b>68</b>). These results are distinct from the observations for a different class of quinazoline VEGFR inhibitors where the heteroaromatic substituents such as imidazole and triazole at the C-7 alkoxy side chain led to very potent submicromolar kinase inhibitors and afforded high plasma levels in mice after oral administration.<sup>34</sup><div class="NLM_table-wrap" id="jm020143rt00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  In Vitro Activity for the C-2-Linked Basic Unit at the C-7 Position</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00004a.gif" alt="" id="_i26" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><sup><i>a</i>,<i>b</i></sup> Same as Table 1.</p></div></div></div><div class="NLM_p"><b>Three Carbon-Linked Basic Functionality at C-7. </b>To optimize the potency of this class of compounds further, we explored the methylene unit extension of the C-7 alkoxy side chain (Table 5<a class="ref showTableEvent internalNav" data-ID="jm020143rt00005" href="#jm020143rt00005"></a>). The 7-morpholinopropoxy analogue resulted in 10-fold increased potency as compared to the 7-morpholinoethoxy analogue (<b>71</b> vs <b>45</b>). A similar improvement in kinase inhibitory activity has been reported in a series of anilinoquinazoline VEGF RTK inhibitors where 7-propoxy linkers were found to be more potent than ethoxy or butoxy linkers.<sup>34</sup> The piperidinepropoxy analogue shows a 3-fold increase in potency (<b>75</b> vs <b>61</b>). In the propoxy series, we also found a lower potency of analogues with aromatic basic functionality in the C-7 position (<b>73</b>, <b>74</b>, <b>78</b>, and <b>79</b>). The 4-isopropoxyphenylurea-containing D-ring analogues are in general 3−8-fold more potent than the corresponding 4-cyanophenylurea-containing D-ring analogues. The potency of the analogues in this series was not appreciably affected by the presence of plasma, suggesting that these analogues may have significantly lower plasma protein binding. For example, the IC<sub>50</sub> values of <b>75</b> in MG63 cells are 26 and 36 nM in the absence and in the presence of plasma, respectively. As it is well-documented in the literature, the oral absorption of drugs is often greatly effected by the basicity of the molecule. The predicted p<i>K</i><sub>a</sub> of the basic units in the propoxy-containing side chain is approximately two units higher than the ethoxy-containing side chain analogues. Therefore, to reduce the basicity of the piperidine ring, 3- and 4-difluoropiperidine rings were also explored as the basic side chain units in order to modulate their basicity. The fluoropiperidine-containing analogues (<b>80</b>−<b>82</b>) were found to retain potency (IC<sub>50</sub> < 150 nM), but their in vitro liver microsomal stability was surprisingly short (<i>T</i><sub>1/2</sub> < 10 min). Interestingly, when we replaced the basic piperidine functionality by a cyclohexyl ring wherein the basic charge has been removed, a very weakly active analogue (<b>83</b>) was obtained. This observation strongly suggests that the basic C-7 side chain has requisite interactions with the kinase. The substitution with 4-methylpiperidine (<b>84</b> and <b>85</b>) and 2-methylpiperidine (<b>86</b> and <b>87</b>) in the C-7 side chain also results in highly potent analogues (IC<sub>50</sub> value < 50 nM, Table 5). The 2- and 4-methylpiperidine-containing analogues were also found to be reasonably stable in vitro in HLM (<i>T</i><sub>1/2</sub> = 30−106 min). The βPDGFR phosphorylation assay shows that many of the compounds reported in this series are very potent inhibitors (Table 5, IC<sub>50</sub> < 200 nM). <div class="NLM_table-wrap" id="jm020143rt00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  In Vitro Activity for the C-3-Linked Basic Unit at the C-7 Position</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00005a.gif" alt="" id="_i27" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a,b</sup></i><sup></sup> See Table 1.</p></div></div></div><div class="NLM_p">Additional analogues with other hydrophilic substituents such as hydroxyl, amidine, imidazoline, and proline carboxylic acid substitutions in the C-7 side chain were also prepared and resulted in weakly active analogues, suggesting that introduction of hydrophilic substituents other than tertiary amines is unfavorable at this position (Table 6<a class="ref showTableEvent internalNav" data-ID="jm020143rt00006" href="#jm020143rt00006"></a>). <div class="NLM_table-wrap" id="jm020143rt00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  In Vitro Activity for 7-Hydrophilic-Substituted Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00006a.gif" alt="" id="_i28" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a,b</sup></i><sup></sup> See Table 1.</p></div></div></div><div class="NLM_p">To obtain potent, stable analogues that did not rely on using a basic functionality in the C-7 side chain, various sulfones were also explored as polar, nonbasic C-7 propoxy side chains. The analogues displayed potency in the following order:  <i>iso</i>-butyl sulfone > <i>iso-</i>pentyl = <i>n</i>-butyl = <i>n</i>-propyl > Et > Me (Table 7<a class="ref showTableEvent internalNav" data-ID="jm020143rt00007" href="#jm020143rt00007"></a>). Unfortunately, the sulfone analogues did not approach the potency of the most active amine-containing analogues and did not have the desired in vivo pharmacokinetic properties (<i>F</i>% < 10%, <i>T</i><sub>1/2</sub> < 2 h). <div class="NLM_table-wrap" id="jm020143rt00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  In Vitro Activity for 7-Substituted Sulfone Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143ru00007a.gif" alt="" id="_i29" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a,b</sup></i><sup></sup> See Table 1.</p></div></div></div><div class="NLM_p"><b>C</b><b>-</b><b>Linkage Modifications. </b>In addition to A-ring and D-ring modifications, we also examined the replacement of the urea linkage by the isosteric thiourea unit as has been previously reported.<sup>21</sup> These analogues showed good inhibitory activity for βPDGFR phosphorylation. Most of the benzylthiourea and arylthiourea analogues are highly specific inhibitors of βPDGFR and c-Kit kinases, whereas 30−300-fold higher concentrations were required for these analogues to inhibit Flt-3 and CSF-1R and will be the subject of a separate publication. </div><div class="NLM_p"><b>In Vitro Characterization for Kinase Selectivity. </b>Some of the more potent compounds prepared were also evaluated for inhibitory activity on related PDGFR kinase family members including c-Kit, Flt-3, and CSF-1R tyrosine kinases using previously reported methods.<sup>21,30</sup> As shown in Table 8<a class="ref showTableEvent internalNav" data-ID="jm020143rt00008" href="#jm020143rt00008"></a>, these compounds inhibited Flt-3, βPDGFR, and c-Kit receptor autophosphorylation with IC<sub>50</sub> values of 50−200 nM and were 15−30-fold less potent against CSF-1R. As shown in Table 8, the IC<sub>50</sub> value of <b>75</b> on PDGFR phosphorylation measured in Chinese hamster ovary (CHO) cells is 200 nM, as compared to that of 26 nM in MG63 cells (Table 5). The difference may in part be due to a 5−10-fold higher level of PDGFR in CHO transfectants than in MG63 cells. To our surprise and gratification, we found that the cyano-substituted D-ring analogues <b>84</b> and <b>86</b> with 2- and 4-methylpiperidine substitution at the C-7 position inhibited βPDGFR and c-Kit with IC<sub>50</sub> values of <150 nM, whereas 30−60-fold higher concentration was required to inhibit Flt-3 kinase. By contrast, the 2- and 4-methylpiperidine analogues <b>85</b> and <b>87 </b>with an isopropoxy D-ring inhibited βPDGFR, c-kit, and Flt-3 receptor autophosphorylation with IC<sub>50</sub> values of 20−200 nM. These observations with kinase specificity suggest that specific substitution in the D-ring has important enzyme interactions that may be influenced by the electronics of this ring. The presence of basic side chains at the C-7 position leads to improved inhibitory activity, good aqueous solubility, improved bioavailability in all species studied, and reduced protein binding. <div class="NLM_table-wrap" id="jm020143rt00008"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 8.  Specificity Analysis of the Potent Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">βPDGFR IC<sub>50</sub> (μM)<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">c-Kit IC<sub>50</sub> (μM)<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">Flt-3 IC<sub>50</sub> (μM)<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">CSF-1R IC<sub>50</sub> (μM)<i><sup>a</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">24 </td><td class="colsep2 rowsep2">0.20 </td><td class="colsep2 rowsep2">0.19 </td><td class="colsep2 rowsep2">0.45 </td><td class="colsep2 rowsep2">5.46 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">61 </td><td class="colsep2 rowsep2">0.25 </td><td class="colsep2 rowsep2">0.11 </td><td class="colsep2 rowsep2">0.07 </td><td class="colsep2 rowsep2">3.43 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">75 (CT53518) </td><td class="colsep2 rowsep2">0.20 </td><td class="colsep2 rowsep2">0.17 </td><td class="colsep2 rowsep2">0.22 </td><td class="colsep2 rowsep2">3.43 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">76 </td><td class="colsep2 rowsep2">0.10 </td><td class="colsep2 rowsep2">0.06 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">1.40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">84 </td><td class="colsep2 rowsep2">0.073 </td><td class="colsep2 rowsep2">0.004 </td><td class="colsep2 rowsep2">1.91 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">85 </td><td class="colsep2 rowsep2">0.039 </td><td class="colsep2 rowsep2">0.021 </td><td class="colsep2 rowsep2">0.128 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">86 </td><td class="colsep2 rowsep2">0.150 </td><td class="colsep2 rowsep2">0.006 </td><td class="colsep2 rowsep2">8.79 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">87 </td><td class="colsep2 rowsep2">0.074 </td><td class="colsep2 rowsep2">0.016 </td><td class="colsep2 rowsep2">0.200 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">STI571 </td><td class="colsep2 rowsep2">0.24 </td><td class="colsep2 rowsep2">0.26 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">0.96</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> CHO cell lines expressing wild-type βPDGFR or βPDGFR/c-Kit, βPDGFR/Flt-3, and βPDGFR/CSF-1R chimeric receptors were grown to confluency in 96 well microtiter plates under standard tissue culture conditions. Phosphorylation assays were performed as described for βPDGFR phosphorylation assay in MG63 cells.</p></div></div></div><div class="NLM_p">The kinase specificity profiles of <b>84</b> and <b>86</b> demonstrate that they are highly specific βPDGFR inhibitors and have similar profiles to STI571 (Gleevec), which inhibits βPDGFR and c-Kit but not Flt-3 or CSF-1R.<sup><a onclick="showRef(event, 'jm020143rb00035'); return false;" href="javascript:void(0);" class="ref jm020143rb00035">35</a></sup><a name="jm004501703783" id="jm004501703783"></a> The analogues <b>23</b>, <b>61</b>, <b>75 </b>(CT53518), <b>76</b>, and <b>85</b> were selected for further in vitro and in vivo characterization because of their potent inhibition of Flt-3, their βPDGFR inhibition, and their stability in HLM. Other RTKs, cytoplasmic tyrosine kinases, serine/threonine kinases, or other members of the MAPK pathways were not found to be significantly inhibited at 100−1000-fold higher concentrations of <b>75</b> and <b>76 </b>(Table 9<a class="ref showTableEvent internalNav" data-ID="jm020143rt00009" href="#jm020143rt00009"></a>). Analogues <b>75 </b>(CT53518) and <b>76</b> were also found to inhibit autophosphorylation of a constitutively activated Flt3/ITD mutant expressed in hematopoietic cells or AML cell lines with an IC<sub>50</sub> value of 30−100 nM (data not shown). <div class="NLM_table-wrap" id="jm020143rt00009"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 9.  IC<sub>50</sub> Values of <b>75</b> and <b>76</b> on Various Kinases</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"><b>75</b> (CT53518)</td><td class="colsep2 rowsep2">76</td><td class="colsep2 rowsep2">staurosporin</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">I. RTKs </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">KDR </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">0.08 μM </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EFGR </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">FGFR </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">0.42 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">InsR </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2"><0.3</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">II. Non-RTKs </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Src </td><td class="colsep2 rowsep2">30 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">0.07 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Abl </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">0.10</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">III. Ser/Thr Kinases </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKC, PKA </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">0.08</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">IV. MAP and MAPK Kinases </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Mek1, Mkk4, Mkk6, Erk2, p38 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2">>30 </td><td class="colsep2 rowsep2"><1</td></tr></tbody></table></div></div></div><div class="NLM_p"><b>In Vivo Characterization. </b>Several of the more potent and metabolically stable analogues (IC<sub>50</sub> < 300 nM, <i>T</i><sub>1/2</sub> (HLM) > 40 min) were also evaluated in vivo. Pharmacokinetic properties of these compounds were obtained from studies in rats, dogs, and monkeys following intravenous and oral administration (Figures 3<a data-tab="pane-pcw-Figures" href="#jm020143rf00003" id="" class=" internalNav"></a> and 4<a data-tab="pane-pcw-Figures" href="#jm020143rf00004" id="" class=" internalNav"></a> and Table 10<a class="ref showTableEvent internalNav" data-ID="jm020143rt00010" href="#jm020143rt00010"></a>). The oral bioavailability of analogues <b>23</b>,<b> 61</b>,<b> 75</b>,<b> 76</b>, and<b> 85</b> following oral dosing ranged from 19 to 100% depending upon the species evaluated. At the oral doses examined, plasma levels <a name="jm004501703784" id="jm004501703784"></a> of these compounds were maintained well above their IC<sub>50</sub> values. Maximum plasma concentrations obtained for <b>23</b>, <b>61</b>, <b>75</b>, <b>76</b>, and <b>85</b> were 762, 414, 256, 49.2, and 82.3 ng/mL, respectively. Apparent terminal half-lives for <b>61</b>, <b>75</b> (CT53518), and <b>85</b> were relatively long (>7 h). Analogue <b>75</b> displayed a consistently long half-life in rats, dogs, and monkeys (<i>T</i><sub>1/2</sub> > 10 h) and good oral bioavailability (>50%). It also maintained plasma concentrations above its IC<sub>50</sub> value for 24 h (Figure 4). <div id="_i30"><figure id="jm020143rf00003" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00003.jpeg" id="_i31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Semilogarithmic plots of dose-normalized plasma concentration−time profiles of selected analogues following oral administration to Lewis rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm020143rf00004" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00004.jpeg" id="_i32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Semilogarithmic plots of mean (±SD) plasma concentration−time profiles of <b>75</b> (CT53518) following an oral administration to Cynomolgus monkeys (5 mg/kg) and Beagle dogs (7.5 mg/kg). </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm020143rt00010"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 10.  Pharmacokinetic Data for Selected Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2"><b>61</b></td><td class="colsep2 rowsep2"><b>75</b> (CT53518)</td><td class="colsep2 rowsep2"><b>76</b></td><td class="colsep2 rowsep2"><b>85</b></td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Rat </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose iv/po<i> </i>(mg/kg) </td><td class="colsep2 rowsep2">1.5/5 </td><td class="colsep2 rowsep2">1/30 </td><td class="colsep2 rowsep2">10/30 </td><td class="colsep2 rowsep2">1.5/5 </td><td class="colsep2 rowsep2">2/20 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>F</i> (%) </td><td class="colsep2 rowsep2">72.1 </td><td class="colsep2 rowsep2">125 </td><td class="colsep2 rowsep2">23.8 </td><td class="colsep2 rowsep2">20.8 </td><td class="colsep2 rowsep2">24.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>T</i><sub>1/2</sub> (h) </td><td class="colsep2 rowsep2">1.38 </td><td class="colsep2 rowsep2">8.32 </td><td class="colsep2 rowsep2">10.6 </td><td class="colsep2 rowsep2">2.76 </td><td class="colsep2 rowsep2">11.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>C</i><sub>max</sub> (ng/mL) </td><td class="colsep2 rowsep2">762 </td><td class="colsep2 rowsep2">414 </td><td class="colsep2 rowsep2">256 </td><td class="colsep2 rowsep2">49.2 </td><td class="colsep2 rowsep2">82.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">AUC<sub>PO</sub> (ng·h/mL) </td><td class="colsep2 rowsep2">1580 </td><td class="colsep2 rowsep2">4412 </td><td class="colsep2 rowsep2">1700 </td><td class="colsep2 rowsep2">176 </td><td class="colsep2 rowsep2">1150</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Dog </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose iv/po<i> </i>(mg/kg) </td><td class="colsep2 rowsep2">0.5/5 </td><td class="colsep2 rowsep2">0.5/5 </td><td class="colsep2 rowsep2">2/7.5 </td><td class="colsep2 rowsep2">0.5/5 </td><td class="colsep2 rowsep2">2/5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>F</i> (%) </td><td class="colsep2 rowsep2">73.6 </td><td class="colsep2 rowsep2">13.5 </td><td class="colsep2 rowsep2">97.6 </td><td class="colsep2 rowsep2">63.3 </td><td class="colsep2 rowsep2">65.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>T</i><sub>1/2</sub> (h) </td><td class="colsep2 rowsep2">1.36 </td><td class="colsep2 rowsep2">14.3 </td><td class="colsep2 rowsep2">14.3 </td><td class="colsep2 rowsep2">7.16 </td><td class="colsep2 rowsep2">7.64 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>C</i><sub>max</sub> (ng/mL) </td><td class="colsep2 rowsep2">1498 </td><td class="colsep2 rowsep2">43.0 </td><td class="colsep2 rowsep2">481 </td><td class="colsep2 rowsep2">183 </td><td class="colsep2 rowsep2">113 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">AUC<sub>PO</sub><i> </i>(ng·h/mL) </td><td class="colsep2 rowsep2">4250 </td><td class="colsep2 rowsep2">387 </td><td class="colsep2 rowsep2">2690 </td><td class="colsep2 rowsep2">1390 </td><td class="colsep2 rowsep2">696</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Monkey </td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose iv/po (mg/kg) </td><td class="colsep2 rowsep2">0.5/5 </td><td class="colsep2 rowsep2">0.5/10 </td><td class="colsep2 rowsep2">0.5/5 </td><td class="colsep2 rowsep2">0.5/5 </td><td class="colsep2 rowsep2">1/25 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>F</i> (%) </td><td class="colsep2 rowsep2">26.6 </td><td class="colsep2 rowsep2">38.8 </td><td class="colsep2 rowsep2">48.9 </td><td class="colsep2 rowsep2">18.9 </td><td class="colsep2 rowsep2">40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>T</i><sub>1/2</sub> (h) </td><td class="colsep2 rowsep2">0.70 </td><td class="colsep2 rowsep2">6.30 </td><td class="colsep2 rowsep2">16.6 </td><td class="colsep2 rowsep2">2.60 </td><td class="colsep2 rowsep2">14.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>C</i><sub>max</sub> (ng/mL) </td><td class="colsep2 rowsep2">636 </td><td class="colsep2 rowsep2">386 </td><td class="colsep2 rowsep2">317 </td><td class="colsep2 rowsep2">135 </td><td class="colsep2 rowsep2">703.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">AUC<sub>PO</sub> (ng·h/mL) </td><td class="colsep2 rowsep2">1250 </td><td class="colsep2 rowsep2">3080 </td><td class="colsep2 rowsep2">2920 </td><td class="colsep2 rowsep2">663 </td><td class="colsep2 rowsep2">16100 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">in vitro<i> T</i><sub>1/2 </sub>(min) in human liver microsomes </td><td class="colsep2 rowsep2">110 </td><td class="colsep2 rowsep2">85 </td><td class="colsep2 rowsep2">285 </td><td class="colsep2 rowsep2">25 </td><td class="colsep2 rowsep2">106</td></tr></tbody></table></div></div></div><div class="NLM_p">On the basis of these data, we chose to demonstrate the in vivo efficacy of <b>75</b>, and we have tested it in two different mouse leukemia models by oral dosing. One is a nude mouse CMML model using Baf3 cells expressing Tel/βPDGFR chimera, which had been found in a subset of CMML patients and can confer IL-3-independent cell proliferation in vitro.<sup><a onclick="showRef(event, 'jm020143rb00036'); return false;" href="javascript:void(0);" class="ref jm020143rb00036">36</a></sup> As shown in Figure 5<a data-tab="pane-pcw-Figures" href="#jm020143rf00005" id="" class=" internalNav"></a>, injection of 1 × 10<sup>6</sup> cells into nude mice caused all animals to die within 20−46 days. Oral gavage of <b>75</b> (CT53518) at 60 mg/kg, twice daily, from day 7 to day 42 significantly delayed mice death with a <i>p</i> < 0.0005. The treated animals did not begin to die until day 40. However, additional deaths occurred in the treated group as late as day 60. These studies provide a “proof of principle” that oral treatment with analogue <b>75 </b>(CT53518) can provide an effective treatment for CMML-like disease in animals. <div id="_i33"><figure id="jm020143rf00005" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00005.jpeg" id="_i34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Improved survival in mouse CMML model with oral administration of <b>75 </b>(CT53518).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Up to 30% of AML patients harbor an ITD within the juxtamembrane domain of the Flt-3 RTK causing constitutive receptor activation. Because <b>75</b> and <b>76</b> are potent inhibitors of Flt-3, we also analyzed their efficacy in a Flt-3/ITD-mediated leukemia mouse model. We found that oral administration of <b>75</b> (CT53518) and <b>76</b> significantly delayed disease progression and promoted mice survival in a dose-dependent manner.<sup><a onclick="showRef(event, 'jm020143rb00037'); return false;" href="javascript:void(0);" class="ref jm020143rb00037">37</a></sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Kinase inhibition represents a novel mechanism-based approach to selectively block signaling pathways that are known to mediate disease processes. The highly successful clinical trials employing Gleevec for the treatment of CML have validated kinase inhibition as <a name="jm004501703785" id="jm004501703785"></a> a therapeutic strategy in oncology.<sup><a onclick="showRef(event, 'jm020143rb00038 jm020143rb00039'); return false;" href="javascript:void(0);" class="ref jm020143rb00038 jm020143rb00039">38,39</a></sup> Our synthetic efforts have focused on preparing PDGFR family specific kinase antagonists from an initial series of 4-piperazinyl quinazolines. Our goals were to enhance the intrinsic potency of this series in human plasma, retain the appropriate kinase specificity of analogues, and achieve desirable pharmacokinetic properties including oral bioavailability and long plasma half-life. Novel piperazinylquinazolines possessing 4-phenylurea substituents, a C-6 methoxy, and a wide range of basic C-7 substituents were found to be nanomolar inhibitors of PDGF RTK enzymes. Through this SAR study and compound optimization, we have identified a specific, potent, orally active piperazinylquinazoline class of inhibitors directed against selected members of the PDGFR family. These analogues are equivalent in potency for βPDGFR, c-Kit, and Flt-3. Analogues <b>84</b> and <b>86</b> are highly specific for βPDGFR and c-Kit, whereas 30−60-fold higher concentrations were required for these analogues to inhibit Flt-3 kinase. Analogues <b>75</b> (CT53518) and <b>85</b> have desirable pharmacokinetic properties in the animal species studied (<i>F</i>% > 50%, <i>T</i><sub>1/2</sub> > 8 h). The oral administration of <b>75</b> (CT53518) at 60 mg/kg showed significant delay in murine death in the nude mouse model of CMML. Oral administration of <b>75</b> (CT53518) and <b>76</b> significantly delayed disease progression and promoted survival in a dose-dependent manner in a Flt-3/ITD-mediated leukemia mouse model. On the basis of the in vitro activity of <b>75</b> (CT53518), its microsomal stability, oral bioavailability, and half-life in vivo, we have chosen it as a development candidate for clinical study. Our data support the development of the small molecule RTK inhibitor such as <b>75</b> (CT53518), initially as a potential treatment of AML due to its inhibition of Flt-3/ITD mutants. This strategy may be extended to the treatment of other diseases that are mediated by the PDGFR family of RTKs. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><sup>1</sup>H nuclear magnetic resonance (NMR) spectra were recorded on a Varian Unity +400 spectrometer unless otherwise noted. Low-resolution mass spectra were recorded with a HP 1100-MSD LC-MS spectrometer. High-resolution mass spectra (HRMS) were recorded with a VG ZAB2-EQ high-resolution mass spectrometer and performed at the University of California, Berkeley. Normal phase silica gel (EM Science, Silica Gel 60) was used for chromatography. Final compounds were purified by reversed phase high-performance liquid chromatography (HPLC) using a Waters 4000Prep, Waters 490E multiwavelength detector, and Vydac 218TP1022 column (10 μm, C<sub>18</sub>, 22 mm × 250 mm). Purity of the compounds was confirmed by two diverse HPLC systems using Waters 600 controller, Waters 996 photodiode array detector, and Vydac 201HS54 column (5 μm, C<sub>18</sub>, 4.6 mm × 250 mm). Analytical HPLC run using 214 nm for detection. HPLC no. 1-Gradient method using a Keystone Beta Basic column (C18, 4.6 mm × 50 mm) or HPLC no. 2-Isocratic method using Keystone Beta Basic column (C18, 4.6 mm × 250 mm). <i>K</i>‘ is the percentage of CH<sub>3</sub>CN employed in the H<sub>2</sub>O mixture with 0.1% trifluoroacetic acid (TFA). The new compounds synthesized were characterized by mass spectrometry (MS) and NMR, and purity was determined by HRMS and two HPLC systems. We did not obtain melting points and elemental analyses of these compounds as most of the derivatives were amorphous and only small amounts were synthesized. </div><div class="NLM_p">The typical synthetic methods for urea formation are described as follows. </div><div class="NLM_p"><b>Method A.</b> A mixture of <b>2</b> (1 mmol) and 4-cyanophenylisocyanate (2 mmol) in DMF (10 mL) was stirred overnight at room temperature. The reaction mixture was poured into water, and then, saturated sodium chloride solution (100 mL) was added. The aqueous layer was extracted with ethyl acetate. The ethyl acetate layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to yield the title compound as a crude residue. This was purified by reversed-phase (RP)-HPLC to afford the title compound <b>4</b> as an off-white solid (0.112 g, 40%). </div><div class="NLM_p"><b>Method B. </b>To the tetrahydrofuran (THF)/DCM (1:1.5 mL) solution of 4-(1<i>H</i>-indol-4yloxy)phenylamine (2 mmol) was added slowly a DCM solution of <i>N</i>,<i>N</i>‘-disuccinimidyl carbonate (2.1 mmol) and triethylamine. The reaction mixture was stirred at room temperature for 30 min. To this was added rapidly a dichloromethane solution (5 mL) of <b>2</b> (2 mmol) and triethylamine (2 mmol), and this reaction mixture was stirred at room temperature overnight. The solvent was evaporated, and the residue was purified by RP-HPLC to afford title compound <b>8</b>. </div><div class="NLM_p"><b>Method C.</b> To a solution of triphosgene (0.45 mmol) in acetonitrile (3 mL) at −5 °C was added a acetonitrile (5 mL) solution of 4-(quinolin-5-yloxy)phenylamine (1.35 mmol) and triethylamine (2.25 mmol) over a period of 15 min. The mixture was stirred for an additional 30 min and then was slowly treated with a acetonitrile (5 mL) solution of <b>2</b> (1.35 mmol) and triethylamine (2.25 mmol). The reaction mixture was slowly warmed to room temperature and stirred overnight. The mixture was diluted with ethyl acetate and washed with water and brine, dried over anhydrous sodium sulfate, filtered, and evaporated to give crude residue. The crude residue was purified by RP-HPLC to afford <b>5</b>. </div><div class="NLM_p"><b>Method D.</b> To a solution of 4-<i>tert</i>-butylamine (0.680 mL, 1.5 mmol) in NMP (10 mL) were added 4-nitrophenyl chloroformate (0.44 g, 2.2 mmol) and triethylamine (1.50 mL, 10.95 mmol) under cooling with ice bath. After the reaction mixture was stirred for 2 h, <b>2</b> (0.30 g, 1.1 mmol) was added and heated at 80 °C for 6 h. The reaction mixture was cooled to room temperature and then poured into water, extracted with ethyl acetate, and dried over sodium sulfate. The residue after evaporation of solvent was purified by RP-HPLC to give compound <b>3</b> (490 mg, 83%). </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-</b><b><i>tert</i></b><b>-Butylphenyl)amide</b><b>(3).</b> Compound <b>3</b> was synthesized using method D as a yellow fluffy solid (0.075 g, 70%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 8.63 (s, 1H), 7.20 (s, 2H), 4.26 (t, 2H, CH<sub>3</sub>OCH<sub>2</sub>C<i>H</i><sub>2</sub>O), 4.22 (t, 2H, CH<sub>3</sub>OC<i>H</i><sub>2</sub>CH<sub>2</sub>O), 3.83 (t, 4H), 3.59 (t, 4H), 3.45 (s, 6H), 3.06 (t, 4H). MS (ES):  538 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 538.3029; found, 538.3015. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (4). </b>Yield 60% using method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.5 (s, 1H), 7.5 (m, 5H), 7.10 (s, 1H), 4.3 (m, 8H), 3.8 (m, 8H), 3.34 (s, 6H). MS (ES):  507 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 507.2355; found, 507.2351. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(Quinolin-5-yloxy)phenyl]amide (5). (a) 4-(Quinolin-5-yloxy)phenylamine.</b> To a dimethyl sulfoxide (DMSO, 7 mL) solution of 5-hydroxyquinoline (0.519 g, 3.58 mmol) under argon at room temperature was added NaH (0.184 g, 4.61 mmol), and the resultant yellow solution was stirred for 1 h at ambient temperature. 1-Fluoro-4-nitrobenzene (0.50 g, 3.54 mmol) was slowly added to the reaction and was heated at 90 °C under argon for 8 h. No starting material was detected by thin-layer chromatography (TLC) and RP-HPLC. The reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate was dried (MgSO<sub>4</sub>), filtered, and evaporated to afford crude residue. The crude residue was purified by silica gel chromatography eluting with 50%EtOAc/Hexane/2%MeOH to afford 5-(4-nitrophenoxy)quinoline as a yellow solid (689 mg, 80%). MS (ES):  267 (M + H)<sup>+</sup>. The nitro compound (0.67 g, 2.52 mmol) was dissolved in EtOH (5 mL) and EtOAc (5 mL). To this solution was added 10% Pd/C (100 mg), and it was hydrogenated under 1 atm for 2.5 h. This mixture was filtered through Celite, and the filtrate was concentrated to afford the desired <a name="jm004501703786" id="jm004501703786"></a> 4-(quinolin-5-yloxy)phenylamine as a yellow solid (580 mg, 98.3%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.87−8.81 (m, 1H), 7.75 (d, 1H, <i>J</i> = 8.4 Hz), 7.68−7.48 (m, 3H), 6.92−6.85 (m, 2H), 6.82−6.70 (m, 3H). MS (ES):  625 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(b)</b><b>Compound</b><b>5.</b> Yield 40% using method C. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 9.41 (d, 1H, <i>J</i> = 8.4 Hz), 9.19 (d, 1H, <i>J</i> = 4.8 Hz), 8.64 (s, 1H), 8.02 (dd, 1H, <i>J</i> = 5, 8.6 Hz), 7.96 (t, 1H, <i>J</i> = 8.2 Hz), 7.85 (d, 1H, <i>J</i> = 8.4 Hz), 7.61 (s, 1H), 7.55 (d, 2H, <i>J</i> = 8.4 Hz), 7.23 (s, 1H), 7.18 (d, 2H, <i>J</i> = 8.8 Hz), 7.10 (d, 1H, <i>J</i> = 7.6 Hz), 4.40−4.36 (m, 8H), 3.88−3.82 (m, 8H), 3.45 (s, 6H). MS (ES):  625 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 625.2774; found, 625.2770. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(Isoquinolin-5-yloxy)phenyl]amide (6). </b>Yield 40% using method C and 4-(isoquinolin-5-yloxy)phenylamine for the urea formation. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 9.81 (s, 1H), 8.79 (d, 1H, <i>J</i> = 6.6 Hz), 8.62 (s, 1H), 8.61 (d, 1H, <i>J</i> = 6.6 Hz), 8.17 (d, 1H, <i>J</i> = 8.4 Hz), 7.90 (t, 1H, <i>J</i> = 8.0 Hz), 7.85, 7.59 (s, 1H), 7.53 (d, 2H, <i>J</i> = 8.8 Hz), 7.23 (s, 1H), 7.44 (d, 1H, <i>J</i> = 8.0 Hz), 7.30 (s, 1H), 7.15 (d, 2H, <i>J</i> = 8.8 Hz), 4.38−4.32 (m, 8H), 3.87−3.80 (m, 8H), 3.45 (s, 6H). MS (ES):  625.3 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 625.27804; found, 625.2776. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(Naphthalen-2-yloxy)phenyl]amide (7). </b>Compound <b>7</b> was synthesized as a white solid (30 mg, 65%) using method C and 4-(naphthalen-2-yloxy)phenylamine instead of 4-(quinolin-5-yloxy)phenylamine. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.58 (s, 1H), 7.81−7.75 (m, 2H), 7.63−7.61 (d, 1H, <i>J</i> = 8 Hz), 7.55−7.53 (d, 1H, <i>J</i> = 8 Hz), 7.38−7.32 (m, 4H), 7.18−7.16 (m, 3H), 6.98−6.96 (d, 2H, <i>J</i> = 8 Hz), 4.38−4.31 (m, 8H), 3.85−3.79 (m, 8H), 3.40 (s, 6H). MS (ES):  624.3 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 624.2831; found, 624.2826. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(1</b><b><i>H</i></b><b>-Indol-4-yloxy)phenyl]amide (8). </b>Compound <b>8</b> was synthesized as a white solid (25 mg, 30%) using method C employing 4-(1<i>H</i>-indol-4-yloxy)phenylamine instead of 4-(quinolin-5-yloxy)phenylamine. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.54 (s, 1H), 7.51 (s, 1H), 7.23−7.21 (d, 2H, <i>J</i> = 8 Hz), 7.13 (s, 1H), 7.10−7.08 (d, 1H, <i>J</i> = 8 Hz), 7.06−7.05 (d, 1H, <i>J</i> = 4 Hz), 6.96−6.92 (t, 1H, <i>J</i> = 8 Hz), 6.85−6.83 (d, 2H, <i>J</i> = 8 Hz), 6.46−6.44 (d, 1H, <i>J</i> = 8 Hz), 6.187−6.181 (d, 1H, <i>J</i> = 2.4 Hz), 4.29−4.25 (m, 8H), 3.78−3.73 (m, 8H), 3.37 (s, 6H). MS (ES):  613.3 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 613.2774; found, 613.2779. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(2,3-Dihydro-1</b><b><i>H</i></b><b>-indol-4-yloxy)phenyl]amide (9). </b>Compound <b>9</b> was synthesized using method B as a creamy solid (0.050 g, 51%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.54 (s, 1H), 7.52 (s, 1H), 7.37−7.35 (dd, 2H, <i>J</i> = 2, 6.5 Hz), 7.32 (t, 1H, <i>J</i> = 8 Hz), 7.16 (s, 1H), 7.14 (t, 1H, <i>J</i> = 8 Hz), 6.93−6.90 (dd, 2H, <i>J</i> = 2, 6.5 Hz), 6.84−6.82 (d, 1H, <i>J</i> = 1, 8 Hz), 4.28−4.27 (m, 8H), 3.77−3.76 (m, 10H), 3.56 (m, 2H), 3.36 (s, 6H). MS (ES):  615 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 615.2931; found, 615.2930. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Phenoxyphenyl)amide (10).</b> Compound <b>10</b> was synthesized as a shiny white solid (132 mg, 88%) using method C employing 4-phenoxyaniline. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.61 (s, 1H), 7.58 (s, 1H), 7.35 (d, 2H, <i>J</i> = 8.8 Hz), 7.29 (t, 2H, <i>J</i> = 7.8 Hz), 7.21 (s, 1H), 7.04 (t, 1H, <i>J</i> = 7.2 Hz), 6.92 (d, 2H, <i>J</i> = 7.6 Hz), 6.91 (d, 2H, <i>J</i> = 8.8 Hz), 4.38−4.30 (m, 8H), 3.81−3.78 (m, 8H), 3.43 (s, 6H). MS (ES):  593 (M + Na)<sup>+</sup>, 574 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(4-</b><b><i>tert</i></b><b>-Butylphenoxy)phenyl]amide (11).</b> Compound <b>11</b> was synthesized as a light yellow solid (34 mg, 80%) using method C. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.55 (s, 1H), 7.52 (s, 1H), 7.29−7.25 (m, 4H), 7.15 (s, 1H), 6.84−6.79 (m, 4H), 4.38−4.27 (m, 8H), 3.79−3.73 (m, 8H), 3.37 (s, 6H). MS (ES):  630.3 (M + H)<sup> +</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 630.3291; found, 630.3289. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-</b><b><i>p</i></b><b>-Tolyloxyphenyl)amide (12).</b> Compound <b>12</b> was synthesized as a shiny white solid (50 mg, 28%) using method C and employing 4-(<i>p</i>-tolyloxy)phenylamine, which was synthesized by the same method as described for compound <b>5</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.53 (s, 1H), 7.49 (s, 1H), 7.25−7.23 (d, 2H, <i>J</i> = 8 Hz), 7.15 (s, 1H), 7.04−7.02 (d, 2H, <i>J</i> = 8 Hz), 6.80−6.78 (d, 2H), 6.75−6.73 (d, 2H, <i>J</i> = 8 Hz), 4.26 (m, 8H), 3.76−3.74 (m, 8H), 3.35 (s, 6H), 2.20 (s, 3H). MS (ES):  588.3 (M + H)<sup> +</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 588.2822; found, 588.2820. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>[4-(4-Bromophenoxy)phenyl]amide (13). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.56 (s, 1H), 7.41−7.38 (m, 2H), 7.231 (s, 1H), 6.93 (d, 2H, <i>J</i> = 8.0 Hz), 6.85 (d, 2H, <i>J</i> = 8.0 Hz), 4.36 (m, 8H), 3.83 (m, 8H), 3.43 (s, 6H). MS (ES):  654.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6,7-Bis-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (14). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.58 (s, 1H), 7.23−7.21 (d, 2H, <i>J</i> = 8 Hz), 7.21 (s, 1H), 6.83−6.81 (d, 2H, <i>J</i> = 8.8 Hz), 6.80−6.78 (d, 2H, <i>J</i> = 8.8 Hz), 6.75−6.73 (d, 2H, <i>J</i> = 8 Hz), 4.51 (hept, 1H), 4.36−4.31(m, 8H), 3.85−3.78 (m, 8H), 3.43 (s, 6H), 1.27 (d, 6H). MS (ES):  540 (M + H)<sup> +</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 540.2822; found, 540.2815. </div><div class="NLM_p"><b><i>N</i></b><b>-</b><b>(4-Indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}c</b><b>arboxamide (18). (a) </b><b><i>tert</i></b><b>-Butyl-4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinecarboxylate. </b>To a DMF (300 mL) solution of the vanillic acid (25 g, 149 mmol) were added K<sub>2</sub>CO<sub>3</sub> (102.7 g, 744 mmol) and BnBr (44.2 g, 372 mmol), and the resulting suspension was stirred at room temperature overnight. The reaction mixture was filtered, EtOAc was added, and the solution was washed with brine, dried, and concentrated. Purification on silica gel chromatography eluting with 10% EtOAc/hexane gave 55 g (96%) of the bis-benzylated product. </div><div class="NLM_p">To a CH<sub>2</sub>Cl<sub>2</sub> solution (100 mL) of the bis-benzyl-protected material (20 g, 57.4 mmol) at −10 °C was slowly added acetic acid (100 mL). To this cold solution was slowly added concentrated HNO<sub>3</sub> (25.8 mL, 574.4 mmol), and the reaction was warmed to room temperature followed by reflux overnight at 100 °C. After it was cooled, it was poured into ice, extracted with EtOAc, washed with brine, and dried with MgSO<sub>4</sub>. The solvent was removed under vacuum to afford the desired intermediate product as a yellow solid (21.8 g, 96.5%). MS (ES):  416 (M + Na). </div><div class="NLM_p">To the EtOAc solution (100 mL) of this nitro derivative (10.9 g, 27.7 mmol) was added SnCl<sub>2</sub>·H<sub>2</sub>O (18.7 g, 83.1 mmol), and the reaction mixture was heated at 50 °C overnight. After it was cooled, the reaction mixture was filtered through Celite, and the filtrate was washed with 10% NaHCO<sub>3</sub> and extracted with EtOAc. The organic layers were dried and evaporated to afford the intermediate amino product as a brown solid (9.5 g, 95%). MS (ES):  364 (M + H)<sup>+</sup>. </div><div class="NLM_p">The amino product (3 g, 8.3 mmol) was dissolved in formamide (20 mL), to this was added ammonium formate (0.781 g, 12.4 mmol), and the reaction mixture was heated at 150 °C for 4 h. During this time period, the SM was consumed as evaluated by HPLC. After it was cooled, the reaction was poured into water to afford a creamy precipitate. The precipitate was collected by filtration, which is the desired intermediate, 7-benzyloxy-6-methoxy-4-quinazolinone (1.9 g, 81%). MS (ES):  283(M + H)<sup>+</sup>. </div><div class="NLM_p">A mixture of 7-benzyloxy-6-methoxy-4-quinazolinone (1 g, 3.5 mmol), thionyl chloride (5 mL), and DMF (0.5 mL) was heated at reflux for 4 h. After the mixture was cooled, excess thionyl chloride was removed by evaporation and the residue was azeotroped with toluene to afford the intermediate, 4-chloro-6-methoxy-7-benzyloxyquinazoline <b>42</b>, as a yellow solid (0.652 g, 62%). MS (ES):  301 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a THF solution (20 mL) of 4-chloro-6-methoxy-7-benzyloxyquinazoline (1.8 g, 6 mmol) was added Boc-piperazine (2.2 g, 12 mmol) followed by DIEA (4.2 mL, 24 mmol), and the solution was heated overnight at 50 °C. The solvent was evaporated, and the residue was dissolved in water and <a name="jm004501703787" id="jm004501703787"></a> extracted with EtOAc. The EtOAc layer was dried, filtered, and evaporated to give the intermediate <i>tert</i>-butyl 4-[6-methoxy-7-phenylmethoxy)quinazolin-4-yl]piperazinecarboxylate as a white solid (2.2 g, 81%). MS (ES):  451 (M + H)<sup>+</sup>. </div><div class="NLM_p">The benzyloxy compound (0.500 g, 1.1 mmol) was dissolved in EtOH (5 mL), to this was added Pd(OH)<sub>2</sub>/C (0.050 g), and the mixture was placed on a Parr hydrogenator at 50 psi H<sub>2</sub> pressure overnight. The reaction mixture was filtered through Celite, washed with EtOH, and evaporated to dryness to afford the intermediate <b>43</b> (0.400 g, 98%). MS (ES):  361 (M + H)<sup>+</sup>. </div><div class="NLM_p">To an acetone solution (10 mL) of <i>tert</i>-butyl 4-(7-hydroxy-6-methoxyquinazolin-4-yl)piperazinecarboxylate (0.410 g, 1.1 mmol), K<sub>2</sub>CO<sub>3</sub> (0.165 g, 1.2 mmol), and <i><sup>n</sup></i><sup></sup>Bu<sub>4</sub>NI (0.020 g) was added 2-bromomethylethyl ether (1.4 mL, 1.2 mmol). The mixture was refluxed overnight. The solvent was evaporated, and the crude residue was purified by RP-HPLC to afford the intermediate <i>tert</i>-butyl-4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinecarboxylate as the desired product (0.180 g, 40%). MS (ES):  419 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(b) </b><b><i>N</i></b><b>-</b><b>(4-Indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}c</b><b>arboxamide (18). </b>To a solution of <i>tert</i>-butyl-4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinecarboxylate (0.050 g, 0.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (0.5 mL), and the reaction was stirred at room temperature for 1 h. The solvent was evaporated, and the residue was resuspended in anhydrous THF/DCM. To a solution of 4-indol-5-yloxyphenylamine (0.046 g, 0.2 mmol) in anhydrous THF/DCM 1:1 (2 mL) at room temperature under argon was added DIEA (0.130 mL, 0.8 mmol) followed by DSC (0.058 g, 0.21 mmol). The resulting solution was stirred at room temperature for 1 h followed by the addition of the solution of [6-methoxy-7-phenylmethoxy)quinazolin-4-yl]piperazine (0.065 g, 0.185 mmol) in THF/DCM, 1:1 (2 mL). The reaction mixture was stirred at room temperature until no starting material could be detected by RP-HPLC. The solvent was evaporated, and the residue was purified by RP-HPLC to give the title compound <b>18</b> (0.090 g, 90%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.6 (s, 1H), 7.48 (s, 1H), 7.34 (d, 1H), 7.30−7.20 (m, 4H), 7.31 (d, 1H), 6.86−6.78 (m, 4H), 6.38 (d, 1H), 4.60 (m, 6H), 4.02 (s, 3H), 3.80−3.60 (m, 6H), 3.48 (s, 3H). MS (ES):  569 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>{4-[7-(2-Methoxyethoxy)quinazolin-4-yl]piperazinyl}-</b><b><i>N</i></b><b>-</b><b>(4-indol-5-yloxyphenyl (19). (a) </b><b>4-Piperazinyl-7-(2-methoxyethoxy)quinazoline (17).</b> To an ethanol solution (15 mL) containing 2-amino-4-fluorobenzoic acid (0.840 g, 5.41 mmol) was added thionyl chloride (1.18 mL, 16.23 mmol), and the resulting suspension was refluxed overnight. The solvent was evaporated followed by addition of EtOAc, washed with 10% NaOH solution, dried, filtered, and evaporated to afford the desired ethylester as a solid (0.811 g, 82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 7.88−7.86 (d, 1H, H-6), 6.35−6.29 (m, 2H, H-3, H-5), 5.86 (bs, 2H, NH<sub>2</sub>), 4.33−4.27 (q, 2H, CH<sub>2</sub>), 137 (t, 3H, CH<sub>3</sub>). MS (ES):  601 (M + H)<sup>+</sup>. MS (ES):  184 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a formamide (6 mL) solution of ethyl-2-amino-4-fluorobenzoate (0.811 g, 4.43 mmol) was added ammonium formate (0.450 g, 7.14 mmol), and the reaction mixture was heated at 140 °C overnight. After the mixture was cooled, water (50 mL) and ethyl acetate (100 mL) were added. The layers were separated, and the EtOAc layer was dried, filtered, and evaporated to give the desired 7-fluoro-4-quinazolinone <b>15</b> (1 g, quantitative). MS (ES):  165 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a DMF solution (3 mL) of 2-methoxyethanol (0.962 mL, 12.2 mmol) at 0 °C was added sodium hydride (0.488 g, 12.2 mmol), and the mixture was stirred for 30 min. To this cold solution was added a DMF solution (3 mL) of intermediate 7-fluoroquinazolinone (0.500 g, 3.05 mmol), and the mixture was heated at 95 °C overnight. The solvent was evaporated, and the residue was purified by RP-HPLC to afford desired product <b>16</b> as a creamy solid (0.459 g, 75%). MS (ES):  221 (M + H)<sup>+</sup>. </div><div class="NLM_p">A mixture of 7-(2-methoxyethoxy)-4-quinazolinone <b>16</b> (0.360 g, 1.68 mmol) and POCl<sub>3</sub> (5 mL) was heated at 90 °C overnight. After it was cooled, excess POCl<sub>3</sub> was removed by evaporation and the residue was azeotroped with toluene to afford crude residue. The residue was dissolved in EtOAc and washed with saturated NaHCO<sub>3</sub> (2 × 50 mL), and the organic layer was dried, filtered, and evaporated to give 4-chloro-7-(2-methoxyethoxy)quinazoline (0.204 g, 54%). MS (ES):  239 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a 2-propanol solution (10 mL) of 4-chloroquinazoline (0.204 g, 0.86 mmol) was added piperazine (0.296 g, 3.44 mmol) and heated for 4 h at 90 °C. The solvent was evaporated, and the residue was purified by RP-HPLC to afford 4-piperazinyl-7-(2-methoxyethoxy)quinazoline <b>17</b> as a white solid (0.150 g, 60%). MS (ES):  289 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(b)</b><b>{4-[7-(2-Methoxyethoxy)quinazolin-4-yl]piperazinyl}-</b><b><i>N</i></b><b>-</b><b>(4-indol-5-yloxyphenyl (19). </b>Compound <b>19</b> (40%) was synthesized by the same method as for <b>18</b> using 4-indol-5-yloxyphenylamine and 4-piperazinyl-7-(2-methoxyethoxy)quinazoline (<b>17</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.57 (s, 1H), 8.20 (d, 1H), 7.30−7.22 (m, 5H), 7.10 (d, 1H), 6.88−6.85 (m, 6H), 4.31−4.26 (m, 6H), 3.77−3.74 (m, 6H), 3.36 (s, 3H). MS (ES):  499 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>{4-[7-(2-Methoxyethoxy)quinazolin-4-yl]piperazinyl}-</b><b><i>N</i></b><b>-</b><b>(4-phenoxyphenyl)carboxamide </b><b>(21).</b> Compound <b>21</b> (38%) was synthesized using the same method as for <b>18</b> employing 4-phenoxyaniline and 4-piperazinyl-7-(2-methoxyethoxy)quinazoline (<b>17</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.57 (s, 1H), 8.20 (d, 1H), 7.30−7.22 (m, 5H), 7.10 (d, 1H), 6.88−6.85 (m, 6H), 4.31−4.26 (m, 6H), 3.77−3.74 (m, 6H), 3.36 (s, 3H). MS (ES):  500 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 500.2297; found, 500.2293. </div><div class="NLM_p"><b>{4-[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}-</b><b><i>N</i></b><b>-[4-(cyano)phenyl]carbo</b><b>xamide (22). </b>To a solution of <i>tert</i>-butyl-4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinecarboxylate (0.050 g, 0.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (0.5 mL), and the reaction was stirred at room temperature for 1 h. After that, the solvent was evaporated, and the residue was resuspended in anhydrous acetonitrile (1 mL) and added to an acetonitrile (1 mL) solution of cyanophenyl isocyanate (0.042 g, 0.26 mmol). The mixture was heated at 90 °C for 2 h, and during that time, no starting material could be detected by TLC and RP-HPLC. The solvent was evaporated, and the residue was purified by RP-HPLC to yield the title compound <b>22</b> as a creamy solid (0.045 g, 76%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 8.40 (s, 1H), 7.80 (s, 1H), 7.38−7.36 (d, 2H), 7.30−7.28 (d, 2H), 7.12 (s, 1H), 4.34 (bs, 2H), 4.24−4.22 (bs, 4H), 3.96 (s, 3H), 3.86−3.80 (m, 6H), 3.40 (s, 3H). MS (ES):  463.50 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (24).</b><sup></sup>The final urea formation was carried out using method C and 4-isopropoxyaniline and 4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazine to afford desired product <b>24</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.61 (s, 1H), 7.46 (s, 1H), 7.23 (s, 1H), 7.21 (d, 2H, <i>J</i> = 8.8 Hz), 6.83 (d, 2H, <i>J</i> = 8.8 Hz), 4.51 (hept, 1H), 4.36−4.34 (m, 6H), 4.00 (s, 3H), 3.83−3.78 (m, 6H) 3.42(s, 3H), 1.27 (s, 3H), 1.26 (s, 3H). MS (ES):  496 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 496.2559; found, 496.2563. </div><div class="NLM_p"><b>4-[7-(2-Methoxyethoxy)-6-(2-morpholin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxyli</b><b>c Acid (4-Cyanophenyl)amide (29). (a) </b><b>7-(2-Methoxyethoxy)-6-(2-morpholin-4-yl-ethoxy)-4-piperazin-1-yl-quinazoline (28b).</b> To a DMF (10 mL) solution of ethyl 3-hydroxy-4-fluorobenzoate (1.00 g, 5.43 mmol) was added K<sub>2</sub>CO<sub>3</sub> (2.63 g, 19.02 mmol) followed by 4-(2-chloroethyl)morpholine (1.02 g, 5.49 mmol), and it was heated to 85 °C for 3.5 h. The reaction mixture was diluted with water and extracted with ethyl acetate. The ethyl acetate layer was washed with brine, dried <b>(</b>MgSO<sub>4</sub>), and filtered, and the solvent was evaporated under reduced pressure to afford 1.50 g (88%) of the intermediate. </div><div class="NLM_p">To a THF solution (5 mL) of 2-methoxyethanol (125 μL, 1.58 mmol) at 0 °C was added sodium hydride (22 mg, 0.528 mmol), and the mixture was stirred for 30 min. To this cold solution was added a THF solution (3 mL) of above intermediate (0.159 g, 0.528 mmol), and the mixture was stirred at room temperature overnight. The solvent was evaporated, and the residue was purified by RP-HPLC to afford intermediate as a white solid (0.150 g, 80%). MS (ES):  354 (M + H)<sup>+</sup>. </div><div class="NLM_p"><a name="jm004501703788" id="jm004501703788"></a>This solid (0.810 g, 2.30 mmol) was dissolved in acetic acid (3 mL), and the solution was cooled to −5 °C and treated dropwise with nitric acid (0.300 mL). After 1 h, a solution of sulfuric acid (0.300 mL) and KNO<sub>3</sub> (0.235 g, 2.32 mmol) was added. The reaction mixture was slowly warmed to room temperature and stirred overnight. After completion of the reaction, NH<sub>4</sub>OH was added to obtain a pH ∼10 and then extracted with ethyl acetate. The ethyl acetate layer was washed with brine, dried, filtered, and evaporated to give nitro intermediate as a brown solid (0.83 g, 90.7%). MS (ES):  421 (M + Na)<sup>+</sup>, 399 (M + H)<sup>+</sup>. </div><div class="NLM_p">This nitro derivative (0.133 g) was dissolved in EtOH (10 mL) and ethyl acetate (5 mL) and then treated with 10% Pd/C (60 mg). Hydrogenation was performed under 1 atm of H<sub>2</sub> overnight during which the reduction was determined to be complete. The solution was filtered through Celite, and the filtrate was evaporated to afford the amino intermediate <b>26b</b> as an oil (0.085 g, 68%). </div><div class="NLM_p">To a formamide solution (2 mL) of 2-amino-4-(2-methoxyethoxy)-5-(2-morpholin-4-yl-ethoxy)benzoic acid ethyl ester (0.713 g, 1.94 mmol) was added ammonium formate (0.196 g, 3.10 mmol) followed by heating the mixture to 140 °C for 3 h. After it was cooled, water (50 mL) was added and the solution was washed with EtOAc (2 × 50 mL). The combined organic extracts were dried (MgSO<sub>4</sub>), and the solvent was removed under reduced pressure to give 7-morpholinoethoxy-6-methoxyethoxy-4-quinazolinone formate salt <b>27b</b> as a yellow solid (0.800 g). MS (ES):  350 (M + H)<sup>+</sup>. </div><div class="NLM_p">A mixture of quinazolinone (0.750 g, 1.79 mmol), thionyl chloride (6 mL), and DMF (300 μL) was heated at reflux for 2 h. After the mixture was cooled, excess thionyl chloride was removed by evaporation and the residue was azeotroped with toluene to afford the intermediate, 4-chloro-quinazoline, as a yellow solid (0.450 g, 80%). MS (ES):  368 (M+H)<sup>+</sup>. </div><div class="NLM_p">To a 2-propanol solution (20 mL) of above chloroquinazoline (0.402 g, 1.09 mmol) were added Boc-piperazine (0.31 g, 1.64 mmol) and triethylamine (0.46 mL, 3.28 mmol), and the reaction mixture was heated at 90 °C for 4 h. The solvent was evaporated, and the residue was purified by RP-HPLC to afford the desired intermediate (0.598 g, 86.6%). MS (ES):  518.2 (M + H)<sup>+</sup>. The deprotection was carried out with 4 N HCl in dioxane at room temperature for 1 h to afford <b>28b</b>. </div><div class="NLM_p"><b>(b) </b><b>4-[7-(2-Methoxyethoxy)-6-(2-morpholin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxyli</b><b>c Acid (4-Cyanophenyl)amide (29). </b>Compound <b>29</b> was synthesized using method A as a yellow solid (0.085 g, 65%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 8.63 (s, 1H), 7.64−7.62 (m, 6H), 7.27 (s, 2H), 4.67−4.63 (m, 3H), 4.40−4.33 (m, 7H), 3.87−3.83 (m, 8H) 3.75−3.71 (m, 4H), 3.42 (bs, 5H). MS (ES):  562.3 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 562.2777; found, 562.2776. </div><div class="NLM_p">The analogues <b>30</b>−<b>32</b> were synthesized from the same intermediate using the procedure described for the synthesis of analogue <b>29</b>. For the isopropoxy analogues, the urea formation was carried out by method B. </div><div class="NLM_p"><b>4-[7-(2-Methoxyethoxy)-6-(2-morpholin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxyli</b><b>c Acid (4-Isopropoxyphenyl)amide (30). </b><sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 8.57 (s, 1H), 7.58 (s, 1H), 7.21 (s, 1H), 7.17 (d, 2H, <i>J</i> = 9.2 Hz), 6.77 (d, 2H, <i>J</i> = 9.2 Hz), 4.62−4.57 (m, 1H), 4.36−4.28 (m, 5H), 4.30−3.98 (m, 2H), 3.88−3.72 (m, 6H) 3.72−3.64 (m, 4H), 3.36 (s, 3H), 1.22−1.19 (m, 6H). MS (ES):  617.3 (M + Na)<sup>+</sup>, 595.3 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 595.3224; found, 595.3233. </div><div class="NLM_p"><b>4-[7-(2-Methoxyethoxy)-6-(2-piperidin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic </b><b>Acid (4-Cyanophenyl)amide (31). </b><sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 8.59 (s, 1H), 7.58 (s, 1H), 7.60−7.52 (m, 5H), 7.20 (s, 1H), 4.58−4.53 (m, 2H), 4.36−4.27 (m, 6H), 3.83−3.73 (m, 6H) 3.74−3.56 (m, 4H), 3.36 (s, 3H), 3.16−3.06 (m, 2H), 1.97−1.74 (m, 5H), 1.57−1.42 (m, 1H). MS (ES):  560 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 560.2985; found, 560.2996. </div><div class="NLM_p"><b>4-[7-(2-Methoxyethoxy)-6-(2-piperidin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic </b><b>Acid (4-Isopropoxyphenyl)amide (32). </b><sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 8.56 (s, 1H), 7.75 (d, 2H, <i>J</i> = 8.4 Hz), 7.56 (s, 1H), 7.19 (s, 1H), 7.15 (d, 2H, <i>J</i> = 8.4 Hz), 7.20 (s, 1H), 4.56−4.52 (m, 2H), 4.48 (hept, 1H, <i>J</i> = 6.0 Hz), 4.34−4.26 (m, 6H), 3.78−3.64 (m, 8H) 3.60−3.56 (m, 2H), 3.34 (s, 3H), 3.16−3.06 (m, 2H), 1.97−1.74 (m, 5H), 1.54−1.40 (m, 1H), 1.97 (s, 3H), 1.81 (s, 3H). MS (ES):  593 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 593.3451; found, 593.3463. </div><div class="NLM_p">The regioisomers <b>37</b>−<b>40</b> were synthesized using similar methods as described for analogue <b>29</b> except that in these instances ethyl-3-hydroxy-4-fluorobenzoate was first alkylated with 2-bromoethyl methyl ether followed by displacement of fluorine with the anion of 2-piperidin-1-yl ethanol, 2-morphilin-1-yl ethanol, or pyrrolinyl-1-yl ethanol. </div><div class="NLM_p"><b>4-[6-(2-Methoxyethoxy)-7-(2-piperidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic </b><b>Acid (4-Cyanophenyl)amide (37).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.65 (s, 1H), 7.63−7.60 (m, 4H), 7.59 (s, 1H), 7.29 (s, 1H), 4.66 (t, 2H, <i>J</i> = 4.6 Hz), 4.38−4.32 (m, 6H), 3.86−3.72 (m, 8H) 3.70 (t, 2H, <i>J</i> = 4.6 Hz), 3.42 (s, 3H), 3.24−3.14 (m, 2H), 2.02−1.78 (m, 5H), 1.62−1.50 (m, 1H). MS (ES):  560 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-(2-Methoxyethoxy)-7-(2-piperidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic </b><b>Acid (4-Isopropoxyphenyl)amide (38).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.64 (s, 1H), 7.60 (s, 1H), 7.29 (s, 1H), 7.22 (d, 2H, <i>J</i> = 8.8 Hz), 6.83 (d, 2H, <i>J</i> = 9.2 Hz), 4.72−4.62 (m, 2H), 4.53 (hept, 1H, <i>J</i> = 6.0 Hz), 4.39−4.30 (m, 6H), 3.86−3.66 (m, 10H) 3.43 (s, 3H), 2.05−1.78 (m, 5H), 1.62−1.50 (m, 1H), 1.29 (s, 3H), 1.27 (s, 1H). MS (ES):  593 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-(2-Methoxyethoxy)-7-(2-pyrrolidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxyli</b><b>c Acid (4-Cyanophenyl)amide (39).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.65 (s, 1H), 7.65−7.55 (m, 6H), 7.30 (s, 1H), 4.64−4.60 (m, 2H), 4.39−4.32 (m, 6H), 3.91−3.78 (m, 12H), 3.42 (s, 3H), 2.27−2.00 (m, 4H). MS (ES):  546 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-(2-Methoxyethoxy)-7-(2-pyrrolidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxyli</b><b>c Acid (4-Isopropoxyphenyl)amide (40).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.64 (s, 1H), 7.59 (s, 1H), 7.30 (s, 1H), 7.23 (d, 2H, <i>J</i> = 9.2 Hz), 6.83 (d, 2H, <i>J</i> = 9.2 Hz), 4.51 (hept, 1H, <i>J</i> = 6.4 Hz), 4.38−4.30 (m, 6H), 3.91−3.76 (m, 10H), 3.42 (s, 3H), 2.26−1.98 (m, 4H), 1.27 (s, 3H), 1.26 (s, 3H). MS (ES):  579.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-morpholin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (45). </b>(a) To a DMF solution (2 mL) of 4-(7-hydroxy-6-methoxy-quinazolin-4-yl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester <b>43</b> (0.040 g, 0.1 mmol) was added Cs<sub>2</sub>CO<sub>3</sub> (0.073 g, 0.22 mmol) followed by chloroethyl tosylate (0.045 mL, 0.22 mmol) and stirred overnight at room temperature. The solvent was evaporated, and residue was purified by RP-HPLC to afford the desired intermediate as a viscous oil (0.023 g, 50%). <sup>1</sup>H NMR (CD<sub>3</sub>OD). MS (ES):  423 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a DMF solution (2 mL) of above intermediate (0.015 g, 0.036 mmol) was added morpholine (0.036 mL, 0.036 mmol) for analogue <b>45</b> or other respective secondary amines and heterocycles as shown in Table 4 for analogues <b>46</b>−<b>55 </b>and<b> 60</b>−<b>69</b>. The reaction mixture was heated at 80 °C overnight and monitored by HPLC for disappearance of starting material. The solvent was evaporated, and the residue was purified by RP-HPLC to afford basic intermediate as white solid (0.016 g, 92%). MS (ES):  472 (M + H)<sup>+</sup>. </div><div class="NLM_p">(b) After deprotection of Boc functionality to afford <b>44a</b>, the urea formation was carried out as in method A to afford analogue <b>45</b> as a white solid (0.100 g, 66%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.6 (s, 1H), 7.62−7.58 (m, 4H), 7.5 (s, 1H), 7.38 (s, 1H), 4.70 (m, 1H), 4.50 (m, 1H), 4.30 (m, 2H), 3.90 (s, 3H), 3.80−3.40 (m, 6H), 3.60−3.50 (m, 4H), 3.60 (m, 2H), 3.18 (m, 2H), 1.40 (m, 2H). MS (ES):  518 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-(2-Methoxy)-7-(2-piperidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (46).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.65 (s, 1H), 7.65−7.60 (m, 4H), 7.50 (s, 1H), 7.25 (s, 1H), 4.62−4.60 (m, 2H), 4.39−4.32 (m, 3H), 3.95 (s, 3H), 3.86−3.82 (m, 3H), 3.72−3.68 (m, 3H), 3.18−3.10 (m, 6H), 2.27−2.00 (m, 2H), 1.86−1.79 (m, 3H). MS (ES):  516.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><a name="jm004501703789" id="jm004501703789"></a><b>4-{7-[2-(4-Hydroxy-piperidin-1-yl)ethoxy]-6-methoxy-quinazolin-4-yl}piperazine-1-carboxy</b><b>lic Acid (4-Cyanophenyl)amide </b>(<b>47</b>)<b>.</b> Yield 30 mg, 63%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.65−7.60 (m, 4H), 7.54 (s, 1H), 7.30 (s, 1H), 4.52−4.50 (m, 4H), 4.36−4.32 (m, 4H), 4.01 (s, 3H), 3.91−3.78 (m, 6H), 3.52−3.48 (m, 3H), 2.27−2.00 (m, 4H). MS (ES):  532.6 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[2-(1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)ethoxy]-6-methoxy-quinazolin-4-yl}piperazine-1</b><b>-carboxylic Acid (4-Cyanophenyl)amide (48).</b> Yield 25 mg, 48%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.64 (s, 1H), 7.62 (s, 4H), 7.50 (s, 1H), 7.34 (s, 1H), 4.62−4.60 (m, 2H), 4.36−4.32 (m, 4H), 4.24−4.01 (m, 6H), 3.95 (s, 3H), 3.84−3.80 (m, 4H), 3.76−3.74 (m, 4H), 2.10−2.00 (m, 4H). MS (ES):  574.64 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[2-(4-Oxo-piperidin-1-yl)ethoxy]-6-methoxy-quinazolin-4-yl}piperazine-1-carboxylic </b><b>Acid (4-Cyanophenyl)amide (49).</b> Yield 7.8 mg, 38.4%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.61 (s, 1H), 7.58 (s, 4H), 7.48 (s, 1H), 7.28 (s, 1H), 4.60−4.58 (m, 2H), 4.30−4.26 (m, 4H), 4.01 (s, 3H), 3.92−3.90 (m, 2H), 3.84−3.80 (m, 4H), 3.74−3.70 (m, 4H), 2.10−2.00 (m, 4H). MS (ES):  530 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-piperazin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (50).</b> Yield 37.2 mg, 59.2%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.65 (s, 1H), 7.65−7.55 (m, 6H), 7.30 (s, 1H), 4.64−4.60 (m, 2H), 4.39−4.32 (m, 6H), 3.91−3.78 (m, 12H), 3.42 (s, 3H), 2.27−2.00 (m, 4H). MS (ES):  517 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 517.2675; found, 517.2664. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[2-(4-methyl-piperazin-1-yl)ethoxy]quinazolin-4-yl}piperazine-1-carboxyli</b><b>c Acid (4-Cyanophenyl)amide (51).</b> Yield 50 mg, 80.2%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.61 (s, 1H), 7.61 (s, 4H), 7.48 (s, 1H), 7.24 (s, 1H), 4.62−4.60 (m, 2H), 4.36−4.32 (m, 4H), 4.01 (s, 3H), 3.82−3.80 (m, 4H), 3.68−3.20 (m, 7H), 2.98 (s, 3H). MS (ES):  531.6 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 531.2832; found, 531.2819. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-thiomorpholin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (52).</b> Yield 43.9 mg, 75.9%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.40 (s, 1H), 7.62 (d, 2H), 7.58 (d, 2H), 7.50 (s, 1H), 7.30 (s, 1H), 4.70 (m, 2H), 4.40−4.36 (m, 4H), 4.02 (s, 3H), 4.00−3.98 (m, 2H), 3.88−3.86 (m, 4H), 3.78 (m, 2H), 3.50−3.46 (m, 2H), 3.28−3.20 (m, 2H), 2.92−2.88 (m, 2H). MS (ES):  534 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 534.2287; found, 534.2284. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-pyrrolidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (53).</b> Yield 40.9 mg, 58.2%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.65 (s, 4H), 7.50 (s, 1H), 7.30 (s, 1H), 4.60 (m, 2H), 4.32−4.30 (m, 4H), 4.0 (s, 3H), 3.84−3.76 (m, 6H), 3.42 (s, 3H), 2.20−2.10 (m, 4H). MS (ES):  502 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 502.2566; found, 502.2570. </div><div class="NLM_p"><b>4-[7-(2-Imidazol-1-yl-ethoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (54). </b>Yield 34 mg, 47.9%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 9.1 (s, 1H), 8.62 (s, 1H), 7.8 (s, 1H), 7.62−7.58 (m, 5H), 7.48 (s, 1H), 7.25 (s, 1H), 4.64−4.60 (m, 2H), 4.39−4.32 (m, 4H), 4.06−4.04 (m, 2H), 4.01 (s, 3H), 3.86−3.82 (m, 4H). MS (ES):  499 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-pyrrol-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (55).</b> Yield 21 mg, 69.8%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.8 (s, 1H), 8.6 (s, 1H), 7.6 (m, 4H), 7.42 (s, 1H), 7.0 (s, 1H), 6.8 (m, 2H), 6.0 (m, 2H), 4.46−4.38 (m, 4H), 4.34−4.30 (m, 4H), 4.0 (s, 3H), 3.84−3.80 (m, 4H). MS (ES):  498 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 498.2253; found, 498.2258. </div><div class="NLM_p">Analogues <b>60</b>−<b>69</b> were synthesized using method B for final urea linkage formation. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-morpholin-4-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (60).</b> Yield 29.6 mg, 52.6%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.65 (s, 1H), 7.52 (s, 1H), 7.32 (s, 1H), 7.22 (d, 2H, <i>J</i> = 8.7 Hz), 6.8 (d, 2H, <i>J</i> = 8.7 Hz), 4.70 (m, 2H), 4.5 (hept, 1H, <i>J</i> = 8 Hz), 4.39−4.32 (m, 4H), 4.10−4.04 (m, 2H), 4.01 (s, 3H), 3.91−3.78 (m, 9H), 3.42−3.36 (m, 2H), 1.27 (d, <i>J</i> = 1 Hz, 3H), 1.24 (d, <i>J</i> = 1 Hz, 3H). MS (ES):  551 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-piperidin-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (61).</b> Yield 338 mg, 93.7%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.49 (s, 1H), 7.31 (s, 1H), 7.23 (dd, 2H, <i>J</i> = 2.4 and 6.8 Hz), 6.83 (dd, 2H, <i>J</i> = 2.4 and 6.8 Hz), 4.67−4.64 (m, 2H), 4.50 (hept, 1H), 4.36−4.32 (m, 4H), 4.03 (s, 3H), 3.81−3.79 (m, 4H), 3.72−3.66 (m, 4H), 3.18−3.10 (m, 2H), 1.98−1.83 (m, 6H), 1.27−1.25 (d. 6H). MS (ES):  549 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 549.3189; found, 549.3178. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (62).</b> Yield 147 mg, 36.87%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 8.30 (s, 1H), 7.70 (s, 1H), 7.42 (s, 1H), 7.24 (s, 1H), 7.18−7.16 (d, 2H), 6.82−6.80 (d, 2H), 4.98−4.97 (m, 2H), 4.65 (m, 2H), 4.50 (hept, 1H), 4.40 (m, 4H), 4.01 (s, 3H), 3.60−3.50 (m, 4H), 1.30 (d, 6H). MS (ES):  533 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 533.2624; found, 533.2631. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-2-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (63).</b> Yield 145 mg, 36.8%. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.70 (s, 1H), 7.42 (s, 1H), 7.24 (d, 2H), 7.10 (s, 1H), 4.98−4.97 (m, 2H), 4.65 (m, 2H), 4.50 (hept, 1H), 4.40 (m, 4H), 3.90 (s, 3H), 3.70−3.65 (m, 4H), 1.30 (d, 6H). MS (ES):  533 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 533.2624; found, 533.2621. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (64</b>)<b>.</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 8.30 (s, 1H), 7.72 (s, 1H), 7.60 (s, 4H), 7.46 (s, 1H), 7.14 (s, 1H), 4.66−4.62 (m, 2H), 4.36−4.30 (m, 5H), 3.98 (s, 3H), 3.82−3.80 (m, 5H). MS (ES):  500 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-2-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (65).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.70 (s, 2H), 7.60 (s, 4H), 7.42 (s, 1H), 7.18 (s, 1H), 4.66−4.62 (m, 4H), 4.36−4.30 (m, 4H), 3.94 (s, 3H), 3.82−3.80 (m, 4H). MS (ES):  500 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[2-(1,1-Dioxo-1</b>λ<b><sup>6</sup></b><sup></sup><b>-thiomorpholin-4-yl)ethoxy]-6-methoxy-quinazolin-4-yl}piperazine-c</b><b>arboxylic Acid (4-Cyanophenyl)amide (66).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.6 (s, 4H), 7.42 (s, 1H), 7.18 (s, 1H), 4.36−4.30 (m, 6H), 4.26−4.22 (m, 2H), 3.98 (s, 3H), 3.96−3.94 (m, 2H), 3.82−3.80 (m, 2H), 3.18−3.12 (m, 4H). MS (ES):  566 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[2-(1,1-Dioxo-1</b>λ<b><sup>6</sup></b><sup></sup><b>-thiomorpholin-4-yl)ethoxy]-6-methoxy-quinazolin-4-yl}piperazine-c</b><b>arboxylic Acid (4-Isopropoxyphenyl)amide (67).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.40 (s, 1H), 7.62 (d, 2H), 7.58 (d, 2H), 7.50 (s, 1H), 7.30 (s, 1H), 4.70 (m, 2H), 4.56 (hept, 1H), 4.40−4.36 (m, 4H), 4.02 (s, 3H), 4.00−3.98 (m, 2H), 3.88−3.86 (m, 4H), 3.78 (m, 2H), 3.50−3.46 (m, 2H), 3.28−3.20 (m, 2H), 2.92−2.88 (m, 2H), 1.27 (d, 6H). MS (ES):  599 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 599.2651; found, 599.2655. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-tetrazol-1-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (68).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 9.30 (s, 1H), 8.60 (s, 1H), 7.46 (s, 1H), 7.20 (d, 2H), 7.18 (s, 1H), 6.80 (d, 2H), 5.02 (m, 2H), 4.70 (m, 2H), 4.50 (hept, 1H), 4.30 (m, 4H), 4.01 (s, 3H), 3.80 (m, 4H), 1.30 (d, 6H). Exact mass (FAB, M + 1)<sup>+</sup> calcd, 534.2577; found, 534.2592. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-tetrazol-2-yl-ethoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (69).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.70 (s, 1H), 8.58 (s, 1H), 7.40 (s, 1H), 7.20 (d, 2H), 7.14 (s, 1H), 6.80 (d, 2H), 5.20 (m, 2H), 4.70 (m, 2H), 4.50 (hept, 1H), 4.30 (m, 4H), 3.90 (s, 3H), 3.75 (m, 4H), 1.20 (d, 6H). Exact mass (FAB, M + 1)<sup>+</sup> calcd, 534.2577; found, 534.2587. </div><div class="NLM_p">Analogues <b>70</b>−<b>87</b> were synthesized as shown in Scheme 5. The synthesis of representative examples <b>70</b> and <b>75</b> is described as follows. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (70). </b>(a) To a DMF solution (3 mL) of 4-(7-hydroxy-6-methoxy-quinazolin-4-yl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester <b>43</b> (0.100 g, 0.28 mmol) was added Cs<sub>2</sub>CO<sub>3</sub> (0.365 g, 1.12 <a name="jm004501703790" id="jm004501703790"></a> mmol) followed by chloropropyl tosylate (0.103 g, 0.42 mmol) and heated overnight at 65 °C. The reaction was filtered, the filtrate was evaporated, and the residue was purified by RP-HPLC to afford the desired intermediate as a solid (0.100 g, 81.9%). MS (ES):  437 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a DMF solution (3 mL) of the above intermediate (0.103 g, 0.236 mmol) was added piperidine (0.376 mL, 2.36 mmol) followed by triethylamine (0.132 mL, 0.944 mmol). The reaction mixture was heated at 70 °C overnight and monitored by HPLC for disappearance of starting material. The solvent was evaporated, and the residue was purified by RP-HPLC to afford intermediate <b>44b</b> as a white solid (0.053 g, 46.4%). MS (ES):  486 (M + H)<sup>+</sup>. </div><div class="NLM_p">(b) The above intermediate (37 mg) was stirred in 4 N HCl/dioxane (1 mL) for 1 h, and the solvent was evaporated to afford 6-methoxy-4-piperazin-1-yl-7-(3-piperidin-1-yl-propoxy)quinazoline intermediate. The urea formation was carried out as in method A with 4-cyanophenyl isocyanate to afford analogue <b>70</b> as a white solid (0.025 g, 50%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.61 (m, 4H), 7.42 (s, 1H), 7.2 (s, 1H), 4.4 (m, 4H), 4.01 (s, 3H), 3.82 (m, 4H), 3.30 (m, 4H), 2.98 (m, 4H), 2.4 (m, 4H), 1.98−1.60 (m, 4H). MS (ES):  530 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 530.2879; found, 530.2877. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(3-morpholin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (71). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.56 (s, 1H), 7.54 (m, 4H), 7.40 (s, 1H), 7.16 (s, 1H), 4.28−4.25 (m, 6H), 4.08−4.0 (m, 2H), 3.94 (s, 3H), 3.76−3.75 (m, 6H), 3.6−3.5 (m, 2H), 3.38 (m, 4H), 2.3 (m, 2H). MS (ES):  532 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 532.2672; found, 532.2681. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(3-pyrrolidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (72).</b> The final urea formation step was carried out using method A with 6-methoxy-4-piperazin-1-yl-7-(3-pyrrolidin-1-yl-propoxy)quinazoline and 4-cyanophenyl isocyanate to afford <b>72</b> as a white solid (65 mg, 69%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.61−7.57 (m, 4H), 7.40 (s, 1H), 7.20 (s, 1H), 4.43−4.40(m, 6H), 4.01 (s, 3H), 3.85−3.83 (m, 6H), 3.50−3.45 (m, 2H), 3.19−3.15 (m, 4H), 2.45−1.98 (m, 4H). MS (ES):  516 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 516.2723; found, 516.2728. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (73).</b> Method A (90 mg, 50%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 8.03 (s, 1H), 7.72 (s, 1H), 7.60 (s, 4H), 7.45 (s, 1H), 7.15 (s, 1H), 4.70 (t, 2H), 4.35−4.33 (m, 4H), 4.21 (t, 2H), 4.01 (s, 3H), 3.84−3.81 (m, 4H), 2.50−2.45 (m, 2H). MS (ES):  514 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 514.2315; found, 514.2310. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-2-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Cyanophenyl)amide (74).</b> Method A (100 mg, 50%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.66 (s, 1H), 7.61 (s, 4H), 7.60 (s, 1H), 7.45 (s, 1H), 7.13 (s, 1H), 4.70 (t, 2H), 4.34−4.32 (m, 4H), 4.20 (t, 2H), 3.85−3.82 (m, 4H), 3.74 (s, 3H), 2.50−2.45 (m, 2H). MS (ES):  514 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 514.2315; found, 514.2315. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (75). </b>Method B (55 mg, 59%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.50 (s, 1H), 7.64 (s, 1H), 7.29 (s, 1H), 7.16−7.14 (dd, <i>J</i> = 8,0, 2 Hz, 2H), 6.74−6.72 (dd, <i>J</i> = 8,0, 2 Hz, 2H), 4.43−4.40 (hept, 1H), 4.32−4.28 (t, 2H), 4.16−4.13 (m, 4H), 3.90 (s, 3H), 3.72−3.69 (m, 4H), 3.52−3.50 (m, 2H), 3.19−3.15 (m, 2H), 2.81−2.78 (m, 2H), 2.35−2.25 (m, 2H), 1.85−1.42 (m, 6H), 1.19−1.17 (d, <i>J</i> = 8 Hz, 6H). MS (ES):  563 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 563.3345; found, 563.3341. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(3-morpholin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (76).</b> The final urea formation step was carried out using method B to afford <b>76</b> as a yellow solid (65 mg, 69%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.46 (s, 1H), 7.26 (s, 1H), 7.23−7.21 (dd, 2H), 6.83−6.81 (dd, 2H), 4.53−4.49 (hept, 1H), 4.35−4.31 (m, 4H), 4.01 (s, 3H), 3.80−3.78 (m, 6H), 3.47−3.44 (t, 2H), 3.19−3.15 (m, 2H), 2.39−2.32 (m, 2H), 2.20−2.03 (m, 4H), 1.19−1.17 (d, 6H). MS (ES):  565.3 (M + H)<sup>+</sup>. Exact mass (FAB, M + 1)<sup>+</sup> calcd, 565.3138; found, 565.3127. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(3-pyrrolidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (77).</b> The final urea formation step was carried out using method B to afford <b>77</b> as a yellow solid (160 mg, 78%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.46 (s, 1H), 7.26 (s, 1H), 7.23−7.21 (dd, 2H), 6.83−6.81 (dd, 2H), 4.53−4.49 (hept, 1H), 4.35−4.31 (m, 4H), 4.01 (s, 3H), 3.80−3.78 (m, 6H), 3.47−3.44 (t, 2H), 3.19−3.15 (m, 2H), 2.39−2.32 (m, 2H), 2.20−2.03 (m, 4H), 1.19−1.17 (d, 6H). MS (ES):  549 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (78).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 8.03 (d, 1H), 7.73 (d, 1H), 7.46 (s, 1H), 7.23−7.21 (dd, 2H), 7.13 (s, 1H), 6.83−6.81 (dd, 2H), 4.70 (t, 2H), 4.52−4.49 (hept, 1H), 4.35−4.31 (m, 4H), 4.21 (t, 2H), 4.01 (s, 3H), 3.80−3.77 (m, 4H), 2.56−2.48 (m, 2H), 1.27−1.25 (d, 6H). MS (ES):  547 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[6-Methoxy-7-(2-[1,2,3]triazol-2-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (79). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.65 (s, 2H), 7.45 (s, 1H), 7.23−7.20 (dd, 2H), 7.12 (s, 1H), 6.83−6.81 (dd, 2H), 4.69 (t, 2H), 4.52−4.49 (hept, 1H), 4.34−4.32 (m, 4H), 4.19 (t, 2H), 4.01 (s, 3H), 3.80−3.77 (m, 4H), 2.56−2.48 (m, 2H), 1.27−1.25 (d, 6H). MS (ES):  547 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[3-(4,4-Difluoro-piperidin-1-yl)propoxy]-6-methoxy-quinazolin-4-yl}piperazine-1-carb</b><b>oxylic Acid (4-Cyanophenyl)amide (80). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.56 (s, 1H), 7.53 (s, 4H), 7.39 (s, 1H), 7.16 (s, 1H), 4.30−4.24 (m, 6H), 3.93 (s, 3H), 3.78−3.74 (m, 6H), 3.4 (t, 4H), 2.38−2.30 (m, 6H). MS (ES):  566 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[3-(4,4-Difluoro-piperidin-1-yl)propoxy]-6-methoxy-quinazolin-4-yl}piperazine-1-carb</b><b>oxylic Acid (4-Isopropoxyphenyl)amide (81). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.55 (s, 1H), 7.40 (s, 1H), 7.16 (s, 1H), 7.15 (dd, <i>J</i> = 8, 2 Hz, 2H), 6.77 (dd, <i>J</i> = 8, 2 Hz, 2H), 4.44 (hept, 1H), 4.29−4.24 (m, 6H), 3.94 (s, 3H), 3.73−3.71 (m, 6H), 3.4 (t, 4H), 2.35−2.30 (m, 6H). MS (ES):  599 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{7-[3-(3,3-Difluoro-piperidin-1-yl)propoxy]-6-methoxy-quinazolin-4-yl}piperazine-1-carb</b><b>oxylic Acid (4-Isopropoxyphenyl)amide (82). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.55 (s, 1H), 7.40 (s, 1H), 7.16 (s, 1H), 7.15 (dd, <i>J</i> = 8, 2 Hz, 2H), 6.77 (dd, <i>J</i> = 8, 2 Hz, 2H), 4.44 (hept, 1H), 4.29−4.24 (m, 6H), 3.94 (s, 3H), 3.73−3.71 (m, 6H), 3.4 (t, 4H), 2.35−2.30 (m, 6H). MS (ES):  599 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Cyclohexyl-propoxy)-6-methoxy-quinazolin-4-yl}piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (83). </b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.61 (s, 1H), 7.45 (s, 1H), 7.22 (d, <i>J</i> = 8.8 Hz, 2H), 7.16 (s, 1H), 6.83 (d, <i>J</i> = 8 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.37−4.28 (m, 4H), 4.48−4.20 (m, 4H), 4.00 (s, 3H), 3.82−3.74 (m, 4H), 3.32−3.23 (m, 6H), 1.84−1.50 (m, 6H), 1.27 (s, 3H), 1.26 (s, 3H), 1.80−0.96 (m, 1H). MS (ES):  548.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(4-methyl-piperidin-1-yl)propoxy]quinazolin-4-yl}piperazine-1-carboxyl</b><b>ic Acid (4-Cyanophenyl)amide (84).</b> Compound <b>84</b> was synthesized using method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.61 (s, 4H), 7.48 (s, 1H), 7.25 (s, 1H), 4.37−4.31 (m, 6H), 4.01 (s, 3H), 3.86−3.80 (m, 4H), 3.66 (d, <i>J</i> = 12.4 Hz, 2H), 3.35 (t, <i>J</i> = 7.4 Hz, 2H), 2.99 (t, <i>J</i> = 12.6 Hz, 2H), 2.41−2.33 (m, 2H), 1.95 (d, <i>J</i> = 13.2 Hz, 2H), 1.78−1.64 (bs, 1H), 1.52−1.40 (m, 2H), 1.02 (d, <i>J</i> = 6.8 Hz, 3H). MS (ES):  544.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(4-methyl-piperidin-1-yl)propoxy]quinazolin-4-yl}piperazine-1-carboxyl</b><b>ic Acid (4-Isopropoxyphenyl)amide (85).</b> Compound <b>85</b> was synthesized using method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.48 (s, 4H), 7.26 (s, 1H), 7.22 (dd, <i>J</i> = 8.8, 2 Hz, 2H), 6.83 (d, <i>J</i> = 8, 2 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.36−4.30 (m, 6H), 4.01 (s, 3H), 3.82−3.76 (m, 4H), 3.66 (bd, <i>J</i> = 12.4 Hz, 2H), 3.35 (t, <i>J</i> = 7.4 Hz, 2H), 3.03−2.94 (m, 2H), 2.40−2.323 (m, 2H), 1.95 (bd, <i>J</i> = 13.6 Hz, 2H), 1.78−1.64 (bs, 1H), 1.52−1.40 (m, 2H), 1.26 (d, <i>J</i> = 5.6 Hz, 6H), 1.02 (d, <i>J</i> = 6.8 Hz, 3H). MS (ES):  577.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><a name="jm004501703791" id="jm004501703791"></a><b>4-{6-Methoxy-7-[3-(2-methyl-piperidin-1-yl)propoxy]quinazolin-4-yl}piperazine-1-carboxyl</b><b>ic Acid (4-Cyanophenyl)amide (86).</b> Compound <b>86</b> was synthesized using method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.61 (s, 4H), 7.48 (s, 1H), 7.25 (s, 1H), 4.36−4.30 (m, 6H), 4.01 (s, 3H), 3.86−3.80 (m, 4H), 3.66−3.52 (m, 2H), 3.40−3.30 (m, 2H), 3.12−3.04 (m, 1H), 2.46−2.26 (m, 2H), 2.06−1.72 (m, 4H), 1.72−1.56 (m, 2H), 1.44 (d, <i>J</i> = 6.0 Hz, 3H). MS (ES):  544.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(2-methyl-piperidin-1-yl)propoxy]quinazolin-4-yl}piperazine-1-carboxyl</b><b>ic Acid (4-Isopropoxyphenyl)amide (87).</b> Compound <b>87</b> was synthesized using method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.47 (s, 4H), 7.28 (s, 1H), 7.22 (d, <i>J</i> = 9.2 Hz, 2H), 6.83 (d, <i>J</i> = 9.2 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.37−4.30 (m, 6H), 4.00 (s, 3H), 3.83−3.75 (m, 4H), 3.67−3.53 (m, 2H), 3.40−3.30 (m, 2H), 3.08 (dt, <i>J</i> = 12.4, 2.8 Hz, 1H), 2.44−2.24 (m, 2H), 2.40−1.70 (m, 4H), 1.70−1.54 (m, 2H), 1.44 and 1.38 (d, <i>J</i> = 6.6 Hz, 3H), 1.26 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  577.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(1-methyl-4,5-dihydro-1</b><b><i>H</i></b><b>-imidazol-2-yl)propoxy]quinazolin-4-yl}pipera</b><b>zine-1-carboxylic Acid (4-Isopropoxyphenyl)amide (90).</b> (a) To a DMF solution (5 mL) of 4-[7-(3-chloropropoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic acid <i>tert</i>-butyl ester (0.357 g, 0.819 mmol) were added sodium cyanide (0.240 g, 4.92 mmol) and sodium iodide (0.123 g, 0.819 mmol), and the reaction was heated to 65 °C for 36 h. During this time, no starting material was apparent by HPLC. The reaction mixture was diluted after it was cooled with water and ethyl acetate. The ethyl acetate layer was separated, dried, filtered, and concentrated to crude residue. The crude residue was purified by RP-HPLC to afford the desired cyano intermediate. MS (ES):  428.2 (M + H)<sup>+</sup>. </div><div class="NLM_p">Into a pyridine/triethylamine (5 mL, 10:1) solution of the above intermediate (0.273 g, 0.639 mmol) was bubbled H<sub>2</sub>S(g) at 0 °C for 10 min. The reaction was stirred at room temperature overnight, during which time complete consumption of starting material was observed by RP-HPLC. The solvent was concentrated under vacuum, and the residue obtained was suspended in acetone (dry, 10 mL) followed by addition of methyl iodide (3 equiv) and then stirred at room temperature overnight. The solvent was evaporated to afford thiomethylimidate intermediate as crude residue. MS (ES):  462.1 (M + H)<sup>+</sup>. </div><div class="NLM_p">To the methanol solution (10 mL) of thiomethylimidate (0.136 g, 0.286 mmol) was added a premixed solution of <i>N</i>-methylethylenediamine (0.020 mL, 0.213 mmol) and acetic acid (0.013 mL) in methanol (1 mL). The mixture was heated to reflux overnight and then, the solvent was evaporated to afford crude residue. The crude residue was purified by RP-HPLC to afford desired <i>N</i>-methylimidazoline intermediate. MS (ES):  485.3 (M + H)<sup>+</sup>. </div><div class="NLM_p">(b) The above intermediate (0.130 g, 0.284 mmol) was stirred in 4 N HCl/dioxane (2 mL) for 1 h, and the solvent was evaporated to afford 6-methoxy-4-piperazin-1-yl-7-{3-(1-methyl-4,5-dihydro-1<i>H</i>-imidazole-2-yl)propoxy}quinazoline intermediate. The urea formation was carried out using method B with 4-isopropoxyphenyl aniline to afford analogue <b>90</b> as a white solid (0.020 g, 20%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.49 (s, 1H), 7.27 (s, 1H), 7.22 (d, <i>J</i> = 9.2 Hz, 2H), 6.83 (d, <i>J</i> = 9.2 Hz, 2H), 4.51 (hept, <i>J</i> = 6.2 Hz, 1H), 4.36−4.30 (m, 4H), 4.03 (s, 3H), 3.98−3.90 (m, 2H), 3.87−3.77 (m, 4H), 3.14 (s, 3H), 2.83 (t, <i>J</i> = 7.2 Hz, 2H), 2.32−2.24 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  562.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Carbamimidoyl-propoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (91).</b> Compound <b>91</b> (0.045 g, 45%) was synthesized using the same method for <b>90</b> and employing ammonium acetate instead of <i>N</i>-methylethylenediamine. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.46 (s, 1H), 7.21 (d, <i>J</i> = 9.2 Hz, 2H), 7.22 (s, 1H), 6.83 (d, <i>J</i> = 9.2 Hz, 2H), 4.50 (hept, <i>J</i> = 6.2 Hz, 1H), 4.33−4.26 (m, 6H), 4.00 (s, 3H), 3.81−3.76 (m, 4H), 2.71 (t, <i>J</i> = 7.6 Hz, 2H), 2.34−2.264 (m, 2H), 1.26 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  522.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Dimethylamino-propoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (92).</b> Compound <b>92</b> (0.045 g, 50%) was synthesized by the same method for <b>90</b> using dimethylamine. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.48 (s, 1H), 7.25 (s, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 2H), 6.83 (d, <i>J</i> = 8.4 Hz, 2H), 4.51 (hept, <i>J</i> = 6.2 Hz, 1H), 4.40−4.28 (m, 6H), 4.02 (s, 3H), 3.84−3.74 (m, 4H), 3.39 (t, <i>J</i> = 7.0 Hz, 2H), 2.97 (s, 6H), 2.40−2.12 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  523.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Aminopropoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (93</b>)<b>.</b> 4-(7-Hydroxy-6-methoxy-quinazolin-4-yl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester <b>43</b> was alkylated with 3-bromopropylamine hydrobromide in the presence of K<sub>2</sub>CO<sub>3</sub> followed by deprotection and urea formation with 4-isopropoxy-aniline to afford <b>93</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.63 (s, 1H), 7.48 (s, 1H), 7.25 (s, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 2H), 6.83 (d, <i>J</i> = 8.4 Hz, 2H), 4.51 (hept, <i>J</i> = 6.2 Hz, 1H), 4.40−4.28 (m, 6H), 4.02 (s, 3H), 3.84−3.74 (m, 4H), 3.39 (t, <i>J</i> = 7.0 Hz, 2H), 2.40−2.12 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  495 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Hydroxypropoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (94).</b><sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.60 (s, 1H), 7.65 (d, 2H), 7.58 (d, 2H), 7.42 (s, 1H), 7.18 (s, 1H), 4.51 (hept, <i>J</i> = 6.2 Hz, 1H), 4.38−4.26(m, 4H), 4.10−3.94 (m, 7H), 3.84−3.80 (m, 2H), 3.50 (m, 2H), 3.0 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  522.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Ethanesulfonyl-propoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic Acid </b><b>(4-Isopropoxyphenyl)amide (95). </b>(a) To an acetone solution (5 mL) of 4-[7-(3-chloropropoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic acid <i>tert</i>-butyl ester (0.250 g, 0.573 mmol) was added sodium ethylthiolate, which was stirred at room temperature for 1 h until complete by TLC and RP-HPLC. The reaction mixture was diluted with saturated NH<sub>4</sub>Cl and dichloromethane. The layers were separated, and the organic layer was washed with brine, dried (MgSO4), filtered, and concentrated in vacuo to afford intermediate (0.287 g). MS (ES):  463.2 (M + H)<sup>+</sup>. </div><div class="NLM_p">To a dichloromethane solution (5 mL) of the above alkylthiol (0.280 g, 0.606 mmol) was added <i>m</i>-chloroperbenzoic acid (0.403 g, 1.8 mmol) and stirred at room temperature for 1 h. The RP-HPLC showed consumption of starting material, and a new peak was observed. The solvent was evaporated, and the residue was dissolved in EtOAc washed with saturated NaHCO<sub>3</sub> and then 1 N NaOH. The organic layer was then dried (MgSO<sub>4</sub>), filtered, and concentrated to the desired sulfone intermediate (0.280 g, 95%). MS (ES):  495 (M + H)<sup>+</sup>. </div><div class="NLM_p">(b) The above intermediate (0.260 g, 0.526 mmol) was stirred in 4 N HCl/dioxane (2 mL) for 1 h, and the solvent was evaporated to afford 6-methoxy-4-piperazin-1-yl-7-(3-methanesulfonyl-propoxy)quinazoline intermediate. The urea formation was carried out using method B with 4-isopropoxyphenyl aniline to afford analogue <b>95</b> as a white solid (0.200 g, 69.8%). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.47 (s, 1H), 7.23 (s, 1H), 7.20 (d, <i>J</i> = 8.8 Hz, 2H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (hept, <i>J</i> = 6.2 Hz, 1H), 4.39−4.31 (m, 6H), 4.01 (s, 3H), 3.82−3.77 (m, 4H), 3.34−3.30 (m, 2H), 315 (q, <i>J</i> = 7.2 Hz, 2H), 2.44−2.36 (m, 2H), 1.36 (t, <i>J</i> = 7.2 Hz, 3H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  594.2 (M + Na), 572.9 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(2-methyl-propane-1-sulfonyl)propoxy]-quinazolin-4-yl}piperazine-1-ca</b><b>rboxylic Acid (4-Isopropoxyphenyl)amide (96). </b>Compound <b>96</b> (0.058 g, 50%) was synthesized by the same method used for <b>95</b> using isobutyl mercaptan. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.54 (s, 1H), 7.39 (s, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 2H), 7.11 (s, 1H), 6.75 (d, <i>J</i> = 8.8 Hz, 2H), 4.43 (hept, <i>J</i> = 6.2 Hz, 1H), 4.31−4.22 (m, 6H), 3.94 (s, 3H), 3.75−3.68 (m, 4H), 3.26−3.22 (m, 2H), 2.97 (d, <i>J</i> = 6.4 Hz, 2H), 2.36−2.28 (m, 2H), 2.25 (hept, <i>J</i> = 6.8 Hz, 1H), 1.19 (d, <i>J</i> = 6.0 Hz, 6H), 1.04 (d, <i>J</i> = 6.8 Hz, 6H). MS (ES):  600.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(propane-1-sulfonyl)propoxy]quinazolin-4-yl}piperazine-1-carboxylic </b><b>Acid (4-Isopropoxyphenyl)amide (97). </b>Compound <b>97</b> (0.100 g, 90%) was <a name="jm004501703792" id="jm004501703792"></a> synthesized by the same method used for <b>95</b> using KHMDS to generate anion of propanethiol instead of sodium hydride for methanethiol. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.47 (s, 1H), 7.22 (d, <i>J</i> = 8.8 Hz, 2H), 7.18 (s, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.39−4.31 (m, 6H), 4.02 (s, 3H), 3.82−3.76 (m, 4H), 3.34−3.30 (m, 2H), 3.14−3.28 (m, 2H), 2.44−2.36 (m, 2H), 1.90−1.80 (m, 2H), 1.26 (d, <i>J</i> = 6.0 Hz, 6H), 1.09 (t, <i>J</i> = 7.6 Hz, 3H). MS (ES):  586.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-[7-(3-Butane-1-sulfonyl-propoxy)-6-methoxy-quinazolin-4-yl]piperazine-1-carboxylic </b><b>Acid (4-Isopropoxyphenyl)amide (98).</b> Compound <b>98</b> (0.058 g, 50%) was synthesized by the same method used for <b>95</b> using KHMDS to generate anion of butanethiol instead of sodium hydride for methanethiol. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.47 (s, 1H), 7.22 (d, <i>J</i> = 9.2 Hz, 2H), 7.18 (s, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.39−4.30 (m, 6H), 4.01 (s, 3H), 3.82−3.77 (m, 4H), 3.34−3.28 (m, 2H), 3.16−3.10 (m, 2H), 2.44−2.36 (m, 2H), 1.83−1.74 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES):  600.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(3-methyl-butane-1-sulfonyl)propoxy]quinazolin-4-yl}piperazine-1-carb</b><b>oxylic Acid (4-Isopropoxyphenyl)amide (99).</b> Compound <b>99</b> (0.045 g, 45%) was synthesized by the same method used for <b>95</b> using KHMDS to generate anion of 3-methyl-butane-1-thiol instead of sodium hydride for methanethiol. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.48 (s, 1H), 7.22 (d, <i>J</i> = 8.8 Hz, 2H), 7.17 (s, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.40−4.30 (m, 6H), 4.02 (s, 3H), 3.82−3.76 (m, 4H), 3.36−3.30 (m, 2H), 3.16−3.10 (m, 2H), 2.44−2.36 (m, 2H), 1.76−1.66 (m, 3H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H), 0.96 (d, <i>J</i> = 6.4 Hz, 6H). MS (ES):  614.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>4-{6-Methoxy-7-[3-(2,2,2-trifluoro-ethanesulfonyl)propoxy]quinazolin-4-yl}piperazine-1-ca</b><b>rboxylic Acid (4-Isopropoxyphenyl)amide (100).</b> Compound <b>100</b> (0.045 g, 45%) was synthesized by the same method used for <b>95</b> using KHMDS to generate anion of 2,2,2-trifluoroethane thiol instead of sodium hydride for methanethiol. <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 8.62 (s, 1H), 7.48 (s, 1H), 7.22 (d, <i>J</i> = 8.8 Hz, 2H), 7.17 (s, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (hept, <i>J</i> = 6.0 Hz, 1H), 4.40−4.30 (m, 6H), 4.01 (s, 3H), 3.82−3.75 (m, 4H), 3.51 (t, <i>J</i> = 7.2 Hz, 2H), 3.19 (q, <i>J</i> = 7.4 Hz, 2H), 2.48−2.40 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H), 0.96 (d, <i>J</i> = 6.4 Hz, 6H). MS (ES):  626.2 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>PDGFR Kinase Phosphorylation Assay in MG63 Cells.</b> Human osteosarcoma MG63 cells expressing endogenous βPDGFR were grown to confluency in 96 well microtiter plates under standard tissue culture conditions, followed by serum starvation for 16 h. Briefly, quiescent cells were incubated at 37 °C with increasing concentrations of the analogues (0.01−30 μM) for 30 min followed by the addition of 8 nM PDGF-BB for 10 min. To measure the effect of plasma on analogue potency, quiescent MG63 cells were incubated with analogues in the presence or absence of 45% human plasma prior to PDGF-BB stimulation. Cells were lysed, and clarified lysates were transferred into a second microtiter plate in which the wells were previously coated with anti-βPDGFR monoclonal antibody and then incubated for 2 h at room temperature. After the cells were washed three times with binding buffer, 250 ng/mL of rabbit polyclonal antiphosphotyrosine antibody (Transduction Laboratory, Lexington, KY) was added and plates were incubated at 37 °C for 60 min. Subsequently, each well was washed three times with binding buffer and incubated with 1 μg/mL of horseradish peroxidase-conjugated antirabbit antibody (Boehringer Mannheim Biochemicals, Indianapolis, IN) at 37 °C for 60 min. Wells were washed prior to adding ABTS (Sigma Chemicals, St. Louis, MO), and the rate of substrate formation was monitored at 650 nm. </div><div class="NLM_p"><b>Specificity Analysis on PDGFR Family Kinases. </b>PDGFR family kinase assays were cell-based enzyme-linked immunosorbent (ELISA) assays using CHO cells expressing chimeric protein containing the extracellular and transmembrane domains of βPDGFR and the cytoplasmic domain of CSF-1R, c-Kit, and Flt-3, which were grown to confluency in 96 well microtiter plates under standard tissue culture conditions, followed by serum starvation for 16 h. Phosphorylation assays were performed as described for the βPDGFR phosphorylation assay in MG63 cells. </div><div class="NLM_p"><b>Pharmacokinetic Analysis. </b>Pharmacokinetics analysis of <b>24</b>, <b>61</b>, <b>75</b>, <b>76</b>, and <b>85</b> was conducted in fasted male Lewis rats, female Beagle dogs, and male Cynomolgus monkeys. The doses studied are summarized in Table 10. Blood samples were collected prior to administration and serially out to 24 or 48 h. The plasma concentration of each compound was analyzed using LC/MS/MS (PE-SCIEX). Pharmacokinetic parameters were calculated by noncompartmental analysis of concentration−time data using Watson program, version 6.1.1. </div><div class="NLM_p last"><b>Metabolic Stability Method. </b>Each compound was incubated with HLM in the presence of cofactors. The experiment was conducted in a shaking waterbath at 37 °C. Incubation mixtures contained a final concentration of 0.1 M phosphate buffer (pH 7.4), 3.3 mM MgCl<sub>2</sub>, 1 mg/mL liver microsomes, 5 mM of compound, and NADPH-generating system. The NADPH-generating system contained 1.3 mM NADP, 3.3 mM glucose-6-phosphate, and 0.4 U/mL glucose-6-phosphate dehydrogenase. The reaction was started by the addition of the NADPH-generating system. A 0.1 mL aliquot was taken from the incubation at 0, 7, 15, 35, and 60 min into a tube containing 0.1 mL of cold acetonitrile and KN1022, an internal standard. The mixture was vortexed and centrifuged. The supernatant was diluted with water and injected into a SCIEX API-365 LC/MS/MS equipped with an APCI source. The slope of disappearance of each compound in the microsomal incubation was determined by a linear regression analysis of the natural logarithm (ln) of peak area ratio of the compound and internal standard vs time. Half-life values were calculated as ln(2) divided by the disappearance slope. </div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anjali Pandey</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah L. Volkots</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Seroogy</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jack W. Rose</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin-Chen Yu</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph L. Lambing</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Athiwat Hutchaleelaha</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanley J. Hollenbach</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Abe</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neill A. Giese</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Scarborough</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Biology Department, Drug Metabolism Pharmacokinetic Department, and In Vivo Sciences, Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, California 94080 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm020143r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Drs. Shoji Oda, Yuji Nomoto, Kenji Matsuno, and Shin-Iche Ide from Kyowa Hakko Kogyo Co., Ltd. for their initial synthetic and biological characterization work in the 6,7-dimethoxyquinazoline series. </p></div><div class="refs-header-label"><a name="jm004501703793" id="jm004501703793"></a></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="jm020143rb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm020143rb00001_1"><span><span class="NLM_string-ref">Schlessinger, J.; Ullrich, A. growth factor Signaling by receptor tyrosine kinases. <i>  Neuron</i><b>1992</b>, <i>9</i>, 383−391.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1992&pages=391&author=J.+Schlessinger&author=A+Ullrich&title=growth+factor+Signaling+by+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3Dgrowth%2520factor%2520Signaling%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNeuron%26date%3D1992%26volume%3D9%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm020143rb00002_1"><span><span class="NLM_string-ref">Claesson-Welsh, L. Platelet-derived growth factor receptor signals. <i>  J. Biol. </i><i>Chem</i>. <b>1994</b>, <i>269</i>, 32023−32026.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=32026&author=L+Claesson-Welsh&title=Platelet-derived+growth+factor+receptor+signals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClaesson-Welsh%26aufirst%3DL%26atitle%3DPlatelet-derived%2520growth%2520factor%2520receptor%2520signals%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D32026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm020143rb00003_1"><span><span class="NLM_string-ref">Wilcox, J. N.; Smith, K. M.; Williams, L. T.; Schwartz, S. M.; Gordon, D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by insitu hybridization. <i>  J. Clin. Invest</i>. <b>1988</b>, <i>82</i>, 1134−1143.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1988&pages=1143&author=J.+N.+Wilcox&author=K.+M.+Smith&author=L.+T.+Williams&author=S.+M.+Schwartz&author=D+Gordon&title=Platelet-derived+growth+factor+mRNA+detection+in+human+atherosclerotic+plaques+by+insitu+hybridization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilcox%26aufirst%3DJ.%2BN.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520mRNA%2520detection%2520in%2520human%2520atherosclerotic%2520plaques%2520by%2520insitu%2520hybridization%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1988%26volume%3D82%26spage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm020143rb00004_1"><span><span class="NLM_string-ref">Heldin, C. H.; Westermark, B. Platelet-derived growth factor:  mechanism of action and possible in vivo function. <i>  Cell Regul</i>. <b>1990</b>, <i>1</i>, 555−566.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1990&pages=566&author=C.+H.+Heldin&author=B+Westermark&title=Platelet-derived+growth+factor%3A%E2%80%89+mechanism+of+action+and+possible+in+vivo+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeldin%26aufirst%3DC.%2BH.%26atitle%3DPlatelet-derived%2520growth%2520factor%253A%25E2%2580%2589%2520mechanism%2520of%2520action%2520and%2520possible%2520in%2520vivo%2520function%26jtitle%3DCell%2520Regul.%26date%3D1990%26volume%3D1%26spage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm020143rb00005_1"><span><span class="NLM_string-ref">Iida, H.; Seifert, R.; Alpers, C. E.; Gronwald, R. G.; Phillips, P. E.; Pritzl, P.; Gordon, K.; Gown, A. M.; Ross, R.; Bowen-Pope, D. F. Platelet-derived growth factor and PDGF receptor are induced in mesangial proliferative nephritis in the rat. <i>  Proc. Natl. Acad. Sci</i>. <i>U.S.A</i>. <b>1991</b>, <i>88</i>, 6560−6564.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=6564&author=H.+Iida&author=R.+Seifert&author=C.+E.+Alpers&author=R.+G.+Gronwald&author=P.+E.+Phillips&author=P.+Pritzl&author=K.+Gordon&author=A.+M.+Gown&author=R.+Ross&author=D.+F+Bowen-Pope&title=Platelet-derived+growth+factor+and+PDGF+receptor+are+induced+in+mesangial+proliferative+nephritis+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIida%26aufirst%3DH.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520and%2520PDGF%2520receptor%2520are%2520induced%2520in%2520mesangial%2520proliferative%2520nephritis%2520in%2520the%2520rat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D6564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm020143rb00006_1"><span><span class="NLM_string-ref">Johnson, R. J.; Raines, E. W.; Floege, J.; Yoshimura, A.; Pritzl, P.; Alpers, C.; Ross, R. Inhibition of mesangial cell proliferation and matrix expansion in glumerulonephritis in the rat by antibody to platelet-derived growth factor<i>. </i><i>J. Exp. Med</i>. <b>1992</b>, <i>175</i>, 1413−1416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1992&pages=1416&author=R.+J.+Johnson&author=E.+W.+Raines&author=J.+Floege&author=A.+Yoshimura&author=P.+Pritzl&author=C.+Alpers&author=R+Ross&title=Inhibition+of+mesangial+cell+proliferation+and+matrix+expansion+in+glumerulonephritis+in+the+rat+by+antibody+to+platelet-derived+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520mesangial%2520cell%2520proliferation%2520and%2520matrix%2520expansion%2520in%2520glumerulonephritis%2520in%2520the%2520rat%2520by%2520antibody%2520to%2520platelet-derived%2520growth%2520factor%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1992%26volume%3D175%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm020143rb00007_1"><span><span class="NLM_string-ref">Rice, A. B.; Moomaw, C. R.; Morgan, D. L.; Bonner, J. C. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. <i>  Am. J. Pathol</i>. <b>1999</b>, <i>155</i>, 213−221.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1999&pages=221&author=A.+B.+Rice&author=C.+R.+Moomaw&author=D.+L.+Morgan&author=J.+C+Bonner&title=Specific+inhibitors+of+platelet-derived+growth+factor+or+epidermal+growth+factor+receptor+tyrosine+kinase+reduce+pulmonary+fibrosis+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DA.%2BB.%26atitle%3DSpecific%2520inhibitors%2520of%2520platelet-derived%2520growth%2520factor%2520or%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520reduce%2520pulmonary%2520fibrosis%2520in%2520rats%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D155%26spage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm020143rb00008_1"><span><span class="NLM_string-ref">Blume-Jensen, P.; Hunter, T. Oncogenic Kinase Signaling. <i>  Nature</i><b>2001</b>, <i>411</i>, 355−365.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=365&author=P.+Blume-Jensen&author=T+Hunter&title=Oncogenic+Kinase+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26atitle%3DOncogenic%2520Kinase%2520Signaling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm020143rb00009_1"><span><span class="NLM_string-ref">Metcalfe, D. D.; Akin, C. Mastocytosis:  molecular mechanisms and clinical disease heterogeneity. <i>  Leuk. Res</i>. <b>2001</b>, <i>25</i>, 577−582.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=582&author=D.+D.+Metcalfe&author=C.+Akin&author=+Mastocytosis&title=molecular+mechanisms+and+clinical+disease+heterogeneity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalfe%26aufirst%3DD.%2BD.%26atitle%3Dmolecular%2520mechanisms%2520and%2520clinical%2520disease%2520heterogeneity%26jtitle%3DLeuk.%2520Res.%26date%3D2001%26volume%3D25%26spage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00010"><div class="reference"><div class="NLM_citation" id="jm020143rb00010_1"><span><span class="NLM_string-ref">Beghini, A.; Peterlongs, P.; Ripamonti, C. B. C-kit mutations in core binding factor leukemias. <i>  Blood</i><b>2000</b>, <i>95</i>, 726.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2000&pages=726&author=A.+Beghini&author=P.+Peterlongs&author=C.+B+Ripamonti&title=C-kit+mutations+in+core+binding+factor+leukemias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeghini%26aufirst%3DA.%26atitle%3DC-kit%2520mutations%2520in%2520core%2520binding%2520factor%2520leukemias%26jtitle%3DBlood%26date%3D2000%26volume%3D95%26spage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm020143rb00011_1"><span><span class="NLM_string-ref">Hirota, S.; Isozaki, K.; Moriyama, Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. <i>  Science</i><b>1998</b>, <i>279</i>, 577−580.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=580&author=S.+Hirota&author=K.+Isozaki&author=Y+Moriyama&title=Gain-of-function+mutations+of+c-kit+in+human+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26atitle%3DGain-of-function%2520mutations%2520of%2520c-kit%2520in%2520human%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm020143rb00012_1"><span><span class="NLM_string-ref">Yokota, S.; Kiyoi, H.; Nakao, M. Internal tandem duplication of the Flt3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. <i>  Leukemia</i><b>1997</b>, <i>11</i>, 1605−1609.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=1609&author=S.+Yokota&author=H.+Kiyoi&author=M+Nakao&title=Internal+tandem+duplication+of+the+Flt3+gene+is+preferentially+seen+in+acute+myeloid+leukemia+and+myelodysplastic+syndrome+among+various+hematological+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYokota%26aufirst%3DS.%26atitle%3DInternal%2520tandem%2520duplication%2520of%2520the%2520Flt3%2520gene%2520is%2520preferentially%2520seen%2520in%2520acute%2520myeloid%2520leukemia%2520and%2520myelodysplastic%2520syndrome%2520among%2520various%2520hematological%2520malignancies%26jtitle%3DLeukemia%26date%3D1997%26volume%3D11%26spage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm020143rb00013_1"><span><span class="NLM_string-ref">Kiyoi, H.; Naoe, T.; Nakano, Y. Prognostic implication of Flt3 and N-RAS gene mutations in acute myeloid leukemia. <i>  Blood</i><b>1999</b>, <i>93</i>, 3074−3080.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=3080&author=H.+Kiyoi&author=T.+Naoe&author=Y+Nakano&title=Prognostic+implication+of+Flt3+and+N-RAS+gene+mutations+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyoi%26aufirst%3DH.%26atitle%3DPrognostic%2520implication%2520of%2520Flt3%2520and%2520N-RAS%2520gene%2520mutations%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D1999%26volume%3D93%26spage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm020143rb00014_1"><span><span class="NLM_string-ref">Blume-Jensen, P.; Hunter, T. Oncogenic kinas signaling. <i>  Nature</i><b>2001</b>, <i>411</i>, 355−365.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=365&author=P.+Blume-Jensen&author=T+Hunter&title=Oncogenic+kinas+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26atitle%3DOncogenic%2520kinas%2520signaling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm020143rb00015_1"><span><span class="NLM_string-ref">Golub, T. R.; Barker, G. F.; Lovett, M.; Gilliland, D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. <i>  Cell</i><b>1994</b>, <i>77</i>, 307−316.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1994&pages=316&author=T.+R.+Golub&author=G.+F.+Barker&author=M.+Lovett&author=D.+G+Gilliland&title=Fusion+of+PDGF+receptor+beta+to+a+novel+ets-like+gene%2C+tel%2C+in+chronic+myelomonocytic+leukemia+with+t%285%3B12%29+chromosomal+translocation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DFusion%2520of%2520PDGF%2520receptor%2520beta%2520to%2520a%2520novel%2520ets-like%2520gene%252C%2520tel%252C%2520in%2520chronic%2520myelomonocytic%2520leukemia%2520with%2520t%25285%253B12%2529%2520chromosomal%2520translocation%26jtitle%3DCell%26date%3D1994%26volume%3D77%26spage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm020143rb00016_1"><span><span class="NLM_string-ref">Maguire, M. P.; Sheets, K. R.; McVety, K.; Spada, A. P.; Zilberstein, A. A new series of PDGF receptor tyrosine kinase inhibitors:  3-substituted quinoline derivatives. <i>  J. Med. Chem</i>. <b>1994</b>, <i>37</i>, 2129−2137.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2137&author=M.+P.+Maguire&author=K.+R.+Sheets&author=K.+McVety&author=A.+P.+Spada&author=A+Zilberstein&title=A+new+series+of+PDGF+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+3-substituted+quinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DM.%2BP.%26atitle%3DA%2520new%2520series%2520of%2520PDGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%25203-substituted%2520quinoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm020143rb00017_1"><span><span class="NLM_string-ref">Kubo, K.; Shimizu, T.; Ohyama, S.; Murooka, H.; Nishitoba, T.; Kato, S.; Kobayashi, Y.; Yagi, M.; Isoe, T.; Nakamura, K.; Osawa, T.; Izawa, T. A novel series of 4-phenoxyquinoxazolines:  potent and highly selective inhibitors of PDGF receptor autophosphorylation. <i>  Bioorg. Med. Chem. </i><i>Lett</i>. <b>1997</b>, <i>7</i>, 2935−2940.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2940&author=K.+Kubo&author=T.+Shimizu&author=S.+Ohyama&author=H.+Murooka&author=T.+Nishitoba&author=S.+Kato&author=Y.+Kobayashi&author=M.+Yagi&author=T.+Isoe&author=K.+Nakamura&author=T.+Osawa&author=T+Izawa&title=A+novel+series+of+4-phenoxyquinoxazolines%3A%E2%80%89+potent+and+highly+selective+inhibitors+of+PDGF+receptor+autophosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26atitle%3DA%2520novel%2520series%2520of%25204-phenoxyquinoxazolines%253A%25E2%2580%2589%2520potent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520PDGF%2520receptor%2520autophosphorylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm020143rb00018_1"><span><span class="NLM_string-ref">Buchdunger, E.; Zimmerman, J.; Mett, H.; Meyer, T.; Muller, M.; Lydon, N. B. Selective inhibition of PDGF signal transduction pathway bya PTK inhibitor of the 2-phenylaminopyrimidine class. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>1995</b>, <i>92</i>, 2558−2562.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=2562&author=E.+Buchdunger&author=J.+Zimmerman&author=H.+Mett&author=T.+Meyer&author=M.+Muller&author=N.+B+Lydon&title=Selective+inhibition+of+PDGF+signal+transduction+pathway+bya+PTK+inhibitor+of+the+2-phenylaminopyrimidine+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuchdunger%26aufirst%3DE.%26atitle%3DSelective%2520inhibition%2520of%2520PDGF%2520signal%2520transduction%2520pathway%2520bya%2520PTK%2520inhibitor%2520of%2520the%25202-phenylaminopyrimidine%2520class%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D2562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm020143rb00019_1"><span><span class="NLM_string-ref">Giese, N. A.; Lokker, N.; Laibelman, A. M.; Scarborough, R. M. U.S. Patent No. 5,916,908, June 29, 1999; <i>  Chem Abstr</i>. <b>1999</b>, <i>131</i>, 58819.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Giese%2C+N.+A.%3B+Lokker%2C+N.%3B+Laibelman%2C+A.+M.%3B+Scarborough%2C+R.+M.+U.S.+Patent+No.+5%2C916%2C908%2C+June+29%2C+1999%3B+Chem+Abstr.+1999%2C+131%2C+58819.+Giese%2C+N.+A.%3B+Lokker%2C+N.%3B+Laibelman%2C+A.+M.%3B+Scarborough%2C+R.+M.+U.S.+Patent+No.+5%2C916%2C908%2C+June+29%2C+1999%3B+Chem+Abstr.+1999%2C+131%2C+58819."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiese%26aufirst%3DN.%2BA.%26jtitle%3DChem%2520Abstr.%26date%3D1999%26volume%3D131%26spage%3D58819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00020"><div class="reference"><div class="NLM_citation" id="jm020143rb00020_1"><span><span class="NLM_string-ref">Palmer, B. D.; Kraher, A. J.; Hartl, B. G.; Panapoulos, A. D.; Panek, R. L.; Batley, B. L.; Lu, G. H.; Trumpp-Kallmeyer, S.; Showalter, H. D. H.; Denny, W. A. Structure activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 2373−2382.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2382&author=B.+D.+Palmer&author=A.+J.+Kraher&author=B.+G.+Hartl&author=A.+D.+Panapoulos&author=R.+L.+Panek&author=B.+L.+Batley&author=G.+H.+Lu&author=S.+Trumpp-Kallmeyer&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Structure+activity+relationships+for+5-substituted+1-phenylbenzimidazoles+as+selective+inhibitors+of+the+platelet-derived+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DStructure%2520activity%2520relationships%2520for%25205-substituted%25201-phenylbenzimidazoles%2520as%2520selective%2520inhibitors%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm020143rb00021_1"><span><span class="NLM_string-ref">Yu, J.-C.; Lokker, N. A.; Hollenbach, S.; Apatira, M.; Li, J.; Betz, A.; Sedlock, D.; Oda, S.; Nomoto, Y.; Matsuno, K.; Ide, S.-I.; Tsukuda, E.; Giese, N. A. Efficacy of the Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on cellular proliferation, Migration, and Suppression of Neointima following Vascular Injury. <i>  J. Pharmacol. </i><i>Exp. Ther</i>. <b>2001</b>, <i>298</i>, 1172−1178. (b) Giese, N. A.; Lokker, N. A.; Yu, J.-C.; Matsuno, K.; Ichimura, M.; Oda, S.; Scarborough, R. M.; Pandey, A. Development of antagonists of the platelet-derived growth factor receptor family. <i>Oncol. Spectrums</i><b>2001</b>, <i>2</i>, 550−556.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2001&pages=1178&author=J.-C.+Yu&author=N.+A.+Lokker&author=S.+Hollenbach&author=M.+Apatira&author=J.+Li&author=A.+Betz&author=D.+Sedlock&author=S.+Oda&author=Y.+Nomoto&author=K.+Matsuno&author=S.-I.+Ide&author=E.+Tsukuda&author=N.+A+Giese&title=Efficacy+of+the+Novel+Selective+Platelet-Derived+Growth+Factor+Receptor+Antagonist+CT52923+on+cellular+proliferation%2C+Migration%2C+and+Suppression+of+Neointima+following+Vascular+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.-C.%26atitle%3DEfficacy%2520of%2520the%2520Novel%2520Selective%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor%2520Antagonist%2520CT52923%2520on%2520cellular%2520proliferation%252C%2520Migration%252C%2520and%2520Suppression%2520of%2520Neointima%2520following%2520Vascular%2520Injury%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D298%26spage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm020143rb00022_1"><span><span class="NLM_string-ref">Matsuno, K.; Nakajima, T.; Tahara, K.; Shigeki, F.; Ichimura, M.; Giese, N. A.; Yu, J.-C.; Iie, J.; Tsukuda, E.; Ide, S.; Oda, S.; Nomoto, Y. <i>  Selective </i><i>inhibitors of PDGF receptor phosphorylation:  synthesis, structure</i><i>−</i><i>activity </i><i>relationships and biological effects</i>, 217th ACS National Meeting, Anaheim, CA, 1999; Abstr. No. 061. (b) Matsuno, K.; Ichimura, M.; Nakajima, T.; Tahara, K.; Fujiwara, S.; Kase, H.; Giese, N. A.; Pandey, A.; Scarborough, R. M.; Yu, J.-C.; Lokker, N. A.; Irie, J.; Tsukuda, E.; Oda, S.; Nomoto, Y. Potent and selective inhibitors of PDGF receptor phosphorylation. 1. Synthesis and structure−activity relationship of a new class of quinazoline derivatives. <i>J. Med. Chem.</i><b>2002</b>, <i>45</i>, 3057−3066.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&conference=217th+ACS+National+Meeting&author=K.+Matsuno&author=T.+Nakajima&author=K.+Tahara&author=F.+Shigeki&author=M.+Ichimura&author=N.+A.+Giese&author=J.-C.+Yu&author=J.+Iie&author=E.+Tsukuda&author=S.+Ide&author=S.+Oda&author=Y.+Nomoto&title=Selective+inhibitors+of+PDGF+receptor+phosphorylation%3A%E2%80%89+synthesis%2C+structure%E2%88%92activity+relationships+and+biological+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuno%26aufirst%3DK.%26atitle%3DSelective%2520inhibitors%2520of%2520PDGF%2520receptor%2520phosphorylation%253A%25E2%2580%2589%2520synthesis%252C%2520structure%25E2%2588%2592activity%2520relationships%2520and%2520biological%2520effects%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm020143rb00023_1"><span><span class="NLM_string-ref">Cronin, T. H.; Hess, H.-J. E. South African Patent Appl. No. 676512, Oct 31, 1967; <i>  Chem. Abstr</i>. <b>1969</b>, <i>70</i>, 68419.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1969&pages=68419&author=T.+H.+Cronin&author=H.-J.+E+Hess&title=South+African+Patent+Appl.+No.+676512%2C+Oct+31%2C+1967%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCronin%26aufirst%3DT.%2BH.%26atitle%3DSouth%2520African%2520Patent%2520Appl.%2520No.%2520676512%252C%2520Oct%252031%252C%25201967%253B%26jtitle%3DChem.%2520Abstr.%26date%3D1969%26volume%3D70%26spage%3D68419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm020143rb00024_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Bridges, A. J.; Showalter, H. D.; Sun, L. Tyrosine Kinase Inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 918−928.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=928&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+J.+Bridges&author=H.+D.+Showalter&author=L+Sun&title=Tyrosine+Kinase+Inhibitors.+9.+Synthesis+and+evaluation+of+fused+tricyclic+quinazoline+analogues+as+ATP+site+inhibitors+of+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%25209.%2520Synthesis%2520and%2520evaluation%2520of%2520fused%2520tricyclic%2520quinazoline%2520analogues%2520as%2520ATP%2520site%2520inhibitors%2520of%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm020143rb00025_1"><span><span class="NLM_string-ref">Woodburn, J. R. The epidermal growth factor receptor and its inhibition in cancer therapy. <i>  Pharmacol. Ther</i>. <b>1999</b>, <i>82</i>, 241−250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=250&author=J.+R+Woodburn&title=The+epidermal+growth+factor+receptor+and+its+inhibition+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR%26atitle%3DThe%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520its%2520inhibition%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm020143rb00026_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent, P. W.; Patmore, S. J. Tyrosine Kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+Kinase+inhibitors.+15.+4-%28Phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520Kinase%2520inhibitors.%252015.%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm020143rb00027_1"><span><span class="NLM_string-ref">Moyer, J. D.; Barbacci, E. G.; Iwata, K. K.; Arnold, L.; Boman, B.; Cunningham, A.; DiOrio, C.; Doty, J.; Morin, M. J.; Moyer, M. P.; Neveu, M.; Pllack, V. A.; Reynolds, M. M.; Sloan, D.; Theleman, A.; Miller, P. Induction of apoptosis and cell cycle arrest by CP-358,774, an epidermal growth factor receptor tyrosine kinase. <i>  Cancer Res</i>. <b>1997</b>, <i>57</i>, 4838−4848.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4848&author=J.+D.+Moyer&author=E.+G.+Barbacci&author=K.+K.+Iwata&author=L.+Arnold&author=B.+Boman&author=A.+Cunningham&author=C.+DiOrio&author=J.+Doty&author=M.+J.+Morin&author=M.+P.+Moyer&author=M.+Neveu&author=V.+A.+Pllack&author=M.+M.+Reynolds&author=D.+Sloan&author=A.+Theleman&author=P+Miller&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+CP-358%2C774%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520CP-358%252C774%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm020143rb00028_1"><span><span class="NLM_string-ref">Woodburn, J. R.; Barker, A. J.; Gibson, K. H.; Ashton, S. E.; Wakeling, A. E. ZD1839, an epidermal growth factor tyrosine kinase inhibitor selected for clinical development. <i>  Proc. Am. Assoc. Cancer Res</i>. <b>1997</b>, <i>38</i>, 6333.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=6333&author=J.+R.+Woodburn&author=A.+J.+Barker&author=K.+H.+Gibson&author=S.+E.+Ashton&author=A.+E.+Wakeling&title=an+epidermal+growth+factor+tyrosine+kinase+inhibitor+selected+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26atitle%3Dan%2520epidermal%2520growth%2520factor%2520tyrosine%2520kinase%2520inhibitor%2520selected%2520for%2520clinical%2520development%26jtitle%3DProc.%2520Am.%2520Assoc.%2520Cancer%2520Res.%26date%3D1997%26volume%3D38%26spage%3D6333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm020143rb00029_1"><span><span class="NLM_string-ref">Traxler, P. Preclinical profile of PKI166:  anovel and potent EGFR tyrosine kinase inhibitor for clinical development. <i>  Clin. Cancer Res</i>. <b>1999</b>, <i>5</i>, 3750S.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=3750S&author=P+Traxler&title=Preclinical+profile+of+PKI166%3A%E2%80%89+anovel+and+potent+EGFR+tyrosine+kinase+inhibitor+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DPreclinical%2520profile%2520of%2520PKI166%253A%25E2%2580%2589%2520anovel%2520and%2520potent%2520EGFR%2520tyrosine%2520kinase%2520inhibitor%2520for%2520clinical%2520development%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D3750S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00030"><div class="reference"><div class="NLM_citation" id="jm020143rb00030_1"><span><span class="NLM_string-ref">Lokker, N. A.; O'Hare, J. P.; Barsoumian, A.; Tomlinson, J. E.; Ramakrishnan, V.; Fretto, L. J.; Giese, N. A. Functional importance of the platelet-derived growth factor receptor extracellular immunoglobin-like domains:  Identification of PDGF binding site and neutralizing monoclonal antibodies. <i>  J. Biol. Chem</i>. <b>1997</b>, <i>272</i>, 33037−33044.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=33044&author=N.+A.+Lokker&author=J.+P.+O%27Hare&author=A.+Barsoumian&author=J.+E.+Tomlinson&author=V.+Ramakrishnan&author=L.+J.+Fretto&author=N.+A+Giese&title=Functional+importance+of+the+platelet-derived+growth+factor+receptor+extracellular+immunoglobin-like+domains%3A%E2%80%89+Identification+of+PDGF+binding+site+and+neutralizing+monoclonal+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLokker%26aufirst%3DN.%2BA.%26atitle%3DFunctional%2520importance%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520extracellular%2520immunoglobin-like%2520domains%253A%25E2%2580%2589%2520Identification%2520of%2520PDGF%2520binding%2520site%2520and%2520neutralizing%2520monoclonal%2520antibodies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D33044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm020143rb00031_1"><span><span class="NLM_string-ref">Bridges, A. J. Current progress towards the development of tyrosine kinase inhibitors as anticancer agents. <i>  Emerging Drugs</i><b>1998</b>, <i>3</i>, 279−292.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=292&author=A.+J+Bridges&title=Current+progress+towards+the+development+of+tyrosine+kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ%26atitle%3DCurrent%2520progress%2520towards%2520the%2520development%2520of%2520tyrosine%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DEmerging%2520Drugs%26date%3D1998%26volume%3D3%26spage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm020143rb00032_1"><span><span class="NLM_string-ref">Gibson, K. H.; Grundy, W.; Godfrey, A. A.; Wooburn, J. R.; Ashton, S. E.; Curry, B. J.; Scarlett, L.; Barker, A. J.; Brown, D. S. Epidermal Growth Factor Receptor Tyrosine Kinase:  Structureactivity Relationships and Antitumor Activity of Novel Quinazolines. <i>  Bioorg. Med. Chem. Lett</i>. <b>1997</b>, <i>7</i>, 2723−2728.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2728&author=K.+H.+Gibson&author=W.+Grundy&author=A.+A.+Godfrey&author=J.+R.+Wooburn&author=S.+E.+Ashton&author=B.+J.+Curry&author=L.+Scarlett&author=A.+J.+Barker&author=D.+S+Brown&title=Epidermal+Growth+Factor+Receptor+Tyrosine+Kinase%3A%E2%80%89+Structureactivity+Relationships+and+Antitumor+Activity+of+Novel+Quinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DK.%2BH.%26atitle%3DEpidermal%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%253A%25E2%2580%2589%2520Structureactivity%2520Relationships%2520and%2520Antitumor%2520Activity%2520of%2520Novel%2520Quinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm020143rb00033_1"><span><span class="NLM_string-ref">Smaill, J. B.; Rewcastle, G. W.; Loo, J. A.; Greis, K. D.; Chan, H. O.; Reyner, E. L.; Lipka, E.; Showalter, H. D. H.; Vincent, P. W.; Elliott, W. L.; Denny, W. A. Tyrosine kinase inhibitors, 17:  Irreversible inhibitors of the epidermal growth factor receptor; 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 1380−1397.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1397&author=J.+B.+Smaill&author=G.+W.+Rewcastle&author=J.+A.+Loo&author=K.+D.+Greis&author=H.+O.+Chan&author=E.+L.+Reyner&author=E.+Lipka&author=H.+D.+H.+Showalter&author=P.+W.+Vincent&author=W.+L.+Elliott&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors%2C+17%3A%E2%80%89+Irreversible+inhibitors+of+the+epidermal+growth+factor+receptor%3B+4-%28Phenylamino%29quinazoline+and+4-%28Phenylamino%29pyrido%5B3%2C2-d%5Dpyrimidine-6-acrylamides+bearing+additional+solubilizing+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors%252C%252017%253A%25E2%2580%2589%2520Irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%253B%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528Phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2520bearing%2520additional%2520solubilizing%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm020143rb00034_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stoker, E. S. E.; Ple, P. A.; Lohmann, J. J. M.; Ogilvie, D. J.; Duker, M.; Wedge, S. R.; Curwen, J. O.; Kendrew, J.; Lambert-vandder Brempt, C. Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 5369−5389.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5389&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stoker&author=P.+A.+Ple&author=J.+J.+M.+Lohmann&author=D.+J.+Ogilvie&author=M.+Duker&author=S.+R.+Wedge&author=J.+O.+Curwen&author=J.+Kendrew&author=+Lambert&title=Design+and+Structure%E2%88%92Activity+Relationship+of+a+New+Class+of+Potent+VEGF+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520VEGF%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm020143rb00035_1"><span><span class="NLM_string-ref">Carroll, M.; Ohno-Jones, S.; Tamura, S.; Buchdanger, E.; Zimmerman, J.; Lydon, N. B.; Gilliland, D. G.; Druker, B. J. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cell expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. <i>  Blood</i><b>1997</b>, <i>90</i>, 4947−4952.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=4952&author=M.+Carroll&author=S.+Ohno-Jones&author=S.+Tamura&author=E.+Buchdanger&author=J.+Zimmerman&author=N.+B.+Lydon&author=D.+G.+Gilliland&author=B.+J.+Druker&title=a+tyrosine+kinase+inhibitor%2C+inhibits+the+growth+of+cell+expressing+BCR-ABL%2C+TEL-ABL%2C+and+TEL-PDGFR+fusion+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DM.%26atitle%3Da%2520tyrosine%2520kinase%2520inhibitor%252C%2520inhibits%2520the%2520growth%2520of%2520cell%2520expressing%2520BCR-ABL%252C%2520TEL-ABL%252C%2520and%2520TEL-PDGFR%2520fusion%2520proteins%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D4952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm020143rb00036_1"><span><span class="NLM_string-ref">Wilbanks, A. M.; Mahajan, S.; Frank, D. A.; Druker, B. J.; Gilliland, D. G.; Carroll, M. TEL/PDGFβR fusion protein activates STAT1 and STAT5:  a common mechanism for transformation by tyrosine kinase fusion proteins. <i>  Exp. Hematol</i>. <b>2000</b>, <i>28</i>, 584−593.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=593&author=A.+M.+Wilbanks&author=S.+Mahajan&author=D.+A.+Frank&author=B.+J.+Druker&author=D.+G.+Gilliland&author=M.+Carroll&author=R+F%CE%B2&title=fusion+protein+activates+STAT1+and+STAT5%3A%E2%80%89+a+common+mechanism+for+transformation+by+tyrosine+kinase+fusion+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilbanks%26aufirst%3DA.%2BM.%26atitle%3Dfusion%2520protein%2520activates%2520STAT1%2520and%2520STAT5%253A%25E2%2580%2589%2520a%2520common%2520mechanism%2520for%2520transformation%2520by%2520tyrosine%2520kinase%2520fusion%2520proteins%26jtitle%3DExp.%2520Hematol.%26date%3D2000%26volume%3D28%26spage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm020143rb00037_1"><span><span class="NLM_string-ref">Kelly, L. M.; Yu, J.-C.; Boulton, C. L.; Apatira, M.; Li, J.; Sullivan, C. M.; Williams, I.; Amaral, S. M.; Curley, D. P.; Duclos, N.; Neuberg, D.; Scarborough, R. M.; Pandey, A.; Hollenbach, S.; Abe, K.; Lokker, N. A.; Ailliland, D. G.; Giese, N. A. CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). <i>  Cancer Cell</i>. <b>2002</b>, <i>1</i>, 421−432.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=432&author=L.+M.+Kelly&author=J.-C.+Yu&author=C.+L.+Boulton&author=M.+Apatira&author=J.+Li&author=C.+M.+Sullivan&author=I.+Williams&author=S.+M.+Amaral&author=D.+P.+Curley&author=N.+Duclos&author=D.+Neuberg&author=R.+M.+Scarborough&author=A.+Pandey&author=S.+Hollenbach&author=K.+Abe&author=N.+A.+Lokker&author=D.+G.+Ailliland&author=N.+A.+Giese&title=a+novel+selective+FLT3+antagonist+for+the+treatment+of+acute+myelogenous+leukemia+%28AML%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DL.%2BM.%26atitle%3Da%2520novel%2520selective%2520FLT3%2520antagonist%2520for%2520the%2520treatment%2520of%2520acute%2520myelogenous%2520leukemia%2520%2528AML%2529%26jtitle%3DCancer%2520Cell.%26date%3D2002%26volume%3D1%26spage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm020143rb00038_1"><span><span class="NLM_string-ref">Druker, B. J.; Talpaz, M.; Resta, D. J. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. <i>  N. </i><i>Engl. J. Med</i>. <b>2001</b>, <i>344</i>, 1031−1037.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1037&author=B.+J.+Druker&author=M.+Talpaz&author=D.+J+Resta&title=Efficacy+and+safety+of+a+specific+inhibitor+of+the+BCR-ABL+tyrosine+kinase+in+chronic+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520a%2520specific%2520inhibitor%2520of%2520the%2520BCR-ABL%2520tyrosine%2520kinase%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm020143rb00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm020143rb00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm020143rb00039_1"><span><span class="NLM_string-ref">Schindler, T.; Bornmann, W.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J. Structural mechanism for STI571 inhibition of abelson tyrosine kinase. <i>  Science</i><b>2000</b>, <i>289</i>, 1938−1942.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1942&author=T.+Schindler&author=W.+Bornmann&author=P.+Pellicena&author=W.+T.+Miller&author=B.+Clarkson&author=J+Kuriyan&title=Structural+mechanism+for+STI571+inhibition+of+abelson+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26atitle%3DStructural%2520mechanism%2520for%2520STI571%2520inhibition%2520of%2520abelson%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm020143rb00001':['jm020143rb00001_1'],'jm020143rb00002':['jm020143rb00002_1'],'jm020143rb00003':['jm020143rb00003_1'],'jm020143rb00004':['jm020143rb00004_1'],'jm020143rb00005':['jm020143rb00005_1'],'jm020143rb00006':['jm020143rb00006_1'],'jm020143rb00007':['jm020143rb00007_1'],'jm020143rb00008':['jm020143rb00008_1'],'jm020143rb00009':['jm020143rb00009_1'],'jm020143rb00010':['jm020143rb00010_1'],'jm020143rb00011':['jm020143rb00011_1'],'jm020143rb00012':['jm020143rb00012_1'],'jm020143rb00013':['jm020143rb00013_1'],'jm020143rb00014':['jm020143rb00014_1'],'jm020143rb00015':['jm020143rb00015_1'],'jm020143rb00016':['jm020143rb00016_1'],'jm020143rb00017':['jm020143rb00017_1'],'jm020143rb00018':['jm020143rb00018_1'],'jm020143rb00019':['jm020143rb00019_1'],'jm020143rb00020':['jm020143rb00020_1'],'jm020143rb00021':['jm020143rb00021_1'],'jm020143rb00022':['jm020143rb00022_1'],'jm020143rb00023':['jm020143rb00023_1'],'jm020143rb00024':['jm020143rb00024_1'],'jm020143rb00025':['jm020143rb00025_1'],'jm020143rb00026':['jm020143rb00026_1'],'jm020143rb00027':['jm020143rb00027_1'],'jm020143rb00028':['jm020143rb00028_1'],'jm020143rb00029':['jm020143rb00029_1'],'jm020143rb00030':['jm020143rb00030_1'],'jm020143rb00031':['jm020143rb00031_1'],'jm020143rb00032':['jm020143rb00032_1'],'jm020143rb00033':['jm020143rb00033_1'],'jm020143rb00034':['jm020143rb00034_1'],'jm020143rb00035':['jm020143rb00035_1'],'jm020143rb00036':['jm020143rb00036_1'],'jm020143rb00037':['jm020143rb00037_1'],'jm020143rb00038':['jm020143rb00038_1'],'jm020143rb00039':['jm020143rb00039_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 92 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Julakanti Satyanarayana Reddy, Chih-Ming Chen, Mohane Selvaraj Coumar, Hsu-Yi Sun, Na Sun, <span class="NLM_string-name hlFld-ContribAuthor">Hsing-Pang Hsieh</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (4)
                                     , 817-830. <a href="https://doi.org/10.1021/acs.oprd.0c00515" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00515%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BRobust%252BScale-Up%252BSynthetic%252BRoute%252Bfor%252BBPR1K871%25253A%252BA%252BClinical%252BCandidate%252Bfor%252Bthe%252BTreatment%252Bof%252BAcute%252BMyeloid%252BLeukemia%252Band%252BSolid%252BTumors%26aulast%3DReddy%26aufirst%3DJulakanti%2BSatyanarayana%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D18022021%26volume%3D25%26issue%3D4%26spage%3D817%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Wei  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Ren-Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Heng-Xiu  Yan</span>, <span class="hlFld-ContribAuthor ">Zhi-Xing  Cao</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Ze-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Pan  Ji</span>, <span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Li-Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Yang</span>, <span class="hlFld-ContribAuthor ">Chun-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuang  Ma</span>, <span class="hlFld-ContribAuthor ">Shan  Feng</span>, <span class="hlFld-ContribAuthor ">Qi-Zheng  Sun</span>, <span class="hlFld-ContribAuthor ">Yu-Quan  Wei</span>, and <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Novel Potent and Selective FLT3 Inhibitor 1-{5-[7-(3- Morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and Its Anti-Acute Myeloid Leukemia (AML) Activities in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (8)
                                     , 3852-3866. <a href="https://doi.org/10.1021/jm300042x" title="DOI URL">https://doi.org/10.1021/jm300042x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300042x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300042x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BNovel%252BPotent%252Band%252BSelective%252BFLT3%252BInhibitor%252B1-%25257B5-%25255B7-%2525283-%252BMorpholinopropoxy%252529quinazolin-4-ylthio%25255D-%25255B1%25252C3%25252C4%25255Dthiadiazol-2-yl%25257D-3-p-tolylurea%252Band%252BIts%252BAnti-Acute%252BMyeloid%252BLeukemia%252B%252528AML%252529%252BActivities%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DLi%26aufirst%3DWei-Wei%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D11012012%26date%3D06042012%26date%3D26042012%26date%3D27032012%26volume%3D55%26issue%3D8%26spage%3D3852%26epage%3D3866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Garofalo</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">Séverine  Ravez</span>, <span class="hlFld-ContribAuthor ">Amélie  Lemoine</span>, <span class="hlFld-ContribAuthor ">Perrine  Six</span>, <span class="hlFld-ContribAuthor ">Philippe  Chavatte</span>, <span class="hlFld-ContribAuthor ">Laurence  Goossens</span>, and <span class="hlFld-ContribAuthor ">Patrick  Depreux</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (3)
                                     , 1189-1204. <a href="https://doi.org/10.1021/jm2013453" title="DOI URL">https://doi.org/10.1021/jm2013453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2013453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2013453%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252B%252528Aryloxy%252529quinazoline%252BUreas%252Bas%252BNovel%25252C%252BPotent%25252C%252Band%252BSelective%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor-2%252BInhibitors%26aulast%3DGarofalo%26aufirst%3DAntonio%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D07102011%26date%3D25012012%26date%3D09022012%26date%3D09012012%26volume%3D55%26issue%3D3%26spage%3D1189%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margaret R.  McLellan</span>, <span class="hlFld-ContribAuthor ">M. Dominic  Ryan</span>, and <span class="hlFld-ContribAuthor ">Curt M.  Breneman</span>  . </span><span class="cited-content_cbyCitation_article-title">Rank Order Entropy: Why One Metric Is Not Enough. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (9)
                                     , 2302-2319. <a href="https://doi.org/10.1021/ci200170k" title="DOI URL">https://doi.org/10.1021/ci200170k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200170k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200170k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DRank%252BOrder%252BEntropy%25253A%252BWhy%252BOne%252BMetric%252BIs%252BNot%252BEnough%26aulast%3DMcLellan%26aufirst%3DMargaret%2BR.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14042011%26date%3D29082011%26date%3D26092011%26volume%3D51%26issue%3D9%26spage%3D2302%26epage%3D2319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">John  Eksterowicz</span>, <span class="hlFld-ContribAuthor ">Stephanie  Geuns-Meyer</span> and <span class="hlFld-ContribAuthor ">Yaxiong  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Analysis of Kinase Inhibitor Selectivity using a Thermodynamics-Based Partition Index. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (11)
                                     , 4502-4510. <a href="https://doi.org/10.1021/jm100301x" title="DOI URL">https://doi.org/10.1021/jm100301x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100301x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100301x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnalysis%252Bof%252BKinase%252BInhibitor%252BSelectivity%252Busing%252Ba%252BThermodynamics-Based%252BPartition%252BIndex%26aulast%3DCheng%26aufirst%3DAlan%2BC.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D06032010%26date%3D11052010%26date%3D10062010%26volume%3D53%26issue%3D11%26spage%3D4502%26epage%3D4510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rajarshi Guha, , <span class="NLM_string-name hlFld-ContribAuthor">John H. Van Drie</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing How Well a Modeling Protocol Captures a Structure−Activity Landscape. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2008,</strong> <em>48 </em>
                                    (8)
                                     , 1716-1728. <a href="https://doi.org/10.1021/ci8001414" title="DOI URL">https://doi.org/10.1021/ci8001414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci8001414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci8001414%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAssessing%252BHow%252BWell%252Ba%252BModeling%252BProtocol%252BCaptures%252Ba%252BStructure%2525E2%252588%252592Activity%252BLandscape%26aulast%3DGuha%26aufirst%3DRajarshi%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D08082008%26date%3D23042008%26volume%3D48%26issue%3D8%26spage%3D1716%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rajarshi  Guha and,   <span class="NLM_string-name hlFld-ContribAuthor">Peter C.  Jurs</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Linear, Ensemble, and Nonlinear Models for the Prediction and Interpretation of the Biological Activity of a Set of PDGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Computer Sciences</span><span> <strong>2004,</strong> <em>44 </em>
                                    (6)
                                     , 2179-2189. <a href="https://doi.org/10.1021/ci049849f" title="DOI URL">https://doi.org/10.1021/ci049849f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci049849f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci049849f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Computer%2520Sciences%26atitle%3DDevelopment%252Bof%252BLinear%25252C%252BEnsemble%25252C%252Band%252BNonlinear%252BModels%252Bfor%252Bthe%252BPrediction%252Band%252BInterpretation%252Bof%252Bthe%252BBiological%252BActivity%252Bof%252Ba%252BSet%252Bof%252BPDGFR%252BInhibitors%26aulast%3DGuha%26aufirst%3DRajarshi%26date%3D2004%26date%3D2004%26date%3D2004%26date%3D04%252005%25202004%2520Received%2520May%25204%252C%25202004%26volume%3D44%26issue%3D6%26spage%3D2179%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>, <span class="hlFld-ContribAuthor ">Mubarak A.  Alamri</span>, <span class="hlFld-ContribAuthor ">Mohammed H.  Geesi</span>, <span class="hlFld-ContribAuthor ">El Hassane  Anouar</span>, <span class="hlFld-ContribAuthor ">Oussama  Ouerghi</span>, <span class="hlFld-ContribAuthor ">Alhumaidi B.  Alabbas</span>, <span class="hlFld-ContribAuthor ">Manal A.  Alossaimi</span>, <span class="hlFld-ContribAuthor ">Ali  Altharawi</span>, <span class="hlFld-ContribAuthor ">Oussama  Dehbi</span>, <span class="hlFld-ContribAuthor ">Safar M.  Alqahtani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>6 </em>, 1-7. <a href="https://doi.org/10.1080/07391102.2021.1890221" title="DOI URL">https://doi.org/10.1080/07391102.2021.1890221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1890221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1890221%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bof%252Ba%252Bnew%252Bquinazolinone-based%252Bderivative%252Bas%252Ba%252Bpotent%252Bdual%252Binhibitor%252Bfor%252BVEGFR-2%252Band%252BEGFR%252Btyrosine%252Bkinases%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2021%26date%3D2021%26volume%3D6%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Lambrinidis</span>, <span class="hlFld-ContribAuthor ">Cedric  Gouedard</span>, <span class="hlFld-ContribAuthor ">Sotiria  Stasinopoulou</span>, <span class="hlFld-ContribAuthor ">Angeliki  Angelopoulou</span>, <span class="hlFld-ContribAuthor ">Vassiliki  Ganou</span>, <span class="hlFld-ContribAuthor ">Aggeliki K.  Meligova</span>, <span class="hlFld-ContribAuthor ">Dimitra J.  Mitsiou</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Marakos</span>, <span class="hlFld-ContribAuthor ">Nicole  Pouli</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>, <span class="hlFld-ContribAuthor ">Michael N.  Alexis</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of new raloxifene analogues of improved antagonist activity and endometrial safety. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104482. <a href="https://doi.org/10.1016/j.bioorg.2020.104482" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104482%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Braloxifene%252Banalogues%252Bof%252Bimproved%252Bantagonist%252Bactivity%252Band%252Bendometrial%252Bsafety%26aulast%3DLambrinidis%26aufirst%3DGeorge%26date%3D2021%26volume%3D106%26spage%3D104482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reem F.  Abutayeh</span>, <span class="hlFld-ContribAuthor ">Jehad  Almaliti</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of New Sulfonamides-Based Flt3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , 403-412. <a href="https://doi.org/10.2174/1573406415666190401144053" title="DOI URL">https://doi.org/10.2174/1573406415666190401144053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190401144053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190401144053%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNew%252BSulfonamides-Based%252BFlt3%252BInhibitors%26aulast%3DAbutayeh%26aufirst%3DReem%2BF.%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D403%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reem Fawaz  Abutayeh</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>88 </em>, 128-151. <a href="https://doi.org/10.1016/j.jmgm.2019.01.011" title="DOI URL">https://doi.org/10.1016/j.jmgm.2019.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2019.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2019.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DDiscovery%252Bof%252Bnovel%252BFlt3%252Binhibitory%252Bchemotypes%252Bthrough%252Bextensive%252Bligand-based%252Band%252Bnew%252Bstructure-based%252Bpharmacophore%252Bmodelling%252Bmethods%26aulast%3DAbutayeh%26aufirst%3DReem%2BFawaz%26date%3D2019%26volume%3D88%26spage%3D128%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asuncion  Martinez-Anton</span>, <span class="hlFld-ContribAuthor ">Delphine  Gras</span>, <span class="hlFld-ContribAuthor ">Arnaud  Bourdin</span>, <span class="hlFld-ContribAuthor ">Patrice  Dubreuil</span>, <span class="hlFld-ContribAuthor ">Pascal  Chanez</span>. </span><span class="cited-content_cbyCitation_article-title">KIT as a therapeutic target for non-oncological diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>197 </em>, 11-37. <a href="https://doi.org/10.1016/j.pharmthera.2018.12.008" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DKIT%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bnon-oncological%252Bdiseases%26aulast%3DMartinez-Anton%26aufirst%3DAsuncion%26date%3D2019%26volume%3D197%26spage%3D11%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zühal  Kilic-Kurt</span>, <span class="hlFld-ContribAuthor ">Filiz  Bakar-Ates</span>, <span class="hlFld-ContribAuthor ">Yeliz  Aka</span>, <span class="hlFld-ContribAuthor ">Ozgur  Kutuk</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro apoptotic mechanism of novel pyrrolopyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 511-519. <a href="https://doi.org/10.1016/j.bioorg.2018.10.060" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bapoptotic%252Bmechanism%252Bof%252Bnovel%252Bpyrrolopyrimidine%252Bderivatives%26aulast%3DKilic-Kurt%26aufirst%3DZ%25C3%25BChal%26date%3D2019%26volume%3D83%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pawan  Kumar</span>, <span class="hlFld-ContribAuthor ">Muhammad Taufiq F.  Mazlee</span>, <span class="hlFld-ContribAuthor ">Muhammad K.  Abdul Wahab</span>, <span class="hlFld-ContribAuthor ">Chandra Kant  Belwal</span>, <span class="hlFld-ContribAuthor ">Ramesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Shahnawaz  Sajid</span>. </span><span class="cited-content_cbyCitation_article-title">Improved protocol for synthesis of N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy) quinazolin-4-amine (gefitinib). </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2019,</strong> <em>73 </em>
                                    (1)
                                     , 39-46. <a href="https://doi.org/10.1007/s11696-018-0564-x" title="DOI URL">https://doi.org/10.1007/s11696-018-0564-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-018-0564-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-018-0564-x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DImproved%252Bprotocol%252Bfor%252Bsynthesis%252Bof%252BN-%2525283-chloro-4-fluorophenyl%252529-7-methoxy-6-%2525283-morpholin-4-ylpropoxy%252529%252Bquinazolin-4-amine%252B%252528gefitinib%252529%26aulast%3DKumar%26aufirst%3DPawan%26date%3D2019%26date%3D2018%26volume%3D73%26issue%3D1%26spage%3D39%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatjana  Kovacevic</span>, <span class="hlFld-ContribAuthor ">Milan  Mesic</span>, <span class="hlFld-ContribAuthor ">Amir  Avdagic</span>, <span class="hlFld-ContribAuthor ">Miroslav  Zegarac</span>. </span><span class="cited-content_cbyCitation_article-title">An alternative synthesis of the non-small cell lung carcinoma drug afatinib. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (47)
                                     , 4180-4182. <a href="https://doi.org/10.1016/j.tetlet.2018.10.026" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.10.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.10.026%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Balternative%252Bsynthesis%252Bof%252Bthe%252Bnon-small%252Bcell%252Blung%252Bcarcinoma%252Bdrug%252Bafatinib%26aulast%3DKovacevic%26aufirst%3DTatjana%26date%3D2018%26volume%3D59%26issue%3D47%26spage%3D4180%26epage%3D4182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hitoshi  Kiyoi</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 167-179. <a href="https://doi.org/10.1007/978-981-10-3332-2_10" title="DOI URL">https://doi.org/10.1007/978-981-10-3332-2_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-3332-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-3332-2_10%26sid%3Dliteratum%253Aachs%26atitle%3DFLT3%252BInhibitors%26aulast%3DKiyoi%26aufirst%3DHitoshi%26date%3D2017%26date%3D2017%26spage%3D167%26epage%3D179%26pub%3DSpringer%2520Singapore%26atitle%3DChemotherapy%252Bfor%252BLeukemia%26aulast%3DUeda%26aufirst%3DTakanori%26date%3D2017%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung  Chang Hsu</span>, <span class="hlFld-ContribAuthor ">Mohane  Selvaraj Coumar</span>, <span class="hlFld-ContribAuthor ">Wen-Chieh  Wang</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Shiao</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Ching-Chuan  Kuo</span>, <span class="hlFld-ContribAuthor ">Chun-Wei  Chang</span>, <span class="hlFld-ContribAuthor ">Fu-Ming  Kuo</span>, <span class="hlFld-ContribAuthor ">Pei-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Sing-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">An-Siou  Li</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Po-Chu  Kuo</span>, <span class="hlFld-ContribAuthor ">Ching-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ming-Hsine  Wu</span>, <span class="hlFld-ContribAuthor ">Chen-Lung  Huang</span>, <span class="hlFld-ContribAuthor ">Kuei-Jung  Yen</span>, <span class="hlFld-ContribAuthor ">Yun-I  Chang</span>, <span class="hlFld-ContribAuthor ">John T.-A.  Hsu</span>, <span class="hlFld-ContribAuthor ">Chiung-Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Chuan  Shih</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BPR1K871, a quinazoline based,  multi-kinase inhibitor for the treatment of AML and solid tumors: Rational  design, synthesis,
              in vitro
              and
              in vivo
              evaluation. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (52)
                                     , 86239-86256. <a href="https://doi.org/10.18632/oncotarget.13369" title="DOI URL">https://doi.org/10.18632/oncotarget.13369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.13369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.13369%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DDiscovery%252Bof%252BBPR1K871%25252C%252Ba%252Bquinazoline%252Bbased%25252C%252Bmulti-kinase%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252BAML%252Band%252Bsolid%252Btumors%25253A%252BRational%252Bdesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%26aulast%3DChang%2BHsu%26aufirst%3DYung%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D52%26spage%3D86239%26epage%3D86256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tracy T.  Batchelor</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Gerstner</span>, <span class="hlFld-ContribAuthor ">Xiaobu  Ye</span>, <span class="hlFld-ContribAuthor ">Serena  Desideri</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Duda</span>, <span class="hlFld-ContribAuthor ">David  Peereboom</span>, <span class="hlFld-ContribAuthor ">Glenn J.  Lesser</span>, <span class="hlFld-ContribAuthor ">Sajeel  Chowdhary</span>, <span class="hlFld-ContribAuthor ">Patrick Y.  Wen</span>, <span class="hlFld-ContribAuthor ">Stuart  Grossman</span>, <span class="hlFld-ContribAuthor ">Jeffrey G.  Supko</span>. </span><span class="cited-content_cbyCitation_article-title">Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology</span><span> <strong>2016,</strong> <em>4 </em>, now185. <a href="https://doi.org/10.1093/neuonc/now185" title="DOI URL">https://doi.org/10.1093/neuonc/now185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/neuonc/now185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fneuonc%2Fnow185%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%26atitle%3DFeasibility%25252C%252Bphase%252BI%25252C%252Band%252Bphase%252BII%252Bstudies%252Bof%252Btandutinib%25252C%252Ban%252Boral%252Bplatelet-derived%252Bgrowth%252Bfactor%252Breceptor-%2525CE%2525B2%252Btyrosine%252Bkinase%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Brecurrent%252Bglioblastoma%26aulast%3DBatchelor%26aufirst%3DTracy%2BT.%26date%3D2016%26date%3D2016%26volume%3D4%26spage%3Dnow185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 493-499. <a href="https://doi.org/10.1517/13543776.2015.1007042" title="DOI URL">https://doi.org/10.1517/13543776.2015.1007042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1007042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1007042%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEvaluation%252Bof%252BWO-2014132220%25252C%252Bselective%252BPDGFR%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D493%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Enzyme Inhibitor, Part I, Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 117-160. <a href="https://doi.org/10.1002/9781118892572.ch8" title="DOI URL">https://doi.org/10.1002/9781118892572.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118892572.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118892572.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DEnzyme%252BInhibitor%25252C%252BPart%252BI%25252C%252BTyrosine%252BKinases%26date%3D2015%26date%3D2015%26spage%3D117%26epage%3D160%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DAntineoplastic%252BDrugs%26aulast%3DLednicer%26aufirst%3DDaniel%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriela  Motyckova</span>, <span class="hlFld-ContribAuthor ">Richard M.  Stone</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Midostaurin as a Tyrosine Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 201-214. <a href="https://doi.org/10.1007/978-1-4939-1393-0_10" title="DOI URL">https://doi.org/10.1007/978-1-4939-1393-0_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-1393-0_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-1393-0_10%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BMidostaurin%252Bas%252Ba%252BTyrosine%252BKinase%252BInhibitor%26aulast%3DMotyckova%26aufirst%3DGabriela%26date%3D2015%26date%3D2014%26spage%3D201%26epage%3D214%26pub%3DSpringer%2520New%2520York%26atitle%3DTargeted%252BTherapy%252Bof%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DAndreeff%26aufirst%3DMichael%26date%3D2015%26volume%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zaheer  Ul-Haq</span>, <span class="hlFld-ContribAuthor ">Syed Kashif  Zafar</span>, <span class="hlFld-ContribAuthor ">Naveed  Khan</span>, <span class="hlFld-ContribAuthor ">Uzma  Mahmood</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based 3D-QSAR studies on quinazoline derivatives as platelets-derived growth factor (PDGFR) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (9)
                                     , 4070-4084. <a href="https://doi.org/10.1007/s00044-014-0946-8" title="DOI URL">https://doi.org/10.1007/s00044-014-0946-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-0946-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-0946-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructure-based%252B3D-QSAR%252Bstudies%252Bon%252Bquinazoline%252Bderivatives%252Bas%252Bplatelets-derived%252Bgrowth%252Bfactor%252B%252528PDGFR%252529%252Binhibitors%26aulast%3DUl-Haq%26aufirst%3DZaheer%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D9%26spage%3D4070%26epage%3D4084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saurabh  Prabhu</span>, <span class="hlFld-ContribAuthor ">Frederick  Harris</span>, <span class="hlFld-ContribAuthor ">Robert  Lea</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Snape</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule clinical trial candidates for the treatment of glioma. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (9)
                                     , 1298-1308. <a href="https://doi.org/10.1016/j.drudis.2014.02.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSmall-molecule%252Bclinical%252Btrial%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252Bglioma%26aulast%3DPrabhu%26aufirst%3DSaurabh%26date%3D2014%26volume%3D19%26issue%3D9%26spage%3D1298%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taslimahemad T.  Khatri</span>, <span class="hlFld-ContribAuthor ">Viresh H.  Shah</span>. </span><span class="cited-content_cbyCitation_article-title">One Pot Synthesis of Novel Cyanopyridones as an Intermediate of Bioactive Pyrido[2,3-d]Pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>58 </em>
                                    (4)
                                     , 366-376. <a href="https://doi.org/10.5012/jkcs.2014.58.4.366" title="DOI URL">https://doi.org/10.5012/jkcs.2014.58.4.366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/jkcs.2014.58.4.366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fjkcs.2014.58.4.366%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DOne%252BPot%252BSynthesis%252Bof%252BNovel%252BCyanopyridones%252Bas%252Ban%252BIntermediate%252Bof%252BBioactive%252BPyrido%25255B2%25252C3-d%25255DPyrimidines%26aulast%3DKhatri%26aufirst%3DTaslimahemad%2BT.%26date%3D2014%26volume%3D58%26issue%3D4%26spage%3D366%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregor  Schwan</span>, <span class="hlFld-ContribAuthor ">Ghadir  Barbar Asskar</span>, <span class="hlFld-ContribAuthor ">Norbert  Höfgen</span>, <span class="hlFld-ContribAuthor ">Lenka  Kubicova</span>, <span class="hlFld-ContribAuthor ">Uta  Funke</span>, <span class="hlFld-ContribAuthor ">Ute  Egerland</span>, <span class="hlFld-ContribAuthor ">Michael  Zahn</span>, <span class="hlFld-ContribAuthor ">Karen  Nieber</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheunemann</span>, <span class="hlFld-ContribAuthor ">Norbert  Sträter</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Detlef  Briel</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-Containing 6,7-Dialkoxybiaryl-Based Inhibitors for Phosphodiesterase 10 A: Synthesis and in vitro Evaluation of Inhibitory Potency, Selectivity, and Metabolism. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 1476-1487. <a href="https://doi.org/10.1002/cmdc.201300522" title="DOI URL">https://doi.org/10.1002/cmdc.201300522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300522%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DFluorine-Containing%252B6%25252C7-Dialkoxybiaryl-Based%252BInhibitors%252Bfor%252BPhosphodiesterase%2525E2%252580%25258510%2525E2%252580%252589A%25253A%252BSynthesis%252Band%252Bin%252Bvitro%252BEvaluation%252Bof%252BInhibitory%252BPotency%25252C%252BSelectivity%25252C%252Band%252BMetabolism%26aulast%3DSchwan%26aufirst%3DGregor%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1476%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyu  Ning</span>, <span class="hlFld-ContribAuthor ">Man  Feng</span>, <span class="hlFld-ContribAuthor ">Shilei  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Chang</span>, <span class="hlFld-ContribAuthor ">Chuanmin  Qi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel [99mTcN]2+ Labeled EGFR Inhibitors as Potential Radiotracers for Single Photon Emission Computed Tomography (SPECT) Tumor Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (5)
                                     , 5508-5521. <a href="https://doi.org/10.3390/molecules19055508" title="DOI URL">https://doi.org/10.3390/molecules19055508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules19055508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules19055508%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252B%25255B99mTcN%25255D2%25252B%252BLabeled%252BEGFR%252BInhibitors%252Bas%252BPotential%252BRadiotracers%252Bfor%252BSingle%252BPhoton%252BEmission%252BComputed%252BTomography%252B%252528SPECT%252529%252BTumor%252BImaging%26aulast%3DZhao%26aufirst%3DMingxia%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D5%26spage%3D5508%26epage%3D5521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nataliya  Belskaya</span>, <span class="hlFld-ContribAuthor ">Julia  Subbotina</span>, <span class="hlFld-ContribAuthor ">Svetlana  Lesogorova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2H-1,2,3-Triazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 51-116. <a href="https://doi.org/10.1007/7081_2014_125" title="DOI URL">https://doi.org/10.1007/7081_2014_125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2014_125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2014_125%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252B2H-1%25252C2%25252C3-Triazoles%26aulast%3DBelskaya%26aufirst%3DNataliya%26date%3D2014%26date%3D2014%26spage%3D51%26epage%3D116%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemistry%252Bof%252B1%25252C2%25252C3-triazoles%26aulast%3DDehaen%26aufirst%3DWim%26date%3D2015%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khadiga M.  Abu-Zied</span>, <span class="hlFld-ContribAuthor ">Tahia K.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Omar K.  Al-Duiaj</span>, <span class="hlFld-ContribAuthor ">Magdi E.A.  Zaki</span>. </span><span class="cited-content_cbyCitation_article-title">A simple approach to fused pyrido[2,3-d]pyrimidines incorporating khellinone and trimethoxyphenyl moieties as new scaffolds for antibacterial and antifungal agents. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2014,</strong> <em>20 </em>
                                    (2)
                                     <a href="https://doi.org/10.1515/hc-2013-0199" title="DOI URL">https://doi.org/10.1515/hc-2013-0199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2013-0199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2013-0199%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DA%252Bsimple%252Bapproach%252Bto%252Bfused%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bincorporating%252Bkhellinone%252Band%252Btrimethoxyphenyl%252Bmoieties%252Bas%252Bnew%252Bscaffolds%252Bfor%252Bantibacterial%252Band%252Bantifungal%252Bagents%26aulast%3DAbu-Zied%26aufirst%3DKhadiga%2BM.%26date%3D2014%26volume%3D20%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin S.  Chaudhari</span>, <span class="hlFld-ContribAuthor ">Ashok B.  Kadam</span>, <span class="hlFld-ContribAuthor ">Neelima  Khairatkar-Joshi</span>, <span class="hlFld-ContribAuthor ">Indranil  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Pallavi V.  Karnik</span>, <span class="hlFld-ContribAuthor ">Anupindi  Raghuram</span>, <span class="hlFld-ContribAuthor ">Shobha S.  Rao</span>, <span class="hlFld-ContribAuthor ">Thamil Selvan  Vaiyapuri</span>, <span class="hlFld-ContribAuthor ">Dinesh P.  Wale</span>, <span class="hlFld-ContribAuthor ">Vikram M.  Bhosale</span>, <span class="hlFld-ContribAuthor ">Girish S.  Gudi</span>, <span class="hlFld-ContribAuthor ">Ramchandra R.  Sangana</span>, <span class="hlFld-ContribAuthor ">Abraham  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1′H-spiro[chromene-2,4′-piperidine]-1′-carboxamides as TRPM8 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (21)
                                     , 6542-6553. <a href="https://doi.org/10.1016/j.bmc.2013.08.031" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bnovel%252BN-aryl-3%25252C4-dihydro-1%2525E2%252580%2525B2H-spiro%25255Bchromene-2%25252C4%2525E2%252580%2525B2-piperidine%25255D-1%2525E2%252580%2525B2-carboxamides%252Bas%252BTRPM8%252Bantagonists%26aulast%3DChaudhari%26aufirst%3DSachin%2BS.%26date%3D2013%26volume%3D21%26issue%3D21%26spage%3D6542%26epage%3D6553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  Samén</span>, <span class="hlFld-ContribAuthor ">Fabian  Arnberg</span>, <span class="hlFld-ContribAuthor ">Li  Lu</span>, <span class="hlFld-ContribAuthor ">Maria Hägg  Olofsson</span>, <span class="hlFld-ContribAuthor ">Tetyana  Tegnebratt</span>, <span class="hlFld-ContribAuthor ">Jan-Olov  Thorell</span>, <span class="hlFld-ContribAuthor ">Staffan  Holmin</span>, <span class="hlFld-ContribAuthor ">Sharon  Stone-Elander</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of Epidermal Growth Factor Receptor Targeting Probe [
              11
              C]PD153035: Impact on Biodistribution and Tumor Uptake in Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2013,</strong> <em>54 </em>
                                    (10)
                                     , 1804-1811. <a href="https://doi.org/10.2967/jnumed.113.120493" title="DOI URL">https://doi.org/10.2967/jnumed.113.120493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.113.120493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.113.120493%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DMetabolism%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BTargeting%252BProbe%252B%25255B%252B11%252BC%25255DPD153035%25253A%252BImpact%252Bon%252BBiodistribution%252Band%252BTumor%252BUptake%252Bin%252BRats%26aulast%3DSam%25C3%25A9n%26aufirst%3DErik%26date%3D2013%26date%3D2013%26volume%3D54%26issue%3D10%26spage%3D1804%26epage%3D1811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sivapriya  Ponnurangam</span>, <span class="hlFld-ContribAuthor ">David  Standing</span>, <span class="hlFld-ContribAuthor ">Parthasarathy  Rangarajan</span>, <span class="hlFld-ContribAuthor ">Dharmalingam  Subramaniam</span>. </span><span class="cited-content_cbyCitation_article-title">Tandutinib Inhibits the Akt/mTOR Signaling Pathway to Inhibit Colon Cancer Growth. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2013,</strong> <em>12 </em>
                                    (5)
                                     , 598-609. <a href="https://doi.org/10.1158/1535-7163.MCT-12-0907" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-12-0907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-12-0907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-12-0907%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTandutinib%252BInhibits%252Bthe%252BAkt%25252FmTOR%252BSignaling%252BPathway%252Bto%252BInhibit%252BColon%252BCancer%252BGrowth%26aulast%3DPonnurangam%26aufirst%3DSivapriya%26date%3D2013%26date%3D2013%26volume%3D12%26issue%3D5%26spage%3D598%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajarshi  Guha</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring structure-activity data using the landscape paradigm. </span><span class="cited-content_cbyCitation_journal-name">Wiley Interdisciplinary Reviews: Computational Molecular Science</span><span> <strong>2012,</strong> <em>2 </em>
                                    (6)
                                     , 829-841. <a href="https://doi.org/10.1002/wcms.1087" title="DOI URL">https://doi.org/10.1002/wcms.1087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1087%26sid%3Dliteratum%253Aachs%26jtitle%3DWiley%2520Interdisciplinary%2520Reviews%253A%2520Computational%2520Molecular%2520Science%26atitle%3DExploring%252Bstructure-activity%252Bdata%252Busing%252Bthe%252Blandscape%252Bparadigm%26aulast%3DGuha%26aufirst%3DRajarshi%26date%3D2012%26date%3D2012%26volume%3D2%26issue%3D6%26spage%3D829%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>, <span class="hlFld-ContribAuthor ">Joachim  Bischof</span>, <span class="hlFld-ContribAuthor ">Klaus  Kramer</span>. </span><span class="cited-content_cbyCitation_article-title">Other tyrosine kinase inhibitors in development and future directions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 50-63. <a href="https://doi.org/10.2217/ebo.12.16" title="DOI URL">https://doi.org/10.2217/ebo.12.16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/ebo.12.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Febo.12.16%26sid%3Dliteratum%253Aachs%26atitle%3DOther%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bdevelopment%252Band%252Bfuture%252Bdirections%26aulast%3DKnippschild%26aufirst%3DUwe%26date%3D2012%26date%3D2012%26spage%3D50%26epage%3D63%26pub%3DFuture%2520Medicine%2520Ltd%26atitle%3DTyrosine%252BKinase%252BInhibitors%252Bfor%252BGastrointestinal%252BStromal%252BTumors%26aulast%3DReichardt%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26volume%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachiko  Ohshima-Hosoyama</span>, <span class="hlFld-ContribAuthor ">Monika A.  Davare</span>, <span class="hlFld-ContribAuthor ">Suresh I.  Prajapati</span>, <span class="hlFld-ContribAuthor ">Jinu  Abraham</span>, <span class="hlFld-ContribAuthor ">Sangeet  Lal</span>, <span class="hlFld-ContribAuthor ">Laura D.  Nelon</span>, <span class="hlFld-ContribAuthor ">Aoife  Kilcoyne</span>, <span class="hlFld-ContribAuthor ">Francis J.  Giles</span>, <span class="hlFld-ContribAuthor ">Martha A.  Hanes</span>, <span class="hlFld-ContribAuthor ">Brian P.  Rubin</span>, <span class="hlFld-ContribAuthor ">Charles  Keller</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Testing of Tandutinib in a Transgenic Medulloblastoma Mouse Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pediatric Hematology/Oncology</span><span> <strong>2012,</strong> <em>34 </em>
                                    (2)
                                     , 116-121. <a href="https://doi.org/10.1097/MPH.0b013e3182309fe4" title="DOI URL">https://doi.org/10.1097/MPH.0b013e3182309fe4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MPH.0b013e3182309fe4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMPH.0b013e3182309fe4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pediatric%2520Hematology%252FOncology%26atitle%3DPreclinical%252BTesting%252Bof%252BTandutinib%252Bin%252Ba%252BTransgenic%252BMedulloblastoma%252BMouse%252BModel%26aulast%3DOhshima-Hosoyama%26aufirst%3DSachiko%26date%3D2012%26volume%3D34%26issue%3D2%26spage%3D116%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dale R.  Shepard</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Cooney</span>, <span class="hlFld-ContribAuthor ">Paul  Elson</span>, <span class="hlFld-ContribAuthor ">Ronald M.  Bukowski</span>, <span class="hlFld-ContribAuthor ">Robert  Dreicer</span>, <span class="hlFld-ContribAuthor ">Brian I.  Rini</span>, <span class="hlFld-ContribAuthor ">Jorge A.  Garcia</span>. </span><span class="cited-content_cbyCitation_article-title">A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2012,</strong> <em>30 </em>
                                    (1)
                                     , 364-367. <a href="https://doi.org/10.1007/s10637-010-9516-1" title="DOI URL">https://doi.org/10.1007/s10637-010-9516-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-010-9516-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-010-9516-1%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DA%252Bphase%252BII%252Bstudy%252Bof%252Btandutinib%252B%252528MLN518%252529%25252C%252Ba%252Bselective%252Binhibitor%252Bof%252Btype%252BIII%252Btyrosine%252Breceptor%252Bkinases%25252C%252Bin%252Bpatients%252Bwith%252Bmetastatic%252Brenal%252Bcell%252Bcarcinoma%26aulast%3DShepard%26aufirst%3DDale%2BR.%26date%3D2012%26date%3D2010%26volume%3D30%26issue%3D1%26spage%3D364%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Mathew</span>, <span class="hlFld-ContribAuthor ">Nizar  Tannir</span>, <span class="hlFld-ContribAuthor ">Shi-Ming  Tu</span>, <span class="hlFld-ContribAuthor ">Sijin  Wen</span>, <span class="hlFld-ContribAuthor ">Charles C.  Guo</span>, <span class="hlFld-ContribAuthor ">Valerie  Marcott</span>, <span class="hlFld-ContribAuthor ">Benjamin Nebiyou  Bekele</span>, <span class="hlFld-ContribAuthor ">Lance  Pagliaro</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2011,</strong> <em>68 </em>
                                    (4)
                                     , 889-896. <a href="https://doi.org/10.1007/s00280-011-1567-2" title="DOI URL">https://doi.org/10.1007/s00280-011-1567-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-011-1567-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-011-1567-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DAccelerated%252Bdisease%252Bprogression%252Bin%252Bprostate%252Bcancer%252Band%252Bbone%252Bmetastases%252Bwith%252Bplatelet-derived%252Bgrowth%252Bfactor%252Breceptor%252Binhibition%25253A%252Bobservations%252Bwith%252Btandutinib%26aulast%3DMathew%26aufirst%3DPaul%26date%3D2011%26date%3D2011%26volume%3D68%26issue%3D4%26spage%3D889%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gadada  Naganagowda</span>, <span class="hlFld-ContribAuthor ">Amorn  Petsom</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antimicrobial activity of some new 2-(3-chloro-1-benzothiophen-2-yl)-3-(substituted-phenyl)-4- (3
              H
              )-quinazolinones derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Sulfur Chemistry</span><span> <strong>2011,</strong> <em>32 </em>
                                    (3)
                                     , 223-233. <a href="https://doi.org/10.1080/17415993.2011.575943" title="DOI URL">https://doi.org/10.1080/17415993.2011.575943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17415993.2011.575943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17415993.2011.575943%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Sulfur%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bsome%252Bnew%252B2-%2525283-chloro-1-benzothiophen-2-yl%252529-3-%252528substituted-phenyl%252529-4-%252B%2525283%252BH%252B%252529-quinazolinones%252Bderivatives%26aulast%3DNaganagowda%26aufirst%3DGadada%26date%3D2011%26date%3D2011%26volume%3D32%26issue%3D3%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun-Young  Han</span>, <span class="hlFld-ContribAuthor ">Young-Won  Chin</span>. </span><span class="cited-content_cbyCitation_article-title">A FLT3-inhibitory constituent from the rhizomes of
              Anemarrhena asphodeloides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2011,</strong> <em>26 </em>
                                    (3)
                                     , 445-448. <a href="https://doi.org/10.3109/14756366.2010.515215" title="DOI URL">https://doi.org/10.3109/14756366.2010.515215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2010.515215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2010.515215%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DA%252BFLT3-inhibitory%252Bconstituent%252Bfrom%252Bthe%252Brhizomes%252Bof%252BAnemarrhena%252Basphodeloides%26aulast%3DHan%26aufirst%3DSun-Young%26date%3D2011%26date%3D2010%26volume%3D26%26issue%3D3%26spage%3D445%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola  Heron</span>. </span><span class="cited-content_cbyCitation_article-title">From Discovery to Clinic: Aurora Kinase Inhibitors as Novel Treatments for Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 195-228. <a href="https://doi.org/10.1002/9783527633470.ch7" title="DOI URL">https://doi.org/10.1002/9783527633470.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527633470.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527633470.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BDiscovery%252Bto%252BClinic%25253A%252BAurora%252BKinase%252BInhibitors%252Bas%252BNovel%252BTreatments%252Bfor%252BCancer%26aulast%3DHeron%26aufirst%3DNicola%26date%3D2011%26date%3D2011%26spage%3D195%26epage%3D228%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein%252BKinases%252Bas%252BDrug%252BTargets%26aulast%3DKlebl%26aufirst%3DBert%26date%3D2011%26volume%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jongkook  Lee</span>, <span class="hlFld-ContribAuthor ">Seung-Mann  Paek</span>, <span class="hlFld-ContribAuthor ">Sun-Young  Han</span>. </span><span class="cited-content_cbyCitation_article-title">FMS-like tyrosine kinase 3 inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (4)
                                     , 483-503. <a href="https://doi.org/10.1517/13543776.2011.560115" title="DOI URL">https://doi.org/10.1517/13543776.2011.560115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.560115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.560115%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFMS-like%252Btyrosine%252Bkinase%252B3%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DLee%26aufirst%3DJongkook%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D4%26spage%3D483%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen Trinh  Pham</span>, <span class="hlFld-ContribAuthor ">Robert N.  Hanson</span>, <span class="hlFld-ContribAuthor ">Sandra L.  Olmsted</span>, <span class="hlFld-ContribAuthor ">Anton  Kozhushnyan</span>, <span class="hlFld-ContribAuthor ">Adam  Visentin</span>, <span class="hlFld-ContribAuthor ">Paul J.  Weglinsky</span>, <span class="hlFld-ContribAuthor ">Chris  Massero</span>, <span class="hlFld-ContribAuthor ">Kristen  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 6- and 7-propargyloxy derivatives of 4-(3-fluoroanilino)-quinazoline. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (10)
                                     , 1053-1056. <a href="https://doi.org/10.1016/j.tetlet.2010.11.107" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.11.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.11.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.11.107%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B6-%252Band%252B7-propargyloxy%252Bderivatives%252Bof%252B4-%2525283-fluoroanilino%252529-quinazoline%26aulast%3DPham%26aufirst%3DHelen%2BTrinh%26date%3D2011%26volume%3D52%26issue%3D10%26spage%3D1053%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianhui  Wu</span>, <span class="hlFld-ContribAuthor ">Ming  Zhao</span>, <span class="hlFld-ContribAuthor ">Shiqi  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazolin-4(3H)-ones capable of upregulating the expression of endogenous apolipoprotein A-1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (3)
                                     , 431-435. <a href="https://doi.org/10.1517/13543776.2011.548322" title="DOI URL">https://doi.org/10.1517/13543776.2011.548322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.548322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.548322%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DQuinazolin-4%2525283H%252529-ones%252Bcapable%252Bof%252Bupregulating%252Bthe%252Bexpression%252Bof%252Bendogenous%252Bapolipoprotein%252BA-1%26aulast%3DWu%26aufirst%3DJianhui%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D3%26spage%3D431%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolas  Fechner</span>, <span class="hlFld-ContribAuthor ">Andreas  Jahn</span>, <span class="hlFld-ContribAuthor ">Georg  Hinselmann</span>, <span class="hlFld-ContribAuthor ">Andreas  Zell</span>. </span><span class="cited-content_cbyCitation_article-title">Estimation of the applicability domain of kernel-based machine learning models for virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2010,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1758-2946-2-2" title="DOI URL">https://doi.org/10.1186/1758-2946-2-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1758-2946-2-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1758-2946-2-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DEstimation%252Bof%252Bthe%252Bapplicability%252Bdomain%252Bof%252Bkernel-based%252Bmachine%252Blearning%252Bmodels%252Bfor%252Bvirtual%252Bscreening%26aulast%3DFechner%26aufirst%3DNikolas%26date%3D2010%26date%3D2010%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert H.  Bradbury</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors: Approved Drugs and Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 295-344. <a href="https://doi.org/10.1002/0471266949.bmc214" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%25253A%252BApproved%252BDrugs%252Band%252BClinical%252BCandidates%26aulast%3DBradbury%26aufirst%3DRobert%2BH.%26date%3D2010%26date%3D2010%26spage%3D295%26epage%3D344%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinglin  Jiang</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Changjun  Liao</span>, <span class="hlFld-ContribAuthor ">Wang  Zan</span>, <span class="hlFld-ContribAuthor ">Zhihe  Zang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling and Virtual Screening of Novel Inhibitors for c-Kit Kinase. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2010,</strong> <em>28 </em>
                                    (7)
                                     , 1199-1206. <a href="https://doi.org/10.1002/cjoc.201090208" title="DOI URL">https://doi.org/10.1002/cjoc.201090208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201090208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201090208%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DPharmacophore%252BModeling%252Band%252BVirtual%252BScreening%252Bof%252BNovel%252BInhibitors%252Bfor%252Bc-Kit%252BKinase%26aulast%3DJiang%26aufirst%3DQinglin%26date%3D2010%26date%3D2010%26volume%3D28%26issue%3D7%26spage%3D1199%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian-kang  Jiang</span>, <span class="hlFld-ContribAuthor ">Matthew B.  Boxer</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Vander Heiden</span>, <span class="hlFld-ContribAuthor ">Min  Shen</span>, <span class="hlFld-ContribAuthor ">Amanda P.  Skoumbourdis</span>, <span class="hlFld-ContribAuthor ">Noel  Southall</span>, <span class="hlFld-ContribAuthor ">Henrike  Veith</span>, <span class="hlFld-ContribAuthor ">William  Leister</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Austin</span>, <span class="hlFld-ContribAuthor ">Hee Won  Park</span>, <span class="hlFld-ContribAuthor ">James  Inglese</span>, <span class="hlFld-ContribAuthor ">Lewis C.  Cantley</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Auld</span>, <span class="hlFld-ContribAuthor ">Craig J.  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (11)
                                     , 3387-3393. <a href="https://doi.org/10.1016/j.bmcl.2010.04.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvaluation%252Bof%252Bthieno%25255B3%25252C2-b%25255Dpyrrole%25255B3%25252C2-d%25255Dpyridazinones%252Bas%252Bactivators%252Bof%252Bthe%252Btumor%252Bcell%252Bspecific%252BM2%252Bisoform%252Bof%252Bpyruvate%252Bkinase%26aulast%3DJiang%26aufirst%3DJian-kang%26date%3D2010%26volume%3D20%26issue%3D11%26spage%3D3387%26epage%3D3393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Wei  Li</span>, <span class="hlFld-ContribAuthor ">Jin-Juan  Chen</span>, <span class="hlFld-ContribAuthor ">Ren-Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Wen-Qin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Xing  Cao</span>, <span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Xiao-Yu  Qing</span>, <span class="hlFld-ContribAuthor ">Liang-Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Li  Yang</span>, <span class="hlFld-ContribAuthor ">Luo-Ding  Yu</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Quan  Wei</span>, <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Taking Quinazoline as a General Support-Nog to Design Potent and Selective Kinase Inhibitors: Application to FMS-like Tyrosine Kinase 3. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (4)
                                     , 513-516. <a href="https://doi.org/10.1002/cmdc.200900537" title="DOI URL">https://doi.org/10.1002/cmdc.200900537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.200900537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.200900537%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTaking%252BQuinazoline%252Bas%252Ba%252BGeneral%252BSupport-Nog%252Bto%252BDesign%252BPotent%252Band%252BSelective%252BKinase%252BInhibitors%25253A%252BApplication%252Bto%252BFMS-like%252BTyrosine%252BKinase%2525E2%252580%2525853%26aulast%3DLi%26aufirst%3DWei-Wei%26date%3D2010%26volume%3D5%26issue%3D4%26spage%3D513%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin S  Laddha</span>, <span class="hlFld-ContribAuthor ">Satyendra P  Bhatnagar</span>. </span><span class="cited-content_cbyCitation_article-title">Novel fused quinazolinones: further studies on the anticonvulsant activity of 1,2,9,11-tetrasubstituted-
              7H
              -thieno[2´,3´:4,5]pyrimido[6,1-b]-quinazolin-7-one and 1,3,10,12-tetrasubstituted-
              8H
              -pyrido[2´,3´:4,5]pyrimido[6,1-b]quinazolin-8-one. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2010,</strong> <em>2 </em>
                                    (4)
                                     , 565-573. <a href="https://doi.org/10.4155/fmc.10.16" title="DOI URL">https://doi.org/10.4155/fmc.10.16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.10.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.10.16%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bfused%252Bquinazolinones%25253A%252Bfurther%252Bstudies%252Bon%252Bthe%252Banticonvulsant%252Bactivity%252Bof%252B1%25252C2%25252C9%25252C11-tetrasubstituted-%252B7H%252B-thieno%25255B2%2525C2%2525B4%25252C3%2525C2%2525B4%25253A4%25252C5%25255Dpyrimido%25255B6%25252C1-b%25255D-quinazolin-7-one%252Band%252B1%25252C3%25252C10%25252C12-tetrasubstituted-%252B8H%252B-pyrido%25255B2%2525C2%2525B4%25252C3%2525C2%2525B4%25253A4%25252C5%25255Dpyrimido%25255B6%25252C1-b%25255Dquinazolin-8-one%26aulast%3DLaddha%26aufirst%3DSachin%2BS%26date%3D2010%26volume%3D2%26issue%3D4%26spage%3D565%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soo Jeong  Choi</span>, <span class="hlFld-ContribAuthor ">Myoung Ju  Moon</span>, <span class="hlFld-ContribAuthor ">So Deok  Lee</span>, <span class="hlFld-ContribAuthor ">Sang-Un  Choi</span>, <span class="hlFld-ContribAuthor ">Sun-Young  Han</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (6)
                                     , 2033-2037. <a href="https://doi.org/10.1016/j.bmcl.2010.01.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIndirubin%252Bderivatives%252Bas%252Bpotent%252BFLT3%252Binhibitors%252Bwith%252Banti-proliferative%252Bactivity%252Bof%252Bacute%252Bmyeloid%252Bleukemic%252Bcells%26aulast%3DChoi%26aufirst%3DSoo%2BJeong%26date%3D2010%26volume%3D20%26issue%3D6%26spage%3D2033%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mm  Neaz</span>, <span class="hlFld-ContribAuthor ">M  Muddassar</span>, <span class="hlFld-ContribAuthor ">Fa  Pasha</span>, <span class="hlFld-ContribAuthor ">Seung Joo  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Structural studies of B-type Aurora kinase inhibitors using computational methods. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2010,</strong> <em>31 </em>
                                    (2)
                                     , 244-258. <a href="https://doi.org/10.1038/aps.2009.188" title="DOI URL">https://doi.org/10.1038/aps.2009.188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2009.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2009.188%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DStructural%252Bstudies%252Bof%252BB-type%252BAurora%252Bkinase%252Binhibitors%252Busing%252Bcomputational%252Bmethods%26aulast%3DNeaz%26aufirst%3DMm%26date%3D2010%26date%3D2010%26volume%3D31%26issue%3D2%26spage%3D244%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin S.  Laddha</span>, <span class="hlFld-ContribAuthor ">Satyendra P.  Bhatnagar</span>. </span><span class="cited-content_cbyCitation_article-title">A new therapeutic approach in Parkinson’s disease: Some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (19)
                                     , 6796-6802. <a href="https://doi.org/10.1016/j.bmc.2009.08.041" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.08.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.08.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnew%252Btherapeutic%252Bapproach%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%25253A%252BSome%252Bnovel%252Bquinazoline%252Bderivatives%252Bas%252Bdual%252Bselective%252Bphosphodiesterase%252B1%252Binhibitors%252Band%252Banti-inflammatory%252Bagents%26aulast%3DLaddha%26aufirst%3DSachin%2BS.%26date%3D2009%26volume%3D17%26issue%3D19%26spage%3D6796%26epage%3D6802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick P.  Zarrinkar</span>, <span class="hlFld-ContribAuthor ">Ruwanthi N.  Gunawardane</span>, <span class="hlFld-ContribAuthor ">Merryl D.  Cramer</span>, <span class="hlFld-ContribAuthor ">Michael F.  Gardner</span>, <span class="hlFld-ContribAuthor ">Daniel  Brigham</span>, <span class="hlFld-ContribAuthor ">Barbara  Belli</span>, <span class="hlFld-ContribAuthor ">Mazen W.  Karaman</span>, <span class="hlFld-ContribAuthor ">Keith W.  Pratz</span>, <span class="hlFld-ContribAuthor ">Gabriel  Pallares</span>, <span class="hlFld-ContribAuthor ">Qi  Chao</span>, <span class="hlFld-ContribAuthor ">Kelly G.  Sprankle</span>, <span class="hlFld-ContribAuthor ">Hitesh K.  Patel</span>, <span class="hlFld-ContribAuthor ">Mark  Levis</span>, <span class="hlFld-ContribAuthor ">Robert C.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Joyce  James</span>, <span class="hlFld-ContribAuthor ">Shripad S.  Bhagwat</span>. </span><span class="cited-content_cbyCitation_article-title">AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2009,</strong> <em>114 </em>
                                    (14)
                                     , 2984-2992. <a href="https://doi.org/10.1182/blood-2009-05-222034" title="DOI URL">https://doi.org/10.1182/blood-2009-05-222034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2009-05-222034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2009-05-222034%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DAC220%252Bis%252Ba%252Buniquely%252Bpotent%252Band%252Bselective%252Binhibitor%252Bof%252BFLT3%252Bfor%252Bthe%252Btreatment%252Bof%252Bacute%252Bmyeloid%252Bleukemia%252B%252528AML%252529%26aulast%3DZarrinkar%26aufirst%3DPatrick%2BP.%26date%3D2009%26volume%3D114%26issue%3D14%26spage%3D2984%26epage%3D2992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Tasler</span>, <span class="hlFld-ContribAuthor ">Oliver  Müller</span>, <span class="hlFld-ContribAuthor ">Tanja  Wieber</span>, <span class="hlFld-ContribAuthor ">Thomas  Herz</span>, <span class="hlFld-ContribAuthor ">Stefano  Pegoraro</span>, <span class="hlFld-ContribAuthor ">Wael  Saeb</span>, <span class="hlFld-ContribAuthor ">Martin  Lang</span>, <span class="hlFld-ContribAuthor ">Rolf  Krauss</span>, <span class="hlFld-ContribAuthor ">Frank  Totzke</span>, <span class="hlFld-ContribAuthor ">Ute  Zirrgiebel</span>, <span class="hlFld-ContribAuthor ">Jan E.  Ehlert</span>, <span class="hlFld-ContribAuthor ">Michael H.G.  Kubbutat</span>, <span class="hlFld-ContribAuthor ">Christoph  Schächtele</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted 2-arylbenzothiazoles as kinase inhibitors: Hit-to-lead optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (18)
                                     , 6728-6737. <a href="https://doi.org/10.1016/j.bmc.2009.07.047" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.07.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.07.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252B2-arylbenzothiazoles%252Bas%252Bkinase%252Binhibitors%25253A%252BHit-to-lead%252Boptimization%26aulast%3DTasler%26aufirst%3DStefan%26date%3D2009%26volume%3D17%26issue%3D18%26spage%3D6728%26epage%3D6737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaled  el-Shami</span>, <span class="hlFld-ContribAuthor ">Richard M  Stone</span>, <span class="hlFld-ContribAuthor ">B Douglas  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3 inhibitors in acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Hematology</span><span> <strong>2008,</strong> <em>1 </em>
                                    (2)
                                     , 153-160. <a href="https://doi.org/10.1586/17474086.1.2.153" title="DOI URL">https://doi.org/10.1586/17474086.1.2.153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17474086.1.2.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17474086.1.2.153%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Hematology%26atitle%3DFLT3%252Binhibitors%252Bin%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3Del-Shami%26aufirst%3DKhaled%26date%3D2008%26date%3D2014%26volume%3D1%26issue%3D2%26spage%3D153%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernd  Wendt</span>, <span class="hlFld-ContribAuthor ">Richard D.  Cramer</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Series Enrichment Analysis (QSEA): a novel procedure for 3D-QSAR analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2008,</strong> <em>22 </em>
                                    (8)
                                     , 541-551. <a href="https://doi.org/10.1007/s10822-008-9195-6" title="DOI URL">https://doi.org/10.1007/s10822-008-9195-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-008-9195-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-008-9195-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DQuantitative%252BSeries%252BEnrichment%252BAnalysis%252B%252528QSEA%252529%25253A%252Ba%252Bnovel%252Bprocedure%252Bfor%252B3D-QSAR%252Banalysis%26aulast%3DWendt%26aufirst%3DBernd%26date%3D2008%26date%3D2008%26volume%3D22%26issue%3D8%26spage%3D541%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Patrick P.  Zarrinkar</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput kinase profiling as a platform for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2008,</strong> <em>7 </em>
                                    (5)
                                     , 391-397. <a href="https://doi.org/10.1038/nrd2541" title="DOI URL">https://doi.org/10.1038/nrd2541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd2541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd2541%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DHigh-throughput%252Bkinase%252Bprofiling%252Bas%252Ba%252Bplatform%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DGoldstein%26aufirst%3DDavid%2BM.%26date%3D2008%26volume%3D7%26issue%3D5%26spage%3D391%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajarshi  Guha</span>, <span class="hlFld-ContribAuthor ">John H.  Van Drie</span>. </span><span class="cited-content_cbyCitation_article-title">Structure−Activity Landscape Index:  Identifying and Quantifying Activity Cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2008,</strong> <em>48 </em>
                                    (3)
                                     , 646-658. <a href="https://doi.org/10.1021/ci7004093" title="DOI URL">https://doi.org/10.1021/ci7004093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci7004093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci7004093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure%2525E2%252588%252592Activity%252BLandscape%252BIndex%25253A%2525E2%252580%252589%252BIdentifying%252Band%252BQuantifying%252BActivity%252BCliffs%26aulast%3DGuha%26aufirst%3DRajarshi%26date%3D2008%26date%3D2008%26volume%3D48%26issue%3D3%26spage%3D646%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Paul F.  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for Enhancing Oral Bioavailability and Brain Penetration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 711-720. <a href="https://doi.org/10.1016/B978-0-12-374194-3.00035-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-374194-3.00035-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-374194-3.00035-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-374194-3.00035-4%26sid%3Dliteratum%253Aachs%26atitle%3DStrategies%252Bfor%252BEnhancing%252BOral%252BBioavailability%252Band%252BBrain%252BPenetration%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2008%26spage%3D711%26epage%3D720%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidines and their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 117-272. <a href="https://doi.org/10.1016/B978-008044992-0.00702-1" title="DOI URL">https://doi.org/10.1016/B978-008044992-0.00702-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-008044992-0.00702-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-008044992-0.00702-1%26sid%3Dliteratum%253Aachs%26atitle%3DPyrimidines%252Band%252Btheir%252BBenzo%252BDerivatives%26aulast%3DRewcastle%26aufirst%3DG.W.%26date%3D2008%26spage%3D117%26epage%3D272%26pub%3DElsevier%26atitle%3DComprehensive%252BHeterocyclic%252BChemistry%252BIII%26date%3D2008%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darrin W.  Hopper</span>, <span class="hlFld-ContribAuthor ">Minu  Dutia</span>, <span class="hlFld-ContribAuthor ">Dan M.  Berger</span>, <span class="hlFld-ContribAuthor ">Dennis W.  Powell</span>. </span><span class="cited-content_cbyCitation_article-title">Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2008,</strong> <em>49 </em>
                                    (1)
                                     , 137-140. <a href="https://doi.org/10.1016/j.tetlet.2007.10.151" title="DOI URL">https://doi.org/10.1016/j.tetlet.2007.10.151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2007.10.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2007.10.151%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DObservation%252Bof%252Bdifferential%252Breactivity%252Bof%252Bcyclic%252Bamines%252Bin%252BSN2%252Band%252BSNAr%252Bdisplacement%252Breactions%252Bin%252Bthe%252Bcourse%252Bof%252Bsynthesizing%252BC-6%25252C%252BC-7%252Bsubstituted%252Bquinolinecarbonitrile%252BMEK1%252Bkinase%252Binhibitors%26aulast%3DHopper%26aufirst%3DDarrin%2BW.%26date%3D2008%26volume%3D49%26issue%3D1%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B. Gayani K.  Perera</span>, <span class="hlFld-ContribAuthor ">Dustin J.  Maly</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and characterization of “clickable” 4-anilinoquinazoline kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2008,</strong> <em>4 </em>
                                    (6)
                                     , 542. <a href="https://doi.org/10.1039/b720014e" title="DOI URL">https://doi.org/10.1039/b720014e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b720014e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb720014e%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bcharacterization%252Bof%252B%2525E2%252580%25259Cclickable%2525E2%252580%25259D%252B4-anilinoquinazoline%252Bkinase%252Binhibitors%26aulast%3DPerera%26aufirst%3DB.%2BGayani%2BK.%26date%3D2008%26volume%3D4%26issue%3D6%26spage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith  Pratz</span>, <span class="hlFld-ContribAuthor ">Mark  Levis</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens. </span><span class="cited-content_cbyCitation_journal-name">Leukemia & Lymphoma</span><span> <strong>2008,</strong> <em>49 </em>
                                    (5)
                                     , 852-863. <a href="https://doi.org/10.1080/10428190801895352" title="DOI URL">https://doi.org/10.1080/10428190801895352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10428190801895352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10428190801895352%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%2520%2526%2520Lymphoma%26atitle%3DIncorporating%252BFLT3%252Binhibitors%252Binto%252Bacute%252Bmyeloid%252Bleukemia%252Btreatment%252Bregimens%26aulast%3DPratz%26aufirst%3DKeith%26date%3D2008%26date%3D2009%26volume%3D49%26issue%3D5%26spage%3D852%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Shuhei  Fukamachi</span>, <span class="hlFld-ContribAuthor ">Daizo  Nakamura</span>, <span class="hlFld-ContribAuthor ">Osamu  Morikawa</span>, <span class="hlFld-ContribAuthor ">Hisatoshi  Konishi</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient Synthesis of 1,4-Dihydro-2H-3,1-benzoxazin-2-ones by Iodocyclization of t-Butyl 2-Vinylphenylcarbamate. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2008,</strong> <em>75 </em>
                                    (1)
                                     , 95. <a href="https://doi.org/10.3987/COM-07-11186" title="DOI URL">https://doi.org/10.3987/COM-07-11186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-07-11186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-07-11186%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DConvenient%252BSynthesis%252Bof%252B1%25252C4-Dihydro-2H-3%25252C1-benzoxazin-2-ones%252Bby%252BIodocyclization%252Bof%252Bt-Butyl%252B2-Vinylphenylcarbamate%26aulast%3DKobayashi%26aufirst%3DKazuhiro%26date%3D2008%26volume%3D75%26issue%3D1%26spage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamalesh K  Sankhala</span>, <span class="hlFld-ContribAuthor ">Kyriakos P  Papadopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Future options for imatinib mesilate-resistant tumors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2007,</strong> <em>16 </em>
                                    (10)
                                     , 1549-1560. <a href="https://doi.org/10.1517/13543784.16.10.1549" title="DOI URL">https://doi.org/10.1517/13543784.16.10.1549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.16.10.1549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.16.10.1549%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DFuture%252Boptions%252Bfor%252Bimatinib%252Bmesilate-resistant%252Btumors%26aulast%3DSankhala%26aufirst%3DKamalesh%2BK%26date%3D2007%26date%3D2007%26volume%3D16%26issue%3D10%26spage%3D1549%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micheal D.  Gaul</span>, <span class="hlFld-ContribAuthor ">Guozhang  Xu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Heidi  Ott</span>, <span class="hlFld-ContribAuthor ">Christian A.  Baumann</span>. </span><span class="cited-content_cbyCitation_article-title">4-Amino-6-piperazin-1-yl-pyrimidine-5-carbaldehyde oximes as potent FLT-3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (17)
                                     , 4861-4865. <a href="https://doi.org/10.1016/j.bmcl.2007.06.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.06.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.06.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Amino-6-piperazin-1-yl-pyrimidine-5-carbaldehyde%252Boximes%252Bas%252Bpotent%252BFLT-3%252Binhibitors%26aulast%3DGaul%26aufirst%3DMicheal%2BD.%26date%3D2007%26volume%3D17%26issue%3D17%26spage%3D4861%26epage%3D4865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siavosh  Mahboobi</span>, <span class="hlFld-ContribAuthor ">Andrea  Uecker</span>, <span class="hlFld-ContribAuthor ">Christophe  Cénac</span>, <span class="hlFld-ContribAuthor ">Andreas  Sellmer</span>, <span class="hlFld-ContribAuthor ">Emerich  Eichhorn</span>, <span class="hlFld-ContribAuthor ">Sigurd  Elz</span>, <span class="hlFld-ContribAuthor ">Frank-D.  Böhmer</span>, <span class="hlFld-ContribAuthor ">Stefan  Dove</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2007,</strong> <em>15 </em>
                                    (5)
                                     , 2187-2197. <a href="https://doi.org/10.1016/j.bmc.2006.12.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2006.12.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2006.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2006.12.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252BFLT3%252Band%252BPDGFR%252Btyrosine%252Bkinase%252Bactivity%252Bby%252Bbis%252528benzo%25255Bb%25255Dfuran-2-yl%252529methanones%26aulast%3DMahboobi%26aufirst%3DSiavosh%26date%3D2007%26volume%3D15%26issue%3D5%26spage%3D2187%26epage%3D2197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Levis</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3: A Prototype Receptor Tyrosine Kinase Target in AML. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2007,</strong>,, 247-261. <a href="https://doi.org/10.1007/978-1-59745-322-6_11" title="DOI URL">https://doi.org/10.1007/978-1-59745-322-6_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-59745-322-6_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-59745-322-6_11%26sid%3Dliteratum%253Aachs%26atitle%3DFLT3%25253A%252BA%252BPrototype%252BReceptor%252BTyrosine%252BKinase%252BTarget%252Bin%252BAML%26aulast%3DLevis%26aufirst%3DMark%26date%3D2007%26spage%3D247%26epage%3D261%26pub%3DHumana%2520Press%26atitle%3DAcute%252BMyelogenous%252BLeukemia%26aulast%3DKarp%26aufirst%3DJudith%2BE.%26date%3D2007%26volume%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">A.J.  Barker</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors for Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2007,</strong>,, 183-220. <a href="https://doi.org/10.1016/B0-08-045044-X/00209-1" title="DOI URL">https://doi.org/10.1016/B0-08-045044-X/00209-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B0-08-045044-X/00209-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB0-08-045044-X%2F00209-1%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bfor%252BCancer%26aulast%3DMortlock%26aufirst%3DA.A.%26date%3D2007%26spage%3D183%26epage%3D220%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BII%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsuyuki  Aoki</span>, <span class="hlFld-ContribAuthor ">Tatsuhiro  Obata</span>, <span class="hlFld-ContribAuthor ">Yosuke  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Mori</span>, <span class="hlFld-ContribAuthor ">Hiroko  Hirokawa</span>, <span class="hlFld-ContribAuthor ">Jun-ichi  Koseki</span>, <span class="hlFld-ContribAuthor ">Tomohisa  Hattori</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Niitsu</span>, <span class="hlFld-ContribAuthor ">Shuichi  Takeda</span>, <span class="hlFld-ContribAuthor ">Masaki  Aburada</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Miyamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Platelet-Derived Growth Factor-.BETA. Receptor (PDGF-.BETA.R) Inhibitors: Synthesis and Structure-Activity Relationships of 7-[3-(Cyclohexylmethyl)ureido]-3-{1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl}quinoxalin-2(1H)-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2007,</strong> <em>55 </em>
                                    (2)
                                     , 255-267. <a href="https://doi.org/10.1248/cpb.55.255" title="DOI URL">https://doi.org/10.1248/cpb.55.255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.55.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.55.255%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DPotent%252BPlatelet-Derived%252BGrowth%252BFactor-.BETA.%252BReceptor%252B%252528PDGF-.BETA.R%252529%252BInhibitors%25253A%252BSynthesis%252Band%252BStructure-Activity%252BRelationships%252Bof%252B7-%25255B3-%252528Cyclohexylmethyl%252529ureido%25255D-3-%25257B1-methyl-1H-pyrrolo%25255B2%25252C3-b%25255Dpyridin-3-yl%25257Dquinoxalin-2%2525281H%252529-one%252BDerivatives%26aulast%3DAoki%26aufirst%3DKatsuyuki%26date%3D2007%26volume%3D55%26issue%3D2%26spage%3D255%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  DeAngelo</span>, <span class="hlFld-ContribAuthor ">Richard M.  Stone</span>, <span class="hlFld-ContribAuthor ">Mark L.  Heaney</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Nimer</span>, <span class="hlFld-ContribAuthor ">Ronald L.  Paquette</span>, <span class="hlFld-ContribAuthor ">Rebecca B.  Klisovic</span>, <span class="hlFld-ContribAuthor ">Michael A.  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Michael R.  Cooper</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Lecerf</span>, <span class="hlFld-ContribAuthor ">Michael D.  Karol</span>, <span class="hlFld-ContribAuthor ">Shihong  Sheng</span>, <span class="hlFld-ContribAuthor ">Nick  Holford</span>, <span class="hlFld-ContribAuthor ">Peter T.  Curtin</span>, <span class="hlFld-ContribAuthor ">Brian J.  Druker</span>, <span class="hlFld-ContribAuthor ">Michael C.  Heinrich</span>. </span><span class="cited-content_cbyCitation_article-title">Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2006,</strong> <em>108 </em>
                                    (12)
                                     , 3674-3681. <a href="https://doi.org/10.1182/blood-2006-02-005702" title="DOI URL">https://doi.org/10.1182/blood-2006-02-005702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2006-02-005702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2006-02-005702%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DPhase%252B1%252Bclinical%252Bresults%252Bwith%252Btandutinib%252B%252528MLN518%252529%25252C%252Ba%252Bnovel%252BFLT3%252Bantagonist%25252C%252Bin%252Bpatients%252Bwith%252Bacute%252Bmyelogenous%252Bleukemia%252Bor%252Bhigh-risk%252Bmyelodysplastic%252Bsyndrome%25253A%252Bsafety%25252C%252Bpharmacokinetics%25252C%252Band%252Bpharmacodynamics%26aulast%3DDeAngelo%26aufirst%3DDaniel%2BJ.%26date%3D2006%26volume%3D108%26issue%3D12%26spage%3D3674%26epage%3D3681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  Samén</span>, <span class="hlFld-ContribAuthor ">Jan-Olov  Thorell</span>, <span class="hlFld-ContribAuthor ">Anna  Fredriksson</span>, <span class="hlFld-ContribAuthor ">Sharon  Stone-Elander</span>. </span><span class="cited-content_cbyCitation_article-title">The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2006,</strong> <em>33 </em>
                                    (8)
                                     , 1005-1011. <a href="https://doi.org/10.1016/j.nucmedbio.2006.09.008" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2006.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2006.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2006.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DThe%252Btyrosine%252Bkinase%252Binhibitor%252BPD153035%25253A%252Bimplication%252Bof%252Blabeling%252Bposition%252Bon%252Bradiometabolites%252Bformed%252Bin%252Bvitro%26aulast%3DSam%25C3%25A9n%26aufirst%3DErik%26date%3D2006%26volume%3D33%26issue%3D8%26spage%3D1005%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna C.  Maroney</span>, <span class="hlFld-ContribAuthor ">Sergey E.  Ilyin</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapy: Genomic Approaches. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2006,</strong>,<a href="https://doi.org/10.1002/3527600906.mcb.200500039" title="DOI URL">https://doi.org/10.1002/3527600906.mcb.200500039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/3527600906.mcb.200500039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F3527600906.mcb.200500039%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BTherapy%25253A%252BGenomic%252BApproaches%26aulast%3DMaroney%26aufirst%3DAnna%2BC.%26date%3D2006%26date%3D2006%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DEncyclopedia%252Bof%252BMolecular%252BCell%252BBiology%252Band%252BMolecular%252BMedicine%26aulast%3DMeyers%26aufirst%3DRobert%2BA.%26date%3D2006%26date%3D2006%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi-Yeon  Jang</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>, <span class="hlFld-ContribAuthor ">Ling-Jie  Gao</span>, <span class="hlFld-ContribAuthor ">Jef  Rozenski</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Synthetic Strategies for the Construction of Pyrido[4,3-d]pyrimidine Libraries – the Discovery of a New Class of PDE-4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2006,</strong> <em>2006 </em>
                                    (18)
                                     , 4257-4269. <a href="https://doi.org/10.1002/ejoc.200600339" title="DOI URL">https://doi.org/10.1002/ejoc.200600339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.200600339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.200600339%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDevelopment%252Bof%252BSynthetic%252BStrategies%252Bfor%252Bthe%252BConstruction%252Bof%252BPyrido%25255B4%25252C3-d%25255Dpyrimidine%252BLibraries%252B%2525E2%252580%252593%252Bthe%252BDiscovery%252Bof%252Ba%252BNew%252BClass%252Bof%252BPDE-4%252BInhibitors%26aulast%3DJang%26aufirst%3DMi-Yeon%26date%3D2006%26volume%3D2006%26issue%3D18%26spage%3D4257%26epage%3D4269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hitoshi  Kiyoi</span>, <span class="hlFld-ContribAuthor ">Tomoki  Naoe</span>. </span><span class="cited-content_cbyCitation_article-title">Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Hematology</span><span> <strong>2006,</strong> <em>83 </em>
                                    (4)
                                     , 301-308. <a href="https://doi.org/10.1532/IJH97.06071" title="DOI URL">https://doi.org/10.1532/IJH97.06071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1532/IJH97.06071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1532%2FIJH97.06071%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Hematology%26atitle%3DBiology%25252C%252BClinical%252BRelevance%25252C%252Band%252BMolecularly%252BTargeted%252BTherapy%252Bin%252BAcute%252BLeukemia%252Bwith%252BFLT3%252BMutation%26aulast%3DKiyoi%26aufirst%3DHitoshi%26date%3D2006%26volume%3D83%26issue%3D4%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bertrand W.  Parcells</span>, <span class="hlFld-ContribAuthor ">Alan K.  Ikeda</span>, <span class="hlFld-ContribAuthor ">Tiffany  Simms-Waldrip</span>, <span class="hlFld-ContribAuthor ">Theodore B.  Moore</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">FMS-Like Tyrosine Kinase 3 in Normal Hematopoiesis and Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Stem Cells</span><span> <strong>2006,</strong> <em>24 </em>
                                    (5)
                                     , 1174-1184. <a href="https://doi.org/10.1634/stemcells.2005-0519" title="DOI URL">https://doi.org/10.1634/stemcells.2005-0519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1634/stemcells.2005-0519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1634%2Fstemcells.2005-0519%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cells%26atitle%3DFMS-Like%252BTyrosine%252BKinase%252B3%252Bin%252BNormal%252BHematopoiesis%252Band%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DParcells%26aufirst%3DBertrand%2BW.%26date%3D2006%26volume%3D24%26issue%3D5%26spage%3D1174%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Knesl</span>, <span class="hlFld-ContribAuthor ">Dirk  Röseling</span>, <span class="hlFld-ContribAuthor ">Ulrich  Jordis</span>. </span><span class="cited-content_cbyCitation_article-title">Improved Synthesis of Substituted 6,7-Dihydroxy-4-quinazolineamines: Tandutinib, Erlotinib and Gefitinib. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2006,</strong> <em>11 </em>
                                    (4)
                                     , 286-297. <a href="https://doi.org/10.3390/11040286" title="DOI URL">https://doi.org/10.3390/11040286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/11040286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2F11040286%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DImproved%252BSynthesis%252Bof%252BSubstituted%252B6%25252C7-Dihydroxy-4-quinazolineamines%25253A%252BTandutinib%25252C%252BErlotinib%252Band%252BGefitinib%26aulast%3DKnesl%26aufirst%3DPetr%26date%3D2006%26date%3D2006%26volume%3D11%26issue%3D4%26spage%3D286%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun-Young  Han</span>, <span class="hlFld-ContribAuthor ">Seok-Soon  Park</span>, <span class="hlFld-ContribAuthor ">Woo Ghil  Lee</span>, <span class="hlFld-ContribAuthor ">Yong Ki  Min</span>, <span class="hlFld-ContribAuthor ">Bum Tae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a novel biotin-tagged photoaffinity probe for VEGF receptor tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2006,</strong> <em>16 </em>
                                    (1)
                                     , 129-133. <a href="https://doi.org/10.1016/j.bmcl.2005.09.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2005.09.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2005.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2005.09.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Ba%252Bnovel%252Bbiotin-tagged%252Bphotoaffinity%252Bprobe%252Bfor%252BVEGF%252Breceptor%252Btyrosine%252Bkinases%26aulast%3DHan%26aufirst%3DSun-Young%26date%3D2006%26volume%3D16%26issue%3D1%26spage%3D129%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keren  Paz</span>, <span class="hlFld-ContribAuthor ">Zhenping  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in targeted therapy of human myelogenous leukaemia. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2005,</strong> <em>9 </em>
                                    (6)
                                     , 1147-1163. <a href="https://doi.org/10.1517/14728222.9.6.1147" title="DOI URL">https://doi.org/10.1517/14728222.9.6.1147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.9.6.1147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.9.6.1147%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DRecent%252Badvances%252Bin%252Btargeted%252Btherapy%252Bof%252Bhuman%252Bmyelogenous%252Bleukaemia%26aulast%3DPaz%26aufirst%3DKeren%26date%3D2005%26date%3D2005%26volume%3D9%26issue%3D6%26spage%3D1147%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig S.  Harris</span>, <span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Emma J.  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of 7-amino anilinoquinazolines via direct amination of the quinazoline core. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2005,</strong> <em>46 </em>
                                    (43)
                                     , 7381-7384. <a href="https://doi.org/10.1016/j.tetlet.2005.08.123" title="DOI URL">https://doi.org/10.1016/j.tetlet.2005.08.123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2005.08.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2005.08.123%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252B7-amino%252Banilinoquinazolines%252Bvia%252Bdirect%252Bamination%252Bof%252Bthe%252Bquinazoline%252Bcore%26aulast%3DHarris%26aufirst%3DCraig%2BS.%26date%3D2005%26volume%3D46%26issue%3D43%26spage%3D7381%26epage%3D7384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeshwar P.  Verma</span>, <span class="hlFld-ContribAuthor ">Corwin  Hansch</span>. </span><span class="cited-content_cbyCitation_article-title">An approach toward the problem of outliers in QSAR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2005,</strong> <em>13 </em>
                                    (15)
                                     , 4597-4621. <a href="https://doi.org/10.1016/j.bmc.2005.05.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2005.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2005.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2005.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bapproach%252Btoward%252Bthe%252Bproblem%252Bof%252Boutliers%252Bin%252BQSAR%26aulast%3DVerma%26aufirst%3DRajeshwar%2BP.%26date%3D2005%26volume%3D13%26issue%3D15%26spage%3D4597%26epage%3D4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Levis</span>, <span class="hlFld-ContribAuthor ">Donald  Small</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3 Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Hematology</span><span> <strong>2005,</strong> <em>82 </em>
                                    (2)
                                     , 100-107. <a href="https://doi.org/10.1532/IJH97.05079" title="DOI URL">https://doi.org/10.1532/IJH97.05079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1532/IJH97.05079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1532%2FIJH97.05079%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Hematology%26atitle%3DFLT3%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DLevis%26aufirst%3DMark%26date%3D2005%26volume%3D82%26issue%3D2%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa K  Minor</span>. </span><span class="cited-content_cbyCitation_article-title">Assays for membrane tyrosine kinase receptors: methods for high-throughput screening and utility for diagnostics. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Molecular Diagnostics</span><span> <strong>2005,</strong> <em>5 </em>
                                    (4)
                                     , 561-571. <a href="https://doi.org/10.1586/14737159.5.4.561" title="DOI URL">https://doi.org/10.1586/14737159.5.4.561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14737159.5.4.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14737159.5.4.561%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Molecular%2520Diagnostics%26atitle%3DAssays%252Bfor%252Bmembrane%252Btyrosine%252Bkinase%252Breceptors%25253A%252Bmethods%252Bfor%252Bhigh-throughput%252Bscreening%252Band%252Butility%252Bfor%252Bdiagnostics%26aulast%3DMinor%26aufirst%3DLisa%2BK%26date%3D2005%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D561%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian J.  Griswold</span>, <span class="hlFld-ContribAuthor ">Lei J.  Shen</span>, <span class="hlFld-ContribAuthor ">Paul  La Rosée</span>, <span class="hlFld-ContribAuthor ">Shadmehr  Demehri</span>, <span class="hlFld-ContribAuthor ">Michael C.  Heinrich</span>, <span class="hlFld-ContribAuthor ">Rita M.  Braziel</span>, <span class="hlFld-ContribAuthor ">Laura  McGreevey</span>, <span class="hlFld-ContribAuthor ">Andrea D.  Haley</span>, <span class="hlFld-ContribAuthor ">Neill  Giese</span>, <span class="hlFld-ContribAuthor ">Brian J.  Druker</span>, <span class="hlFld-ContribAuthor ">Michael W.N.  Deininger</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2004,</strong> <em>104 </em>
                                    (9)
                                     , 2912-2918. <a href="https://doi.org/10.1182/blood-2003-05-1669" title="DOI URL">https://doi.org/10.1182/blood-2003-05-1669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2003-05-1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2003-05-1669%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DEffects%252Bof%252BMLN518%25252C%252Ba%252Bdual%252BFLT3%252Band%252BKIT%252Binhibitor%25252C%252Bon%252Bnormal%252Band%252Bmalignant%252Bhematopoiesis%26aulast%3DGriswold%26aufirst%3DIan%2BJ.%26date%3D2004%26volume%3D104%26issue%3D9%26spage%3D2912%26epage%3D2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer J.  Clark</span>, <span class="hlFld-ContribAuthor ">Jan  Cools</span>, <span class="hlFld-ContribAuthor ">David P.  Curley</span>, <span class="hlFld-ContribAuthor ">Jin-Chen  Yu</span>, <span class="hlFld-ContribAuthor ">Nathalie A.  Lokker</span>, <span class="hlFld-ContribAuthor ">Neill A.  Giese</span>, <span class="hlFld-ContribAuthor ">D. Gary  Gilliland</span>. </span><span class="cited-content_cbyCitation_article-title">Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2004,</strong> <em>104 </em>
                                    (9)
                                     , 2867-2872. <a href="https://doi.org/10.1182/blood-2003-12-4446" title="DOI URL">https://doi.org/10.1182/blood-2003-12-4446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2003-12-4446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2003-12-4446%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DVariable%252Bsensitivity%252Bof%252BFLT3%252Bactivation%252Bloop%252Bmutations%252Bto%252Bthe%252Bsmall%252Bmolecule%252Btyrosine%252Bkinase%252Binhibitor%252BMLN518%26aulast%3DClark%26aufirst%3DJennifer%2BJ.%26date%3D2004%26volume%3D104%26issue%3D9%26spage%3D2867%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie A.  Heath</span>, <span class="hlFld-ContribAuthor ">Mukund M.  Mehrotra</span>, <span class="hlFld-ContribAuthor ">Shannon  Chi</span>, <span class="hlFld-ContribAuthor ">Jin-Chen  Yu</span>, <span class="hlFld-ContribAuthor ">Athiwat  Hutchaleelaha</span>, <span class="hlFld-ContribAuthor ">Stanley J.  Hollenbach</span>, <span class="hlFld-ContribAuthor ">Neill A.  Giese</span>, <span class="hlFld-ContribAuthor ">Robert M.  Scarborough</span>, <span class="hlFld-ContribAuthor ">Anjali  Pandey</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2004,</strong> <em>14 </em>
                                    (19)
                                     , 4867-4872. <a href="https://doi.org/10.1016/j.bmcl.2004.07.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2004.07.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2004.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2004.07.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B4-piperazin-1-yl-quinazoline%252Btemplate%252Bbased%252Baryl%252Band%252Bbenzyl%252Bthioureas%252Bas%252Bpotent%25252C%252Bselective%25252C%252Band%252Borally%252Bbioavailable%252Binhibitors%252Bof%252Bplatelet-derived%252Bgrowth%252Bfactor%252B%252528PDGF%252529%252Breceptor%26aulast%3DHeath%26aufirst%3DJulie%2BA.%26date%3D2004%26volume%3D14%26issue%3D19%26spage%3D4867%26epage%3D4872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Levitzki</span>. </span><span class="cited-content_cbyCitation_article-title">PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2004,</strong> <em>15 </em>
                                    (4)
                                     , 229-235. <a href="https://doi.org/10.1016/j.cytogfr.2004.03.010" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2004.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2004.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2004.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DPDGF%252Breceptor%252Bkinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BPDGF%252Bdriven%252Bdiseases%26aulast%3DLevitzki%26aufirst%3DAlexander%26date%3D2004%26volume%3D15%26issue%3D4%26spage%3D229%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lolita  Banerji</span>, <span class="hlFld-ContribAuthor ">Martin  Sattler</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2004,</strong> <em>8 </em>
                                    (3)
                                     , 221-239. <a href="https://doi.org/10.1517/14728222.8.3.221" title="DOI URL">https://doi.org/10.1517/14728222.8.3.221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.8.3.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.8.3.221%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bmutated%252Btyrosine%252Bkinases%252Bin%252Bthe%252Btherapy%252Bof%252Bmyeloid%252Bleukaemias%26aulast%3DBanerji%26aufirst%3DLolita%26date%3D2004%26date%3D2005%26volume%3D8%26issue%3D3%26spage%3D221%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshiyuki  Shimizu</span>, <span class="hlFld-ContribAuthor ">Yasunari  Fujiwara</span>, <span class="hlFld-ContribAuthor ">Tatsushi  Osawa</span>, <span class="hlFld-ContribAuthor ">Teruyuki  Sakai</span>, <span class="hlFld-ContribAuthor ">Kinya  Kubo</span>, <span class="hlFld-ContribAuthor ">Kazuo  Kubo</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Nishitoba</span>, <span class="hlFld-ContribAuthor ">Kaname  Kimura</span>, <span class="hlFld-ContribAuthor ">Terufumi  Senga</span>, <span class="hlFld-ContribAuthor ">Hideko  Murooka</span>, <span class="hlFld-ContribAuthor ">Akemi  Iwai</span>, <span class="hlFld-ContribAuthor ">Kayoko  Fukushima</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Yoshino</span>, <span class="hlFld-ContribAuthor ">Atsushi  Miwa</span>. </span><span class="cited-content_cbyCitation_article-title">Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2004,</strong> <em>14 </em>
                                    (4)
                                     , 875-879. <a href="https://doi.org/10.1016/j.bmcl.2003.12.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2003.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2003.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOrally%252Bactive%252Banti-proliferation%252Bagents%25253A%252Bnovel%252Bdiphenylamine%252Bderivatives%252Bas%252BFGF-R2%252Bautophosphorylation%252Binhibitors%26aulast%3DShimizu%26aufirst%3DToshiyuki%26date%3D2004%26volume%3D14%26issue%3D4%26spage%3D875%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Levis</span>, <span class="hlFld-ContribAuthor ">Donald  Small</span>. </span><span class="cited-content_cbyCitation_article-title">Novel FLT3 tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2003,</strong> <em>12 </em>
                                    (12)
                                     , 1951-1962. <a href="https://doi.org/10.1517/13543784.12.12.1951" title="DOI URL">https://doi.org/10.1517/13543784.12.12.1951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.12.12.1951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.12.12.1951%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DNovel%252BFLT3%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DLevis%26aufirst%3DMark%26date%3D2003%26date%3D2005%26volume%3D12%26issue%3D12%26spage%3D1951%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Padmakar V.  Khadikar</span>, <span class="hlFld-ContribAuthor ">Anjali  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Vijay K.  Agrawal</span>, <span class="hlFld-ContribAuthor ">Shachi  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Topological designing of 4-piperazinylquinazolines as antagonists of PDGFR tyrosine kinase family. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2003,</strong> <em>13 </em>
                                    (18)
                                     , 3009-3014. <a href="https://doi.org/10.1016/S0960-894X(03)00636-X" title="DOI URL">https://doi.org/10.1016/S0960-894X(03)00636-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0960-894X(03)00636-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0960-894X%2803%2900636-X%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTopological%252Bdesigning%252Bof%252B4-piperazinylquinazolines%252Bas%252Bantagonists%252Bof%252BPDGFR%252Btyrosine%252Bkinase%252Bfamily%26aulast%3DKhadikar%26aufirst%3DPadmakar%2BV.%26date%3D2003%26volume%3D13%26issue%3D18%26spage%3D3009%26epage%3D3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank  Würthner</span>, <span class="hlFld-ContribAuthor ">Stefan  Bräse</span>, <span class="hlFld-ContribAuthor ">Norbert  Sewald</span>, <span class="hlFld-ContribAuthor ">Rainer  Herges</span>, <span class="hlFld-ContribAuthor ">Matthias O.  Senge</span>, <span class="hlFld-ContribAuthor ">Thorsten  Bach</span>, <span class="hlFld-ContribAuthor ">Thomas  Gottwald</span>, <span class="hlFld-ContribAuthor ">Thomas  Kopf</span>, <span class="hlFld-ContribAuthor ">Kristina  Ŝpehar</span>, <span class="hlFld-ContribAuthor ">Jens  Hartung</span>, <span class="hlFld-ContribAuthor ">Dietmar  Plattner</span>, <span class="hlFld-ContribAuthor ">Andreas  Gansäuer</span>, <span class="hlFld-ContribAuthor ">Martin  Oestreich</span>, <span class="hlFld-ContribAuthor ">Reinhard  Brückner</span>, <span class="hlFld-ContribAuthor ">Jörg  Pietruszka</span>, <span class="hlFld-ContribAuthor ">Roderick  Süßmuth</span>, <span class="hlFld-ContribAuthor ">Michael  Müller</span>, <span class="hlFld-ContribAuthor ">Elmar  Weinhold</span>, <span class="hlFld-ContribAuthor ">Andres  Jäschke</span>, <span class="hlFld-ContribAuthor ">Markus  Albrecht</span>, <span class="hlFld-ContribAuthor ">Henning  Priepke</span>, <span class="hlFld-ContribAuthor ">Gerhard  Roth</span>, <span class="hlFld-ContribAuthor ">Klaus  Ditrich</span>, <span class="hlFld-ContribAuthor ">Alexander  Ernst</span>, <span class="hlFld-ContribAuthor ">Lars  Wortmann</span>, <span class="hlFld-ContribAuthor ">Schering  Ag</span>. </span><span class="cited-content_cbyCitation_article-title">Organische Chemie 2002. </span><span class="cited-content_cbyCitation_journal-name">Nachrichten aus der Chemie</span><span> <strong>2003,</strong> <em>51 </em>
                                    (3)
                                     , 286-315. <a href="https://doi.org/10.1002/nadc.20030510309" title="DOI URL">https://doi.org/10.1002/nadc.20030510309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/nadc.20030510309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fnadc.20030510309%26sid%3Dliteratum%253Aachs%26jtitle%3DNachrichten%2520aus%2520der%2520Chemie%26atitle%3DOrganische%252BChemie%252B2002%26aulast%3DW%25C3%25BCrthner%26aufirst%3DFrank%26date%3D2003%26date%3D2010%26volume%3D51%26issue%3D3%26spage%3D286%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew D  Westwell</span>. </span><span class="cited-content_cbyCitation_article-title">Monitor: molecules and profiles. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2002,</strong> <em>7 </em>
                                    (22)
                                     , 1144-1146. <a href="https://doi.org/10.1016/S1359-6446(02)02496-0" title="DOI URL">https://doi.org/10.1016/S1359-6446(02)02496-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1359-6446(02)02496-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1359-6446%2802%2902496-0%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DMonitor%25253A%252Bmolecules%252Band%252Bprofiles%26aulast%3DWestwell%26aufirst%3DAndrew%2BD%26date%3D2002%26volume%3D7%26issue%3D22%26spage%3D1144%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Known class of PDGFR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00001.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Boc-piperazine, K<sub>2</sub>CO<sub>3</sub>, DMF, 65 °C, 6 h. (b) 4 N HCl/dioxane. (c) Method A:  R-PhNCO, CH<sub>2</sub>Cl<sub>2</sub> or DMF; method B:  (i) R-NH<sub>2</sub>, DSC, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (ii) Compound <b>2</b>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; method C:  (i) R-PhNH<sub>2</sub>, triphosgene, Et<sub>3</sub>N, CH<sub>3</sub>CN; (ii) Compound <b>2</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN; method D:  (i) R-PhNH<sub>2</sub>, 4-NO<sub>2</sub>Ph-OCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (ii) Compound <b>2</b>, heat.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00002.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) HCONH<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, 140 °C, o/n. (b) 2-Methoxy ethanol, NaH, DMF, 90 °C. (c) POCl<sub>3</sub>, 110 °C. (d) Piperazine, <i>i</i>PrOH, reflux, 2 h. (e) See Scheme 1 urea formation.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00003.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) 1-(2-Chloroethyl)piperidine or 1-(2-chloroethyl)morpholine, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 6 h. (b) 2-Methoxy ethanol, NaH, DMF, 90 °C. (c) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, AcOH, −5 °C to room temperature. (d) 10% Pd/C. (e) HCONH<sub>2</sub>, HCO<sub>2</sub>NH, reflux, 12 h. (f) SOCl<sub>2</sub>, catalytic DMF, 60 °C. (g) Boc-piperazine, isopropanol, reflux. (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>. (i) See Scheme 1 urea formation.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00004" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00004.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Methoxyethoxy bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 6 h. (b) 2-Piperidin-1-yl-ethanol or 2-morpholin-1-yl ethanol or 2-pyrrolin-1-yl ethanol, NaH, DMF, 90 °C. (c) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, AcOH, −5 °C to room temperature. (d) 10% Pd/C. (e) HCONH<sub>2</sub>, HCO<sub>2</sub>NH, reflux, 12 h. (f) SOCl<sub>2</sub>, catalytic DMF, 60 °C. (g) Boc-piperazine, isopropanol, reflux. (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>. (i) See Scheme 1 urea formation. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00005" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00005.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, room temperature. (b) HNO<sub>3</sub>, AcOH, 0−100 °C, o/n. (c) SnCl<sub>2</sub>, 2H<sub>2</sub>O, EtOAc, 50 °C, o/n. (d) HCONH<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, 145 °C, 12 h. (e) SOCl<sub>2</sub>, catalytic DMF, toluene, reflux. (f) Boc-piperazine, DIEA, THF, 40 °C, o/n. (g) Pd(OH)<sub>2</sub>/C, EtOH, 50 psi H<sub>2</sub>, o/n. (h) Chloroethyl tosylate for <i>n</i> = 0 and chloropropyl tosylate for <i>n</i> = 1, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, o/n. (i) R1 = basic moiety such as piperidine etc., DMF, 80 °C. (j) 4 N HCl, dioxane. (k) Substituted anilines; methods A−D as in Scheme 1. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00006" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00006.jpeg" id="rightTab-_i17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) For <i>n</i> = 0, chloroethyl tosylate or for <i>n</i> = 1, 1-bromo-3-chloropropane, K<sub>2</sub>CO<sub>3</sub>, DMF, reflux. (b) HNO<sub>3</sub>, AcOH, 0−20 °C. (c) R<sub>1</sub> = basic substituent, K<sub>2</sub>CO<sub>3</sub>, <i>n</i>Bu<sub>4</sub>NBr, toluene, 90 °C. (d) 10% Pd/C, HCO<sub>2</sub>K, EtOH, H<sub>2</sub>O. (e) HCONH<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, 135 °C, 12 h. (f) SOCl<sub>2</sub>, catalytic DMF, toluene, reflux. (g) K<sub>2</sub>CO<sub>3</sub>, DMF, toluene, 45 °C, 8 h. (h) EtOH, AcCl. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rh00007" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rh00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00007.jpeg" id="rightTab-_i19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Chloropropyl tosylate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, o/n. (b) R<sub>1</sub>SH, NaH, or KHMDS, THF, room temperature. (c) <i>m</i>CPBA, DCM, room temperature. (d) 4 N HCl, dioxane. (e) DSC, Et<sub>3</sub>N, DCM.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rh00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rh00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rf00002" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00002.jpeg" id="rightTab-_i22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 EGFR tyrosine kinase inhibitors in clinic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rf00003" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00003.jpeg" id="rightTab-_i31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Semilogarithmic plots of dose-normalized plasma concentration−time profiles of selected analogues following oral administration to Lewis rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rf00004" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00004.jpeg" id="rightTab-_i32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Semilogarithmic plots of mean (±SD) plasma concentration−time profiles of <b>75</b> (CT53518) following an oral administration to Cynomolgus monkeys (5 mg/kg) and Beagle dogs (7.5 mg/kg). </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm020143rf00005" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/medium/jm020143rf00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00005.jpeg" id="rightTab-_i34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Improved survival in mouse CMML model with oral administration of <b>75 </b>(CT53518).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-17/jm020143r/production/images/large/jm020143rf00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm020143r&amp;id=jm020143rf00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004501703793" id="jm004501703793"></a></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm020143rb00001"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00001_1"><span><span class="NLM_string-ref">Schlessinger, J.; Ullrich, A. growth factor Signaling by receptor tyrosine kinases. <i>  Neuron</i><b>1992</b>, <i>9</i>, 383−391.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1992&pages=391&author=J.+Schlessinger&author=A+Ullrich&title=growth+factor+Signaling+by+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3Dgrowth%2520factor%2520Signaling%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNeuron%26date%3D1992%26volume%3D9%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00002"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00002_1"><span><span class="NLM_string-ref">Claesson-Welsh, L. Platelet-derived growth factor receptor signals. <i>  J. Biol. </i><i>Chem</i>. <b>1994</b>, <i>269</i>, 32023−32026.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=32026&author=L+Claesson-Welsh&title=Platelet-derived+growth+factor+receptor+signals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClaesson-Welsh%26aufirst%3DL%26atitle%3DPlatelet-derived%2520growth%2520factor%2520receptor%2520signals%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D32026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00003"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00003_1"><span><span class="NLM_string-ref">Wilcox, J. N.; Smith, K. M.; Williams, L. T.; Schwartz, S. M.; Gordon, D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by insitu hybridization. <i>  J. Clin. Invest</i>. <b>1988</b>, <i>82</i>, 1134−1143.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1988&pages=1143&author=J.+N.+Wilcox&author=K.+M.+Smith&author=L.+T.+Williams&author=S.+M.+Schwartz&author=D+Gordon&title=Platelet-derived+growth+factor+mRNA+detection+in+human+atherosclerotic+plaques+by+insitu+hybridization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilcox%26aufirst%3DJ.%2BN.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520mRNA%2520detection%2520in%2520human%2520atherosclerotic%2520plaques%2520by%2520insitu%2520hybridization%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1988%26volume%3D82%26spage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00004"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00004_1"><span><span class="NLM_string-ref">Heldin, C. H.; Westermark, B. Platelet-derived growth factor:  mechanism of action and possible in vivo function. <i>  Cell Regul</i>. <b>1990</b>, <i>1</i>, 555−566.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1990&pages=566&author=C.+H.+Heldin&author=B+Westermark&title=Platelet-derived+growth+factor%3A%E2%80%89+mechanism+of+action+and+possible+in+vivo+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeldin%26aufirst%3DC.%2BH.%26atitle%3DPlatelet-derived%2520growth%2520factor%253A%25E2%2580%2589%2520mechanism%2520of%2520action%2520and%2520possible%2520in%2520vivo%2520function%26jtitle%3DCell%2520Regul.%26date%3D1990%26volume%3D1%26spage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00005"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00005_1"><span><span class="NLM_string-ref">Iida, H.; Seifert, R.; Alpers, C. E.; Gronwald, R. G.; Phillips, P. E.; Pritzl, P.; Gordon, K.; Gown, A. M.; Ross, R.; Bowen-Pope, D. F. Platelet-derived growth factor and PDGF receptor are induced in mesangial proliferative nephritis in the rat. <i>  Proc. Natl. Acad. Sci</i>. <i>U.S.A</i>. <b>1991</b>, <i>88</i>, 6560−6564.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=6564&author=H.+Iida&author=R.+Seifert&author=C.+E.+Alpers&author=R.+G.+Gronwald&author=P.+E.+Phillips&author=P.+Pritzl&author=K.+Gordon&author=A.+M.+Gown&author=R.+Ross&author=D.+F+Bowen-Pope&title=Platelet-derived+growth+factor+and+PDGF+receptor+are+induced+in+mesangial+proliferative+nephritis+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIida%26aufirst%3DH.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520and%2520PDGF%2520receptor%2520are%2520induced%2520in%2520mesangial%2520proliferative%2520nephritis%2520in%2520the%2520rat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D6564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00006"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00006_1"><span><span class="NLM_string-ref">Johnson, R. J.; Raines, E. W.; Floege, J.; Yoshimura, A.; Pritzl, P.; Alpers, C.; Ross, R. Inhibition of mesangial cell proliferation and matrix expansion in glumerulonephritis in the rat by antibody to platelet-derived growth factor<i>. </i><i>J. Exp. Med</i>. <b>1992</b>, <i>175</i>, 1413−1416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1992&pages=1416&author=R.+J.+Johnson&author=E.+W.+Raines&author=J.+Floege&author=A.+Yoshimura&author=P.+Pritzl&author=C.+Alpers&author=R+Ross&title=Inhibition+of+mesangial+cell+proliferation+and+matrix+expansion+in+glumerulonephritis+in+the+rat+by+antibody+to+platelet-derived+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520mesangial%2520cell%2520proliferation%2520and%2520matrix%2520expansion%2520in%2520glumerulonephritis%2520in%2520the%2520rat%2520by%2520antibody%2520to%2520platelet-derived%2520growth%2520factor%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1992%26volume%3D175%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00007"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00007_1"><span><span class="NLM_string-ref">Rice, A. B.; Moomaw, C. R.; Morgan, D. L.; Bonner, J. C. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. <i>  Am. J. Pathol</i>. <b>1999</b>, <i>155</i>, 213−221.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1999&pages=221&author=A.+B.+Rice&author=C.+R.+Moomaw&author=D.+L.+Morgan&author=J.+C+Bonner&title=Specific+inhibitors+of+platelet-derived+growth+factor+or+epidermal+growth+factor+receptor+tyrosine+kinase+reduce+pulmonary+fibrosis+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DA.%2BB.%26atitle%3DSpecific%2520inhibitors%2520of%2520platelet-derived%2520growth%2520factor%2520or%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520reduce%2520pulmonary%2520fibrosis%2520in%2520rats%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D155%26spage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00008"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00008_1"><span><span class="NLM_string-ref">Blume-Jensen, P.; Hunter, T. Oncogenic Kinase Signaling. <i>  Nature</i><b>2001</b>, <i>411</i>, 355−365.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=365&author=P.+Blume-Jensen&author=T+Hunter&title=Oncogenic+Kinase+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26atitle%3DOncogenic%2520Kinase%2520Signaling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00009"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00009_1"><span><span class="NLM_string-ref">Metcalfe, D. D.; Akin, C. Mastocytosis:  molecular mechanisms and clinical disease heterogeneity. <i>  Leuk. Res</i>. <b>2001</b>, <i>25</i>, 577−582.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=582&author=D.+D.+Metcalfe&author=C.+Akin&author=+Mastocytosis&title=molecular+mechanisms+and+clinical+disease+heterogeneity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalfe%26aufirst%3DD.%2BD.%26atitle%3Dmolecular%2520mechanisms%2520and%2520clinical%2520disease%2520heterogeneity%26jtitle%3DLeuk.%2520Res.%26date%3D2001%26volume%3D25%26spage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm020143rb00010_1"><span><span class="NLM_string-ref">Beghini, A.; Peterlongs, P.; Ripamonti, C. B. C-kit mutations in core binding factor leukemias. <i>  Blood</i><b>2000</b>, <i>95</i>, 726.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2000&pages=726&author=A.+Beghini&author=P.+Peterlongs&author=C.+B+Ripamonti&title=C-kit+mutations+in+core+binding+factor+leukemias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeghini%26aufirst%3DA.%26atitle%3DC-kit%2520mutations%2520in%2520core%2520binding%2520factor%2520leukemias%26jtitle%3DBlood%26date%3D2000%26volume%3D95%26spage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00011"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00011_1"><span><span class="NLM_string-ref">Hirota, S.; Isozaki, K.; Moriyama, Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. <i>  Science</i><b>1998</b>, <i>279</i>, 577−580.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=580&author=S.+Hirota&author=K.+Isozaki&author=Y+Moriyama&title=Gain-of-function+mutations+of+c-kit+in+human+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26atitle%3DGain-of-function%2520mutations%2520of%2520c-kit%2520in%2520human%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00012"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00012_1"><span><span class="NLM_string-ref">Yokota, S.; Kiyoi, H.; Nakao, M. Internal tandem duplication of the Flt3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. <i>  Leukemia</i><b>1997</b>, <i>11</i>, 1605−1609.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=1609&author=S.+Yokota&author=H.+Kiyoi&author=M+Nakao&title=Internal+tandem+duplication+of+the+Flt3+gene+is+preferentially+seen+in+acute+myeloid+leukemia+and+myelodysplastic+syndrome+among+various+hematological+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYokota%26aufirst%3DS.%26atitle%3DInternal%2520tandem%2520duplication%2520of%2520the%2520Flt3%2520gene%2520is%2520preferentially%2520seen%2520in%2520acute%2520myeloid%2520leukemia%2520and%2520myelodysplastic%2520syndrome%2520among%2520various%2520hematological%2520malignancies%26jtitle%3DLeukemia%26date%3D1997%26volume%3D11%26spage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00013"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00013_1"><span><span class="NLM_string-ref">Kiyoi, H.; Naoe, T.; Nakano, Y. Prognostic implication of Flt3 and N-RAS gene mutations in acute myeloid leukemia. <i>  Blood</i><b>1999</b>, <i>93</i>, 3074−3080.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=3080&author=H.+Kiyoi&author=T.+Naoe&author=Y+Nakano&title=Prognostic+implication+of+Flt3+and+N-RAS+gene+mutations+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyoi%26aufirst%3DH.%26atitle%3DPrognostic%2520implication%2520of%2520Flt3%2520and%2520N-RAS%2520gene%2520mutations%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D1999%26volume%3D93%26spage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00014"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00014_1"><span><span class="NLM_string-ref">Blume-Jensen, P.; Hunter, T. Oncogenic kinas signaling. <i>  Nature</i><b>2001</b>, <i>411</i>, 355−365.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=365&author=P.+Blume-Jensen&author=T+Hunter&title=Oncogenic+kinas+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26atitle%3DOncogenic%2520kinas%2520signaling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00015"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00015_1"><span><span class="NLM_string-ref">Golub, T. R.; Barker, G. F.; Lovett, M.; Gilliland, D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. <i>  Cell</i><b>1994</b>, <i>77</i>, 307−316.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1994&pages=316&author=T.+R.+Golub&author=G.+F.+Barker&author=M.+Lovett&author=D.+G+Gilliland&title=Fusion+of+PDGF+receptor+beta+to+a+novel+ets-like+gene%2C+tel%2C+in+chronic+myelomonocytic+leukemia+with+t%285%3B12%29+chromosomal+translocation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DFusion%2520of%2520PDGF%2520receptor%2520beta%2520to%2520a%2520novel%2520ets-like%2520gene%252C%2520tel%252C%2520in%2520chronic%2520myelomonocytic%2520leukemia%2520with%2520t%25285%253B12%2529%2520chromosomal%2520translocation%26jtitle%3DCell%26date%3D1994%26volume%3D77%26spage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00016"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00016_1"><span><span class="NLM_string-ref">Maguire, M. P.; Sheets, K. R.; McVety, K.; Spada, A. P.; Zilberstein, A. A new series of PDGF receptor tyrosine kinase inhibitors:  3-substituted quinoline derivatives. <i>  J. Med. Chem</i>. <b>1994</b>, <i>37</i>, 2129−2137.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2137&author=M.+P.+Maguire&author=K.+R.+Sheets&author=K.+McVety&author=A.+P.+Spada&author=A+Zilberstein&title=A+new+series+of+PDGF+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+3-substituted+quinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DM.%2BP.%26atitle%3DA%2520new%2520series%2520of%2520PDGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%25203-substituted%2520quinoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00017"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00017_1"><span><span class="NLM_string-ref">Kubo, K.; Shimizu, T.; Ohyama, S.; Murooka, H.; Nishitoba, T.; Kato, S.; Kobayashi, Y.; Yagi, M.; Isoe, T.; Nakamura, K.; Osawa, T.; Izawa, T. A novel series of 4-phenoxyquinoxazolines:  potent and highly selective inhibitors of PDGF receptor autophosphorylation. <i>  Bioorg. Med. Chem. </i><i>Lett</i>. <b>1997</b>, <i>7</i>, 2935−2940.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2940&author=K.+Kubo&author=T.+Shimizu&author=S.+Ohyama&author=H.+Murooka&author=T.+Nishitoba&author=S.+Kato&author=Y.+Kobayashi&author=M.+Yagi&author=T.+Isoe&author=K.+Nakamura&author=T.+Osawa&author=T+Izawa&title=A+novel+series+of+4-phenoxyquinoxazolines%3A%E2%80%89+potent+and+highly+selective+inhibitors+of+PDGF+receptor+autophosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26atitle%3DA%2520novel%2520series%2520of%25204-phenoxyquinoxazolines%253A%25E2%2580%2589%2520potent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520PDGF%2520receptor%2520autophosphorylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00018"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00018_1"><span><span class="NLM_string-ref">Buchdunger, E.; Zimmerman, J.; Mett, H.; Meyer, T.; Muller, M.; Lydon, N. B. Selective inhibition of PDGF signal transduction pathway bya PTK inhibitor of the 2-phenylaminopyrimidine class. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>1995</b>, <i>92</i>, 2558−2562.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=2562&author=E.+Buchdunger&author=J.+Zimmerman&author=H.+Mett&author=T.+Meyer&author=M.+Muller&author=N.+B+Lydon&title=Selective+inhibition+of+PDGF+signal+transduction+pathway+bya+PTK+inhibitor+of+the+2-phenylaminopyrimidine+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuchdunger%26aufirst%3DE.%26atitle%3DSelective%2520inhibition%2520of%2520PDGF%2520signal%2520transduction%2520pathway%2520bya%2520PTK%2520inhibitor%2520of%2520the%25202-phenylaminopyrimidine%2520class%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D2562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00019"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00019_1"><span><span class="NLM_string-ref">Giese, N. A.; Lokker, N.; Laibelman, A. M.; Scarborough, R. M. U.S. Patent No. 5,916,908, June 29, 1999; <i>  Chem Abstr</i>. <b>1999</b>, <i>131</i>, 58819.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Giese%2C+N.+A.%3B+Lokker%2C+N.%3B+Laibelman%2C+A.+M.%3B+Scarborough%2C+R.+M.+U.S.+Patent+No.+5%2C916%2C908%2C+June+29%2C+1999%3B+Chem+Abstr.+1999%2C+131%2C+58819.+Giese%2C+N.+A.%3B+Lokker%2C+N.%3B+Laibelman%2C+A.+M.%3B+Scarborough%2C+R.+M.+U.S.+Patent+No.+5%2C916%2C908%2C+June+29%2C+1999%3B+Chem+Abstr.+1999%2C+131%2C+58819."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiese%26aufirst%3DN.%2BA.%26jtitle%3DChem%2520Abstr.%26date%3D1999%26volume%3D131%26spage%3D58819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm020143rb00020_1"><span><span class="NLM_string-ref">Palmer, B. D.; Kraher, A. J.; Hartl, B. G.; Panapoulos, A. D.; Panek, R. L.; Batley, B. L.; Lu, G. H.; Trumpp-Kallmeyer, S.; Showalter, H. D. H.; Denny, W. A. Structure activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 2373−2382.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2382&author=B.+D.+Palmer&author=A.+J.+Kraher&author=B.+G.+Hartl&author=A.+D.+Panapoulos&author=R.+L.+Panek&author=B.+L.+Batley&author=G.+H.+Lu&author=S.+Trumpp-Kallmeyer&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Structure+activity+relationships+for+5-substituted+1-phenylbenzimidazoles+as+selective+inhibitors+of+the+platelet-derived+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DStructure%2520activity%2520relationships%2520for%25205-substituted%25201-phenylbenzimidazoles%2520as%2520selective%2520inhibitors%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00021"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00021_1"><span><span class="NLM_string-ref">Yu, J.-C.; Lokker, N. A.; Hollenbach, S.; Apatira, M.; Li, J.; Betz, A.; Sedlock, D.; Oda, S.; Nomoto, Y.; Matsuno, K.; Ide, S.-I.; Tsukuda, E.; Giese, N. A. Efficacy of the Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on cellular proliferation, Migration, and Suppression of Neointima following Vascular Injury. <i>  J. Pharmacol. </i><i>Exp. Ther</i>. <b>2001</b>, <i>298</i>, 1172−1178. (b) Giese, N. A.; Lokker, N. A.; Yu, J.-C.; Matsuno, K.; Ichimura, M.; Oda, S.; Scarborough, R. M.; Pandey, A. Development of antagonists of the platelet-derived growth factor receptor family. <i>Oncol. Spectrums</i><b>2001</b>, <i>2</i>, 550−556.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2001&pages=1178&author=J.-C.+Yu&author=N.+A.+Lokker&author=S.+Hollenbach&author=M.+Apatira&author=J.+Li&author=A.+Betz&author=D.+Sedlock&author=S.+Oda&author=Y.+Nomoto&author=K.+Matsuno&author=S.-I.+Ide&author=E.+Tsukuda&author=N.+A+Giese&title=Efficacy+of+the+Novel+Selective+Platelet-Derived+Growth+Factor+Receptor+Antagonist+CT52923+on+cellular+proliferation%2C+Migration%2C+and+Suppression+of+Neointima+following+Vascular+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.-C.%26atitle%3DEfficacy%2520of%2520the%2520Novel%2520Selective%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor%2520Antagonist%2520CT52923%2520on%2520cellular%2520proliferation%252C%2520Migration%252C%2520and%2520Suppression%2520of%2520Neointima%2520following%2520Vascular%2520Injury%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D298%26spage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00022"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00022_1"><span><span class="NLM_string-ref">Matsuno, K.; Nakajima, T.; Tahara, K.; Shigeki, F.; Ichimura, M.; Giese, N. A.; Yu, J.-C.; Iie, J.; Tsukuda, E.; Ide, S.; Oda, S.; Nomoto, Y. <i>  Selective </i><i>inhibitors of PDGF receptor phosphorylation:  synthesis, structure</i><i>−</i><i>activity </i><i>relationships and biological effects</i>, 217th ACS National Meeting, Anaheim, CA, 1999; Abstr. No. 061. (b) Matsuno, K.; Ichimura, M.; Nakajima, T.; Tahara, K.; Fujiwara, S.; Kase, H.; Giese, N. A.; Pandey, A.; Scarborough, R. M.; Yu, J.-C.; Lokker, N. A.; Irie, J.; Tsukuda, E.; Oda, S.; Nomoto, Y. Potent and selective inhibitors of PDGF receptor phosphorylation. 1. Synthesis and structure−activity relationship of a new class of quinazoline derivatives. <i>J. Med. Chem.</i><b>2002</b>, <i>45</i>, 3057−3066.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&conference=217th+ACS+National+Meeting&author=K.+Matsuno&author=T.+Nakajima&author=K.+Tahara&author=F.+Shigeki&author=M.+Ichimura&author=N.+A.+Giese&author=J.-C.+Yu&author=J.+Iie&author=E.+Tsukuda&author=S.+Ide&author=S.+Oda&author=Y.+Nomoto&title=Selective+inhibitors+of+PDGF+receptor+phosphorylation%3A%E2%80%89+synthesis%2C+structure%E2%88%92activity+relationships+and+biological+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuno%26aufirst%3DK.%26atitle%3DSelective%2520inhibitors%2520of%2520PDGF%2520receptor%2520phosphorylation%253A%25E2%2580%2589%2520synthesis%252C%2520structure%25E2%2588%2592activity%2520relationships%2520and%2520biological%2520effects%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00023"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00023_1"><span><span class="NLM_string-ref">Cronin, T. H.; Hess, H.-J. E. South African Patent Appl. No. 676512, Oct 31, 1967; <i>  Chem. Abstr</i>. <b>1969</b>, <i>70</i>, 68419.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1969&pages=68419&author=T.+H.+Cronin&author=H.-J.+E+Hess&title=South+African+Patent+Appl.+No.+676512%2C+Oct+31%2C+1967%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCronin%26aufirst%3DT.%2BH.%26atitle%3DSouth%2520African%2520Patent%2520Appl.%2520No.%2520676512%252C%2520Oct%252031%252C%25201967%253B%26jtitle%3DChem.%2520Abstr.%26date%3D1969%26volume%3D70%26spage%3D68419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00024"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00024_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Bridges, A. J.; Showalter, H. D.; Sun, L. Tyrosine Kinase Inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 918−928.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=928&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+J.+Bridges&author=H.+D.+Showalter&author=L+Sun&title=Tyrosine+Kinase+Inhibitors.+9.+Synthesis+and+evaluation+of+fused+tricyclic+quinazoline+analogues+as+ATP+site+inhibitors+of+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%25209.%2520Synthesis%2520and%2520evaluation%2520of%2520fused%2520tricyclic%2520quinazoline%2520analogues%2520as%2520ATP%2520site%2520inhibitors%2520of%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00025"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00025_1"><span><span class="NLM_string-ref">Woodburn, J. R. The epidermal growth factor receptor and its inhibition in cancer therapy. <i>  Pharmacol. Ther</i>. <b>1999</b>, <i>82</i>, 241−250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=250&author=J.+R+Woodburn&title=The+epidermal+growth+factor+receptor+and+its+inhibition+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR%26atitle%3DThe%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520its%2520inhibition%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00026"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00026_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent, P. W.; Patmore, S. J. Tyrosine Kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+Kinase+inhibitors.+15.+4-%28Phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520Kinase%2520inhibitors.%252015.%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00027"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00027_1"><span><span class="NLM_string-ref">Moyer, J. D.; Barbacci, E. G.; Iwata, K. K.; Arnold, L.; Boman, B.; Cunningham, A.; DiOrio, C.; Doty, J.; Morin, M. J.; Moyer, M. P.; Neveu, M.; Pllack, V. A.; Reynolds, M. M.; Sloan, D.; Theleman, A.; Miller, P. Induction of apoptosis and cell cycle arrest by CP-358,774, an epidermal growth factor receptor tyrosine kinase. <i>  Cancer Res</i>. <b>1997</b>, <i>57</i>, 4838−4848.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4848&author=J.+D.+Moyer&author=E.+G.+Barbacci&author=K.+K.+Iwata&author=L.+Arnold&author=B.+Boman&author=A.+Cunningham&author=C.+DiOrio&author=J.+Doty&author=M.+J.+Morin&author=M.+P.+Moyer&author=M.+Neveu&author=V.+A.+Pllack&author=M.+M.+Reynolds&author=D.+Sloan&author=A.+Theleman&author=P+Miller&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+CP-358%2C774%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520CP-358%252C774%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00028"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00028_1"><span><span class="NLM_string-ref">Woodburn, J. R.; Barker, A. J.; Gibson, K. H.; Ashton, S. E.; Wakeling, A. E. ZD1839, an epidermal growth factor tyrosine kinase inhibitor selected for clinical development. <i>  Proc. Am. Assoc. Cancer Res</i>. <b>1997</b>, <i>38</i>, 6333.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=6333&author=J.+R.+Woodburn&author=A.+J.+Barker&author=K.+H.+Gibson&author=S.+E.+Ashton&author=A.+E.+Wakeling&title=an+epidermal+growth+factor+tyrosine+kinase+inhibitor+selected+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26atitle%3Dan%2520epidermal%2520growth%2520factor%2520tyrosine%2520kinase%2520inhibitor%2520selected%2520for%2520clinical%2520development%26jtitle%3DProc.%2520Am.%2520Assoc.%2520Cancer%2520Res.%26date%3D1997%26volume%3D38%26spage%3D6333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00029"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00029_1"><span><span class="NLM_string-ref">Traxler, P. Preclinical profile of PKI166:  anovel and potent EGFR tyrosine kinase inhibitor for clinical development. <i>  Clin. Cancer Res</i>. <b>1999</b>, <i>5</i>, 3750S.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=3750S&author=P+Traxler&title=Preclinical+profile+of+PKI166%3A%E2%80%89+anovel+and+potent+EGFR+tyrosine+kinase+inhibitor+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DPreclinical%2520profile%2520of%2520PKI166%253A%25E2%2580%2589%2520anovel%2520and%2520potent%2520EGFR%2520tyrosine%2520kinase%2520inhibitor%2520for%2520clinical%2520development%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D3750S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm020143rb00030_1"><span><span class="NLM_string-ref">Lokker, N. A.; O'Hare, J. P.; Barsoumian, A.; Tomlinson, J. E.; Ramakrishnan, V.; Fretto, L. J.; Giese, N. A. Functional importance of the platelet-derived growth factor receptor extracellular immunoglobin-like domains:  Identification of PDGF binding site and neutralizing monoclonal antibodies. <i>  J. Biol. Chem</i>. <b>1997</b>, <i>272</i>, 33037−33044.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=33044&author=N.+A.+Lokker&author=J.+P.+O%27Hare&author=A.+Barsoumian&author=J.+E.+Tomlinson&author=V.+Ramakrishnan&author=L.+J.+Fretto&author=N.+A+Giese&title=Functional+importance+of+the+platelet-derived+growth+factor+receptor+extracellular+immunoglobin-like+domains%3A%E2%80%89+Identification+of+PDGF+binding+site+and+neutralizing+monoclonal+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLokker%26aufirst%3DN.%2BA.%26atitle%3DFunctional%2520importance%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520extracellular%2520immunoglobin-like%2520domains%253A%25E2%2580%2589%2520Identification%2520of%2520PDGF%2520binding%2520site%2520and%2520neutralizing%2520monoclonal%2520antibodies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D33044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00031"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00031_1"><span><span class="NLM_string-ref">Bridges, A. J. Current progress towards the development of tyrosine kinase inhibitors as anticancer agents. <i>  Emerging Drugs</i><b>1998</b>, <i>3</i>, 279−292.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=292&author=A.+J+Bridges&title=Current+progress+towards+the+development+of+tyrosine+kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ%26atitle%3DCurrent%2520progress%2520towards%2520the%2520development%2520of%2520tyrosine%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DEmerging%2520Drugs%26date%3D1998%26volume%3D3%26spage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00032"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00032_1"><span><span class="NLM_string-ref">Gibson, K. H.; Grundy, W.; Godfrey, A. A.; Wooburn, J. R.; Ashton, S. E.; Curry, B. J.; Scarlett, L.; Barker, A. J.; Brown, D. S. Epidermal Growth Factor Receptor Tyrosine Kinase:  Structureactivity Relationships and Antitumor Activity of Novel Quinazolines. <i>  Bioorg. Med. Chem. Lett</i>. <b>1997</b>, <i>7</i>, 2723−2728.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2728&author=K.+H.+Gibson&author=W.+Grundy&author=A.+A.+Godfrey&author=J.+R.+Wooburn&author=S.+E.+Ashton&author=B.+J.+Curry&author=L.+Scarlett&author=A.+J.+Barker&author=D.+S+Brown&title=Epidermal+Growth+Factor+Receptor+Tyrosine+Kinase%3A%E2%80%89+Structureactivity+Relationships+and+Antitumor+Activity+of+Novel+Quinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DK.%2BH.%26atitle%3DEpidermal%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%253A%25E2%2580%2589%2520Structureactivity%2520Relationships%2520and%2520Antitumor%2520Activity%2520of%2520Novel%2520Quinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00033"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00033_1"><span><span class="NLM_string-ref">Smaill, J. B.; Rewcastle, G. W.; Loo, J. A.; Greis, K. D.; Chan, H. O.; Reyner, E. L.; Lipka, E.; Showalter, H. D. H.; Vincent, P. W.; Elliott, W. L.; Denny, W. A. Tyrosine kinase inhibitors, 17:  Irreversible inhibitors of the epidermal growth factor receptor; 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 1380−1397.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1397&author=J.+B.+Smaill&author=G.+W.+Rewcastle&author=J.+A.+Loo&author=K.+D.+Greis&author=H.+O.+Chan&author=E.+L.+Reyner&author=E.+Lipka&author=H.+D.+H.+Showalter&author=P.+W.+Vincent&author=W.+L.+Elliott&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors%2C+17%3A%E2%80%89+Irreversible+inhibitors+of+the+epidermal+growth+factor+receptor%3B+4-%28Phenylamino%29quinazoline+and+4-%28Phenylamino%29pyrido%5B3%2C2-d%5Dpyrimidine-6-acrylamides+bearing+additional+solubilizing+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors%252C%252017%253A%25E2%2580%2589%2520Irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%253B%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528Phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2520bearing%2520additional%2520solubilizing%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00034"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00034_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stoker, E. S. E.; Ple, P. A.; Lohmann, J. J. M.; Ogilvie, D. J.; Duker, M.; Wedge, S. R.; Curwen, J. O.; Kendrew, J.; Lambert-vandder Brempt, C. Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 5369−5389.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5389&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stoker&author=P.+A.+Ple&author=J.+J.+M.+Lohmann&author=D.+J.+Ogilvie&author=M.+Duker&author=S.+R.+Wedge&author=J.+O.+Curwen&author=J.+Kendrew&author=+Lambert&title=Design+and+Structure%E2%88%92Activity+Relationship+of+a+New+Class+of+Potent+VEGF+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520VEGF%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00035"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00035_1"><span><span class="NLM_string-ref">Carroll, M.; Ohno-Jones, S.; Tamura, S.; Buchdanger, E.; Zimmerman, J.; Lydon, N. B.; Gilliland, D. G.; Druker, B. J. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cell expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. <i>  Blood</i><b>1997</b>, <i>90</i>, 4947−4952.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=4952&author=M.+Carroll&author=S.+Ohno-Jones&author=S.+Tamura&author=E.+Buchdanger&author=J.+Zimmerman&author=N.+B.+Lydon&author=D.+G.+Gilliland&author=B.+J.+Druker&title=a+tyrosine+kinase+inhibitor%2C+inhibits+the+growth+of+cell+expressing+BCR-ABL%2C+TEL-ABL%2C+and+TEL-PDGFR+fusion+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DM.%26atitle%3Da%2520tyrosine%2520kinase%2520inhibitor%252C%2520inhibits%2520the%2520growth%2520of%2520cell%2520expressing%2520BCR-ABL%252C%2520TEL-ABL%252C%2520and%2520TEL-PDGFR%2520fusion%2520proteins%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D4952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00036"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00036_1"><span><span class="NLM_string-ref">Wilbanks, A. M.; Mahajan, S.; Frank, D. A.; Druker, B. J.; Gilliland, D. G.; Carroll, M. TEL/PDGFβR fusion protein activates STAT1 and STAT5:  a common mechanism for transformation by tyrosine kinase fusion proteins. <i>  Exp. Hematol</i>. <b>2000</b>, <i>28</i>, 584−593.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=593&author=A.+M.+Wilbanks&author=S.+Mahajan&author=D.+A.+Frank&author=B.+J.+Druker&author=D.+G.+Gilliland&author=M.+Carroll&author=R+F%CE%B2&title=fusion+protein+activates+STAT1+and+STAT5%3A%E2%80%89+a+common+mechanism+for+transformation+by+tyrosine+kinase+fusion+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilbanks%26aufirst%3DA.%2BM.%26atitle%3Dfusion%2520protein%2520activates%2520STAT1%2520and%2520STAT5%253A%25E2%2580%2589%2520a%2520common%2520mechanism%2520for%2520transformation%2520by%2520tyrosine%2520kinase%2520fusion%2520proteins%26jtitle%3DExp.%2520Hematol.%26date%3D2000%26volume%3D28%26spage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00037"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00037_1"><span><span class="NLM_string-ref">Kelly, L. M.; Yu, J.-C.; Boulton, C. L.; Apatira, M.; Li, J.; Sullivan, C. M.; Williams, I.; Amaral, S. M.; Curley, D. P.; Duclos, N.; Neuberg, D.; Scarborough, R. M.; Pandey, A.; Hollenbach, S.; Abe, K.; Lokker, N. A.; Ailliland, D. G.; Giese, N. A. CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). <i>  Cancer Cell</i>. <b>2002</b>, <i>1</i>, 421−432.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=432&author=L.+M.+Kelly&author=J.-C.+Yu&author=C.+L.+Boulton&author=M.+Apatira&author=J.+Li&author=C.+M.+Sullivan&author=I.+Williams&author=S.+M.+Amaral&author=D.+P.+Curley&author=N.+Duclos&author=D.+Neuberg&author=R.+M.+Scarborough&author=A.+Pandey&author=S.+Hollenbach&author=K.+Abe&author=N.+A.+Lokker&author=D.+G.+Ailliland&author=N.+A.+Giese&title=a+novel+selective+FLT3+antagonist+for+the+treatment+of+acute+myelogenous+leukemia+%28AML%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DL.%2BM.%26atitle%3Da%2520novel%2520selective%2520FLT3%2520antagonist%2520for%2520the%2520treatment%2520of%2520acute%2520myelogenous%2520leukemia%2520%2528AML%2529%26jtitle%3DCancer%2520Cell.%26date%3D2002%26volume%3D1%26spage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00038"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00038_1"><span><span class="NLM_string-ref">Druker, B. J.; Talpaz, M.; Resta, D. J. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. <i>  N. </i><i>Engl. J. Med</i>. <b>2001</b>, <i>344</i>, 1031−1037.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1037&author=B.+J.+Druker&author=M.+Talpaz&author=D.+J+Resta&title=Efficacy+and+safety+of+a+specific+inhibitor+of+the+BCR-ABL+tyrosine+kinase+in+chronic+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520a%2520specific%2520inhibitor%2520of%2520the%2520BCR-ABL%2520tyrosine%2520kinase%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm020143rb00039"><div class="reference"><strong class="refLabel"><a href="#jm020143rb00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm020143rb00039_1"><span><span class="NLM_string-ref">Schindler, T.; Bornmann, W.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J. Structural mechanism for STI571 inhibition of abelson tyrosine kinase. <i>  Science</i><b>2000</b>, <i>289</i>, 1938−1942.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1942&author=T.+Schindler&author=W.+Bornmann&author=P.+Pellicena&author=W.+T.+Miller&author=B.+Clarkson&author=J+Kuriyan&title=Structural+mechanism+for+STI571+inhibition+of+abelson+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm020143rb00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26atitle%3DStructural%2520mechanism%2520for%2520STI571%2520inhibition%2520of%2520abelson%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm020143r&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2002.45.issue-17%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm020143r%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm020143r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                282KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aa240ee6524c7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
